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ABSTRACT

Proteases are essential for regulating a wide range of physiological and pathological
processes. The imbalance of protease activation and inhibition will result in a number of major
diseases including cancers, atherosclerosis, and neurodegenerative diseases. Although
fluorescence resonance energy transfer (FRET)-based protease probes, a small molecular dye
and other methods are powerful, they still have drawbacks or limitations for providing significant
information about the dynamics and pattern of endogenous protease activation and inhibition in a
single living cell or in vivo. Currently protease sensors capable of quantitatively measuring
specific protease activity in real time and monitoring activation and inhibition of enzymatic
activity in various cellular compartments are highly desired. In this dissertation, we report a
novel strategy to create protease sensors by grafting an enzymatic cleavage linker into a sensitive
location for changing chromophore properties of enhanced green fluorescent protein (EGFP)
following protease cleavage, which can be used to determine protease activity and track protease

activation and inhibition with a ratiometric measurement mode in living cells. Our designed
protease sensors exhibit large relative ratiometric optical signal change in both absorbance and
fluorescence, and fast response to proteases. Meanwhile, these protease sensors exhibiting high
enzymatic selectivity and kinetic responses are comparable or better than current small peptide
probes and FRET-based protease probes. Additionally, our protease sensors can be utilized for
real-time monitoring of cellular enzymogen activation and effects of inhibitors in living cells.
This novel strategy opens a new avenue for developing specific protease sensors to investigate
enzymatic activity in real time, to probe disease mechanisms corresponding to proteases in vitro
and in vivo, and to screen protease inhibitors with therapeutic effects. Strong fluorescence was
still retained in the cleaved EGFP-based protease sensors, which stimulated us to identify the
EGFP fragment with fluorescence properties for further understanding chromophore formation
mechanisms

and

investigating

protein-protein

interactions

through

fluorescence

complementation of split EGFP fragments. Through fusing EF-hand motifs from calbindin D9k
to split EGFP fragments, a novel molecular probe was developed to simultaneously track the
calcium change or calcium signaling pathways and calcium-dependent protein-protein
interaction in living cells in real time.

INDEX WORDS: Protease sensor, Ratiometeric measurement, EGFP, Calcium-dependent,
Protein-protein interactions, Fluorescence complementation
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Chapter 1

Background of monitoring intracellular processes related to protease
activity and calcium signaling in living cells

1. 1

Intracellular processes
Cells are the basic compositions of human body, which is involved in many pivotal

biological processes including calcium homeostasis, calcium signaling, protease generation,
activation, regulation and inhibition, and complicated cross-talks between proteins and signal
pathways (Radosevic, de Grooth et al. 1995; Kruger, Albrecht et al. 2000; Putney and Ribeiro
2000; Chakraborti, Das et al. 2007). All of these intracellular processes have direct or indirect
contributions on the different levels of cellular functions, ranging from genome sequence to
transcriptional and translational profiles (Chin, Cade et al. 1987; Peiretti, Alessi et al. 1997;
Dijkmans, van Hooijdonk et al. 2008). Many diseases, such as acute or chronic pancreatic
diseases, cardiovascular diseases, neurodegenerative diseases and cancers, can be attributed to
the misfunction of these intracellular processes (Basu, Castle et al. 2006; Leger, Covic et al.
2006; Chakraborti, Das et al. 2007). A large number of components in the cellular processes,
their strong regulatory coupling, the intricate stoichiometry, and the nonlinear nature of the
underlying mechanisms, are some of the key elements of cellular complexity that limit our
understanding of intracellular systems despite the large amount of information about the
elements of these systems. Although advances in genomic or proteomic technologies and
instrumentation have provided the tools to know more information for understanding of
intracellular processes and corresponding cellular functions (Afjehi-Sadat, Gruber-Olipitz et al.
2004; Chen, He et al. 2004; He, Rosen et al. 2007), direct, novel and effective methods to realtime monitor protease activation or inhibition and calcium-dependent protein-protein interactions
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in living cells are still highly desired. These methods will be greatly benefited for the
understanding of intracellular processes, which can be used to probe mechanisms of diseases
related to these intracellular processes and to develop treatment strategies for these diseases.

1. 2

Proteases

1.2.1 Protease functions
Proteases, also called proteolytic enzymes or proteinases, are a group of enzymes that
conduct catalysis for the breakdown of proteins through hydrolysis of peptide bonds. Proteases
can be found in many different cellular locations in all organisms and constitute approximately
2% of the genomes based on the bioinformatic analysis of mouse and human genomes (Puente,
Sanchez et al. 2003; Rawlings, Tolle et al. 2004). As enzymatic proteins, proteases are involved
in the control of basic biological processes and the regulation of cellular signaling in living cells,
tissues or organisms at a post-translational level (Coughlin 2000; Sakakihara, Fujii et al. 2001;
Camerer 2007; Traynelis and Trejo 2007). Therefore, proteases play pivotal regulatory roles in
both normal physiological development and pathological processes through the tight regulation
of protease activation and inhibition (Laxman, Hall et al. 2002; Buhling, Groneberg et al. 2006;
Nixon and Wood 2006; Lopez-Otin and Matrisian 2007). Protease signaling in living organisms
is accomplished through comprehensive behaviors, such as the generation and release of
proteases, availability of cofactors, presence of protease inhibitors, and activation or inactivation
of protease-activated receptors (PARs), which are the four-member family of G protein-coupled
receptors (Ossovskaya and Bunnett 2004). Under certain circumstances, proteases are not only
involved in protein degradation, but may also participate in activation, growth, cell division,
differentiation, migration, signaling and other cellular processes. Under normal physiological
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conditions, the control of proteolysis in an organism or tissue is achieved through the balance of
protease production, degradation and inactivation as a result of interactions with corresponding
endogenous inhibitors for maintaining normal tissue homeostasis (Hirota, Ohmuraya et al. 2006;
Nixon and Wood 2006). Alteration in protease expression and activity patterns are linked to a
plethora of human pathological processes, including arthritis, bacterial and viral infections,
osteoporosis, cardiovascular diseases, cancers, Alzheimer’s disease and other neurodegenerative
diseases (Puente, Sanchez et al. 2003; Ossovskaya and Bunnett 2004; Qiu, Owen et al. 2007;
Turk and Stoka 2007). Therefore, a detailed understanding of the temporal and spatial functions,
or activation and inhibition modes or pathways for a particular protease in a complex cellular
environment is of fundamental importance to our understanding of disease progression. The most
powerful and direct way to address these issues is to develop sensitive and effective methods that
allow for tracking the dynamic imaging of protease activity within a living cell or organism,
which will improve our ability to understand the role of proteases, physiological control
mechanisms of proteases and pathological modulation methods of imbalanced protease activities.
From this we anticipate the development of novel and effective treatments or drugs for proteaserelated diseases including pancreatic diseases, cardiovascular diseases, neurodegenerative
diseases and cancers. The efficiency of such new drugs or treatments, however, will depend on
our detailed understanding of protease activation or inhibition in living cells, which emphasizes
the importance of developing probes or sensors capable of monitoring the cellular protease
activity in real time.
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1.2.2 Significance of protease investigations
Due to the elegant balance between activation and inhibition of proteases under normal
physiological conditions, and the alteration involved in either initiation or progression of the
diseases, proteases are becoming important potential targets for medical intervention and for
studies aimed at revealing important physiological functions regulated by these important
enzymes. Several protease inhibitors are already available as drugs. For example, angiotensinconverting enzyme (ACE) inhibitors capable of successfully lowering blood pressure (Atkinson,
Brown et al. 1980; Staffileno 2005) and the recently-introduced human immunodeficiency virus
(HIV) protease inhibitors (Havlir and O'Marro 2004; Poveda, Briz et al. 2005; Temesgen and
Feinberg 2007) have attracted extensive attention. Although most inhibitors are available to
target ACE or the HIV protease, we still face problems to fight the diseases related to these
proteases because the complete human genome contains approximately 500 different members
belonging to various protease families with multiple activation and inhibition pathways and more
than 400 unknown human proteases (Korenberg, Chen et al. 1995; Robinson, Wu et al. 2000;
Southan 2000; Southan 2001; Rossi, Deveraux et al. 2004). These large gaps in our knowledge
suggest the potential for new discoveries related to protease involvement in disease processes,
their evaluation as drug targets, drug discovery, and the development of therapies for diseases
related to protease dys-regulation (Southan 2001). On the other hand, it is already known that a
single amino acid mutation in human proteases could result in hereditary or genetic diseases,
which also provides our new directions to investigate the mechanisms of diseases resulting from
the dysfunction of proteases (Dluhy 2002; Molinari, Meskanaite et al. 2003; Howes, Lerch et al.
2004; Kokame and Miyata 2004). Meanwhile, abnormal physiology and disease can also be
resulted from the dysfunction of a particular crucial protease or imbalance in the levels of natural
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activators and inhibitors of proteases due to either genetic disorder or environmental conditions
(Fujishima, Tochikubo et al. 1983; Ahn, Bae et al. 2007). Currently, many other protease
inhibitors are being developed to treat parasitic, fungal and viral infections; inflammatory,
immunological,

respiratory,

cardiovascular and neurodegenerative

disorders

including

Alzheimer's disease, and cancers (Elkin, Miao et al. 2000; Fear, Komarnytsky et al. 2007).
Human proteases have also been identified as important prognostic indicators of diseases, such
as kallikreins (e.g. prostate specific antigen), cathepsin B, and matrix metalloproteinases
(MMPs), which are promising diagnostics for prostate and breast cancers, respectively (Lah,
Cercek et al. 2000; Ayala, Tuxhorn et al. 2003; Stephan, Yousef et al. 2004; Talvensaari-Mattila
and Turpeenniemi-Hujanen 2005). Hence, protease sensors with high sensitivity and high
selectivity for specific proteases are highly desired to improve our ability to diagnose illness and
develop targeted drugs and/or therapies.
Moreover, some proteases are also responsible for generating and destroying receptor
agonists, and activating and inactivating receptors on the surface of cells, both of which are
critical to signal transduction (Ossovskaya and Bunnett 2004). Certain proteases generated from
the circulation, inflammatory cells, epithelial or neural tissues, or from other unspecified sources
can regulate cell behaviors through the cleavage of PARs. The cleavage performed within the
extracellular amino terminus of PARs has provided an exposed tethered ligand domain to bind to,
and activate PARs for initiating multiple signaling cascades (Bunnett 2006). Although the
activation of PARs through a cleavage-induced mode is an irreversible process, the termination
of protease activation receptor signaling can be successfully realized through receptor
desensitization, as seen with receptor phosphorylation and uncoupling from G proteins, or
downregulation such as receptor degradation by cell-surface and lysosomal proteases (Coughlin
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1999; Qualmann, Kessels et al. 2000; Trejo 2003; Stalheim, Ding et al. 2005). Meanwhile, since
protease signaling in tissues is also closely-related to the generation and release of proteases,
availability of cofactors, presence of protease inhibitors, and activation and inactivation of PARs,
tissue injury or damage can result in the generation of proteases and activation of proteaseactivated receptors (Marutsuka, Hatakeyama et al. 2005; Tsuboi, Naito et al. 2007). Therefore,
protease-activated receptors make pivotal contributions to physiological and pathological
responses due to tissue damage, homeostasis alteration and cell survival. Mimicking or
interfering with the protease activation receptor processes or pathways are two strategies that
have been attracted attention with respect to developing effective therapies for diseases. The
exacerbated cleavage of PARs and imbalance between activation and inactivation of PARs can
be successfully halted through selective protease inhibitors and PAR antagonists. Developing
selective agonists and antagonists can be used to probe functions of PARs and treat diseases, and
investigating proteases and PARs may lead to improve medicine and drug development, such as
small-molecule or mimic peptide inhibitors for targeting PARs (Leger, Covic et al. 2006). In
addition, understanding the role of protease and protease activation receptors in physiological
control mechanisms and pathological processes of human diseases will also be a major challenge
in the future. However, all of these investigations on protease activators or inhibitors, protease
activation receptor agonists or antagonists, are closely associated with protease activity in
organisms.

1.2.3 Protease classifications
Proteases are classified according to their catalytic mechanisms. Four mechanistic classes
have been recognized by the International Union of Biochemistry and Molecular Biology: serine
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proteases, cysteine proteases, aspartic acid proteases and metalloproteases. Their mechanisms are
demonstrated to cleave a peptide bond through creating an amino acid residue. Serine or cysteine
(peptidases) or a water molecule (aspartic acid proteases and metalloproteases) is used as a
nucleophilic to attack the peptide carbonyl group. One way to make a nucleophile is by a
catalytic triad, where a histidine residue is used to activate serine, cysteine or threonine as a
nucleophile. However, two additional classes of proteases, threonine and glutamic acid
proteases, were not described until 1995 and 2004, respectively (Hedstrom 2002; Hooper 2002;
Barrett, Rawlings et al. 2003).
Serine proteases play critical roles in many important functions in mammals, especially
in digestion and blood clotting system. The digestive enzymes include trypsin, chymotrypsin and
elastase, which are responsible for protein digestion. The common activated clotting factors are
thrombin, which are in charge of blood clotting. Caspases, cathepsins, calpains and papain are
the major members of the cysteine protease family. Aspartic acid proteases have two highlyconserved aspartate residues in the active site, and function with increased activity in acidic pH
conditions. The major members of this family are composed of HIV-1 protease, chymosin, renin,
cathepsin D, pepsin and plasmesin. Metalloproteases bind a metal ion such as Zn2+ in the active
site. The most widely-studied metalloproteases are digestive enzymes such as carboxypeptidases
A, carboxypeptides B and thermolysin. Metalloproteases are important in many aspects of
biology, ranging from cell proliferation, differentiation and remodeling of the extracellular
matrix to vascularization and cell migration. Currently, the matrix metalloproteases (MMPs)
have been attracted extensive attentions in the biomedical field due to their involvement of tumor
development (Chang and Werb 2001).
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1.2.4 Substrate specificity of proteases
The substrate specificity of an enzyme is determined by its capacity to form a stable
complex between the substrate and the enzyme with a particular ligand in both the ground state
and the transition state. Steric constraints, intermolecular forces, and hydrophobic effects
contribute to the stability of a given complex. Therefore, in order to improve the specificity
between the substrate and the enzyme, the catalytic site should be able to be flanked on one or
both sides by specificity subsites for accommodating the sidechain of a single amino acid
residue. Traditionally, substrate specificity mainly based on the primary sequence structure.
Secondary and tertiary structural information of the substrate specificity should be involved in.
Based on their specific accommodation, these sites are numbered from the catalytic site, S1...Sn
towards the N-terminus of the substrate, and S1'...Sn' towards the C-terminus. The residues they
accommodate are numbered P1...Pn, and P1'...Pn', respectively, as shown in Figure 1.1. However,
differences in the catalytic sites of the different proteases exhibit the various preferences of the
residue in their substrates.

1.2.5 Current methods for protease detection
Because many diseases, including inflammationary diseases, arteriosclerosis, cancers and
neurodegenerative diseases, have long been associated with altered proteolytic activity of
proteases or disruption in the balance and control between protease activation and inhibition, it is
highly-desirable to track protease signaling, protease activation and inhibition using very
sensitive and effective methods. Dynamic visualization of intracellular protease activity can
provide valuable information about their physiological roles and pathological processes.
Objective and quantitative noninvasive imaging of protease activity would represent a significant
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Figure 1. 1. Specificity diagram between enzyme and substrate.
The amino acid residues (Pn-Pn’) around the scissile bond in the substrate should have high
complementary with the subsites of the enzyme.
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advance towards rapid and dynamic screening as well as monitoring the effects of therapeutic
agents. The studies of protease actions, signaling and pathways in living systems are frequently
hindered by the lack of tools or probes capable of monitoring dynamic protease processes in
various cellular locations.
Currently, protease activity is determined by several methods in cells. Real-time
polymerase chain reaction (RT-PCR) (Gelmini, Tricarico et al. 2003; Peluffo, Young et al. 2005;
House, Catchpole et al. 2007) and Western blot (Kossakowska, Edwards et al. 1998; Persad, Liu
et al. 2004) were used to monitor the elevated gene expression, and protein expression of
proteases and protease inhibitors, respectively. Although RT-PCR and Western blot are sensitive
to assess the existence of proteases and their substrate products, limited information for
understanding the dynamic activity of proteases in cells or in vivo is still provided.
One of the most commonly-used and commercially-available substrates for protease
activity measurement is the application of chromogenic or fluorogenic peptide kits in cell lysate
assays (Goddard and Reymond 2004). These methods generally measure the actions of most
proteases in cell lysates using: chromophores conjugated to short peptides; peptide mimics
encompassing enzymatic cleavage sites (Talanian, Quinlan et al. 1997; Thornberry, Rano et al.
1997). The most common chromophores linked to short peptide fragments of 3-6 amino acids
that mimic the sequence encompassing the P1 to Pn cleavage sites (usually up to P3) are: pnitroaniline (pNA), 7-amino-4-methylcoumarin (AMC), 7-amino-4-trifluromethyl coumarin
(AFC), rhodamine or fluorescein isothiocyanate-labeled casein (FITC). Although newlydeveloped peptide probes are able to penetrate cells, these probes are not ideal for the continuous
dynamic imaging of enzyme actions due to limited lifetime, specificity and stability of these
protease substrates, resulting from a lack of defined structure in solution because of their short
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sequences. However, these short peptides usually degrade rapidly and can not be delivered into
specific sub-cellular locations. Moreover, determination of protease activity using the
chromophores conjugated with the mimic, small peptide dye is accomplished through the
elimination of quenching to emit the absorbance or fluorescence following protease cleavage of
the linker. This method is also hampered by poor specificity due to the difficulties in considering
the P’ region amino acid residues of the cleavage linker. On the other hand, the diagnosis of
diseases, such as chronic pancreatitis, are largely restricted to later stages of the illness due to
limitations inherent in the currently available peptide kits designed for the detection of trypsin
activity in cell lysate (DiMagno 1988; Lemaitre and D'Armiento 2006). Activation of
trypsinogen and chymotrypsinogen by caerulein was previously reported in pancreatic cancer
cells, MIA PaCa-2 via PAR1 and the PAR pathway using cell lysate assays (Yamaguchi, Kimura
et al. 1989; Halangk, Sturzebecher et al. 1997; Kruger, Lerch et al. 1998; Namkung, Han et al.
2004; Yamasaki, Takeyama et al. 2006).
Due to the limitations in real-time determination of protease activation and inhibition, a
powerful method using fluorescence resonance energy transfer (FRET) of fluorescent protein
pairs has been extensively investigated to track protease activity in vitro and in vivo. FRETbased protease probes are created using a GFP pair connected by a enzymatic cleavage linker
(Figure 1.2). The properties of fluorescent proteins that allow for cofactor-independent
chromophore formation and expression to provide the capability of monitoring numerous cellular
events in living cells or organisms via living cell imaging (Shimomura, Johnson et al. 1962;
Chalfie, Tu et al. 1994; Inouye and Tsuji 1994; Wang and Hazelrigg 1994; Chalfie 1995; Tsien
1998; Akemann, Raj et al. 2001; Shimomura 2005). Taking advantage of wild type GFP’s
resistance to the cleavage for proteases and denaturation, the cleavage of the peptide bond at the
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Figure 1. 2. The model of FRET-based protease sensor.
FRET-based protease sensors are mostly constructed by fluorescent protein pair (eg. cyan
fluorescent protein (CFP) and yellow fluorescent protein (YFP)) through the connection of a
cleavage linker for proteases. Once the cleavage linker is cleaved, the change of fluorescence
resonance energy transfer is used to monitor protease activity.
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connecting linker between GFP pair results in a change of fluorescence resonance energy
transfer. This method has been applied to track the activity of many proteases including trypsin
(Pollok and Heim 1999; Eggeling, Jager et al. 2005), caspase-3 (Xu, Gerard et al. 1998; Harpur,
Wouters et al. 2001; Luo, Yu et al. 2001), caspase-8 (Luo, Yu et al. 2003) and thrombin (Zhang
2004; Wang, Cao et al. 2005), and offers the advantage of being able to monitor the dynamic
processes of protease activation in vitro and targeting of specific locations in vivo. Although
FRET-based protease sensors can be used to track the protease activity in living organisms, this
strategy has still not been extended to practical applications, and no FRET-based protease
sensors are commercially-available. Additionally, the catalytic kinetic parameters (kcat, Km and
kcat/Km) of FRET-based protease sensors have not been extensively discussed in the literature.

1.2.6 Criteria for an ideal protease sensors
To design functional protease probes capable of monitoring dynamic protease activation
or inhibiton in living cells, several factors must be considered. First, the protease sensor must be
able to monitor the dynamics of enzymatic activity over the entire natural course of activation or
inhibition in intact living cells in real time. Also, the addition of signal peptide sequences can be
used to develop probes capable of targeting specific cellular compartments. Some currentlyavailable detection methods simply rely on passive diffusion of the probe through the membrane,
and permit only short snapshots of enzymatic actions without the capability of detecting
reactions at targeted cellular locations. Second, protease sensors should have high sensitivity and
exhibit a large dynamic change following protease actions. Ideally, the fluorescence emission or
excitation wavelength of the chromophore will be changed by the cleavage reaction and provide
a ratiometric measurement. Such a ratiometric change permits more precise quantitative
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measurement of enzymatic activity by normalizing the analytical response to account for
variations in sensor concentrations, fluorescence signal changes due to quenching by different
cellular factors and conditions, and instability associated with the instrumentation. A single
wavelength, by contrast, allows for less precise quantitative measurement. Third, the optical
signal change must rapidly respond to catalytic cleavage associated with an optimal kinetic
activity. Fourth, the designed protease sensor must have good selectivity for the enzymatic action
of interest.

1. 3

Calcium signaling
It is well known that Ca2+ is the most ubiquitous and pluripotent cellular signaling ion, as

the second messenger controlling a wide variety of physiological reactions such as muscle
contraction, cellular motility, metabolism, gene transcription, regulation of enzyme activity, ion
pump functions, cell proliferation and cell death (Berridge 1993; Clapham 1995; Simpson,
Challiss et al. 1995). Ca2+ plays the critical roles in pathological processes as the major causes of
many human diseases including osteoporosis, cardiovascular diseases, Alzheimer’s disease,
neurodegenerative diseases, and cancers (Matsuura 2006; Blair, Schlesinger et al. 2007; Capiod,
Shuba et al. 2007; Monteith, McAndrew et al. 2007; Yamamoto, Wajima et al. 2007). The
calcium signaling system is operated through highly conserved transporters and channels, or a
large number of calcium-sensitive effectors or calcium buffers to execute the movements across
biological membranes of calcium ions. The movements across biological membrane of calcium
ions are controlled by its ON and OFF mechanisms, which are often organized to produce brief
spikes and waves of calcium. The ON and OFF mechanisms are shown in Figure 1.3.
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Figure 1. 3. The ON and OFF mechansims and modulation of intracellular calcium levels.
Interacellualr calcium signaling was regulated by the ON and OFF modulation of calcium ions.
The ON mechanisms are dependent on calcium ion entry through channels in the plasma
membrane or calcium ion release through receptors. The OFF mechanisms remove calcium from
cytoplasm using pumps. The symbols + in red and – in blue demonstrate the activation and
inhibition processes, respectively. During calcium signaling, VOC (voltage-operated channel),
ROC (receptor-operated channel) and SOC (store-operated channel) are major calcium channels.
Phosphatidylinositol bisphosphate (PIP2) is a substrate of phospholipase (PLC) on the receptors
(R). Following the cleavage of PIP2, inositol 1,4,5-trisphosphate (IP3) is generated to bind the
IP3 receptors (IP3R) or ryanodine receptors (RyRs), which is modulated by their agnoists and
antagnoists. Calmodulin (CaM) and troponin C (TnC) are major Ca2+ sensors. Modified after
(Berridge, Lipp et al. 2000; Berridge, Bootman et al. 2003)
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1.3.1 Regulation of intracellular calcium
The alteration of intracellular calcium ion concentration ([Ca2+]i) can result in the
occurrence of calcium signaling through the activation of ion channels and the release of calcium
ions from intracellular stores due to stimulation or indirect signal transduction pathways like G
protein-coupled receptors (Brown and MacLeod 2001; Jorgensen, Teilmann et al. 2003). As
shown in Figure 1.3, [Ca2+]i increases can be generated from sources both within and outside the
cell: Ca2+ release from intracellular calcium stores and Ca2+ influx across the plasma-membrane.
The calcium levels outside cells are 10,000 times higher than free intracellular Ca2+ in the
cytosol (Artalejo and Garcia-Sancho 1988). However, free [Ca2+]i in the cytosol is the
physiologically active form of calcium, which is strictly regulated and maintained low level
(~100 nM) through the action of a number of calcium-binding proteins and ion exchange
mechanisms (Clapham 1995). Since Ca2+ signal transduction is based on rises in free cytosolic
Ca2+ concentration, Ca2+ efflux from the extracellular space or release from intracellular stores
are responsible for calcium signal transduction.
The endoplasmic reticulum (ER) is well known to be a major site for sequestered calcium
ions (Brostrom and Brostrom 1990). Recent studies indicate that the Golgi apparatus may also be
a calcium ion store (Pinton, Pozzan et al. 1998). The accumulation of calcium ions at
intracellular stores can be mediated in the following manners: calcium ion pumps, receptors,
calcium-binding protein or calcium buffers (Clapham 1995; Clapham 1995; Putney 1999).
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1.3.2 Major players to mediate intracellular calcium accumulation
Extracellular calcium ion channels: Three major extracellular calcium ion channels are
located in the plasma membrane of the cells to mediate the intracellular calcium accumulation
from high calcium ion concentration of extracelluar matrix.
Voltage-operated channels (VOCs): This is the family of calcium ion channels that are
responsible for the channel opening in response to membrane depolarization. This channel
family can selectively mediate the entry of calcium ions from extracellular matrix to result in
calcium signaling (Catterall 1998). Based on their kinetics and pharmacological properties, this
family of channels has several sub-types, L, N, P/Q, R and T types. Channel agonists or channel
blockers such as ionomycin for this channel family can modulate calcium signaling.
Receptor-operated channels (ROCs): This is the family of calcium ion channels that are
opened by the binding of specific agonists, usually neurotransmitters, such as glutamate (the
NMDA receptor) (Sucher, Lei et al. 1991) or ATP (Sela, Ram et al. 1991).
Store-operated channels (SOCs): This family of calcium ion channels exists in the plasma
membrane of many cells, which are opened by the emptying of internal stores (Parekh and
Putney 2005). However, the mechanism for mediating calcium signaling between the empty
stores and the membrane SOCs is still unclear. The calcium influx factor (CIF) or information
transfer through a direct protein-protein interaction has been proposed in the previous
investigation (Bolotina 2004).
Intracellular calcium ion channels: External calcium ions arriving at the cell plasma
membrane receptors initiate cell-signaling pathways to achieve the final result, increased
intracellular calcium concentration through receptor-mediated calcium ion channels. Three major
families of receptor-mediated intracellular channels responsible for releasing calcium ions from
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the internal store located in the endoplasmic reticulum/sarcoplasmic reticulum (ER/SR)
(Berridge 1993; Pozzan, Rizzuto et al. 1994).
Inositol 1,4,5-trisphosphate (IP3) receptors: IP3 receptors (IP3R) belong to the family of
receptor-mediated calcium ion channels, which perform energy-requiring transduction to activate
phospholipase C (PLC) and hydrolyze the lipid precursor phosphatidylinositol 4,5-biphosphate
(PIP2) to generate both diacylglycerol (DAG) and IP3. Following the binding between IP3 and its
receptors, stored calcium ions are mobilized to promote an influx of external calcium ions.
Meanwhile, IP3 also can be generated through the stimulation of G-protein-linked or tyrosine
kinase-linked receptors upon the actions of agonists (Michikawa, Miyawaki et al. 1996).
Ryanodine receptors (RyRs): Ryanodine also binds to its receptors and can initiate
calcium release by locking the calcium channel in an open configuration. Cyclic ADP ribose is a
putative second messenger for regulating the activity of RyRs (Galione and White 1994;
Bootman and Berridge 1995). RyR-induced calcium ion release can be activated by caffeine, and
RyR channels can be modulated by various associated proteins such as FK506 binding protein 12
(FKBP12). Originally described in muscle cells, these RyRs are also found in neurons and other
cell types (MacKrill 1999).
Calcium-binding proteins: A variety of calcium-binding proteins function either as
sensors to carry out the messenger role of calcium ions or as buffers to shape the cellular
response in cells. Both the cytoplasm and the lumen of the ER or sarcoplasmic reticulum (SR)
have proteins capable of buffering calcium ions (Baimbridge, Celio et al. 1992; Koster, Hartog et
al. 1995; Rakhilin, Olson et al. 2004). For example, the major intracellular mediator for calcium
ions is calmodulin (CaM). When calcium ions transfer to the cytosol, they are rapidly buffered
by proteins such as calbindin, calretinin, and parvalbumin.
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1.3.3 Calcium signaling and related diseases
Abnormalities or mutations in one of above-mentioned calcium-transporting channels,
receptors or proteins may lead to diseases associated with calcium. Recent investigations
elucidated the important role for calcium dysregulation in the pathogenesis of Alzheimer's
disease, because the dysregulation of calcium signaling can result in the disorder of the gating of
IP3 receptor and calcium-conducting channels (Missiaen, Robberecht et al. 2000; Green and
LaFerla 2008). Abnormal intracellular calcium ion concentration handled by SR is a critical
factor in the development of heart failure. Several mutations of RyRs have been reported in
patients with lethal cardiac arrhythmia (Yano 2008). In addition, alteration of calcium
homeostasis, disorder of calcium ion channels, and changes of calcium signaling pattern resulted
from extracellular stimuli, have a direct effect on ER calcium ion level and protein expression of
Bcl-2 family, which can remodel the expression of many cancer cells and mediate the cell
proliferation and cell death (Rizzuto, Pinton et al. 2003; Roderick and Cook 2008). The large
cytoplasmic domain of the RyR serves as a scaffold protein, which binds to calstabins [FK506binding proteins (FKBPs)], calmodulin, phosphodiesterase, kinases, phosphatases, and their
targeting proteins for modulating functions of calcium ion channels. Recent progresses have also
described the disease mechanisms associated with the dysregulation of RyR and channels (Zalk,
Lehnart et al. 2007).
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1. 4

Fluorescent proteins

1.4.1 Properties of green fluorescent proteins
GFP was first discovered and isolated from the jellyfish Aequorea victoria in 1961 as a
companion protein to aequorin (Shimomura, Johnson et al. 1962; Shimomura 2005) and
exhibited absorption or excitation peaks at 400 and 480 nm, and an emission peak at 510 nm
with a quantum yield of 0.72 when excited at 470 nm, after it was purified and crystallized
successfully (Morise, Shimomura et al. 1974; Prendergast and Mann 1978). GFP is a stable,
soluble, globular, monomeric protein with 238 amino acid residues with a molecular mass of 27
kDa (Prendergast and Mann 1978). This protein is composed of an 11-stranded anti-parallel βbarrel, a single central α-helix, which contains the chromophore in the β-barrel, and short helices
that cap the ends of the barrel (Figure 1.4) (Yang, Moss et al. 1996). Discovery of GFP has
opened a new era in biology, medicine, pharmaceuticals, drug discovery and material sciences
(Shimomura, Johnson et al. 1962; Akemann, Raj et al. 2001; Shimomura 2005). The
chromophore self-formation and GFP expression in the absence of any substrates or cofactors
make it possible to examine physiological, pathological change during cellular and organ
development (Inouye and Tsuji 1994; Sengupta, Colbert et al. 1994; Wang and Hazelrigg 1994;
Chalfie 1995; Tsien 1998; Tucker 2001; Wouters, Verveer et al. 2001; Zhang, Campbell et al.
2002). Therefore, GFP and its variants have been attracted extensive attention on studies such as
protein-protein interactions, spatial and temporal change of protein translocation and transport,
and proteolysis, as well as protein phosphorylation in intact cells (Tsien 1998; Ni, Heard et al.
1999; Periasamy and Day 1999; Zacharias, Baird et al. 2000; Belmont 2001; Toomre and
Manstein 2001; Wouters, Verveer et al. 2001; Periasamy, Elangovan et al. 2002; Zimmer 2002;
Lippincott-Schwartz and Patterson 2003; Fehr, Ehrhardt et al. 2004; Shimi, Koujin et al. 2004).
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Figure 1. 4. Schematic topology of the secondary structure of GFP.
GFP is composed of 11 β strands (green ribbon) and 3 helices (red cylinder) connected through
loops (purple line), which formed a compacted β-can structure. The chromophore of GFP is
located in the middle of β-can. The tripeptide chromophore (Ser65-Tyr66-Gly67) is highlighted
in blue cylinder.
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1.4.2 Chromophore formation of green fluorescent proteins
Due to the extensive applications of GFP, scientists are making their efforts to probe
chromophore formation mechanisms for accelerating chromophore maturation and developing
various fluorescent protein variants with characteristic optical properties, such as enhanced
fluorescence intensity, improved thermo-stability, or multiple colors. Therefore, a more powerful
fluorescent reporter or genetic probe capable of tracking a variety of intracellular dynamic events
in a non-invasive mode can be developed and extended through the modification of GFP.
Although GFP has attracted tremendous attention due to its potentially useful
characteristics, and the chromophore structure has been confirmed, rather little is known about
the detailed mechanisms of folding and chromophore formation of GFP in vitro and in vivo. The
mechanisms of chromophore formation are still not well understood. The chromophore of GFP
was first demonstrated to form through the cyclization of the tripeptide Ser65-Tyr66-Gly67
(Shimomura 1979; Perozzo, Ward et al. 1988; Cody, Prasher et al. 1993; Inouye and Tsuji 1994;
Inouye and Tsuji 1994) located inside of the β-barrel composed of 11 anti-parallel strands and a
single central α-helix. Short helices cap the ends of the barrel (Ormo, Cubitt et al. 1996; Yang,
Moss et al. 1996). The active chromophore in GFP is a tripeptide, which requires the presence of
oxygen to mature (Inouye and Tsuji 1994). The cylinder of GFP has a diameter of about 30 Å
and a length of about 40 Å (Yang, Moss et al. 1996). Physical and chemical studies of purified
GFP also indicated that several important characteristics are related to its specific structure.
Extensive hydrogen bond interactions within protein frame or between protein frame and water
molecules have significant effects on chromophore resulting in various folding status (Wood,
Barondeau et al. 2005). An enhanced green fluorescent protein (EGFP) was otained through a
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mutation S65T in GFP. Following this mutation, EGFP has improved fluorescence intensity and
thermo-sensitivity. Tsien proposed an autocatalytic mechanism accounting for spontaneous
chromophore formation in various GFP-expressing organisms (Heim, Prasher et al. 1994), which
suggested chromophore formation through autocatalytic cyclization and oxidation from residues
Thr65, Tyr66, Gly67 (Figure 1.5), consisting of an internal tripeptide motif that enables the
protein to emit fluorescence in the absence of a cofactor (Dopf and Horiagon 1996). Certain
mutation of the chromophore has significant effect on the rate of the chromophore formation in
vivo and can alter the spectral characteristics of the matured GFP variants. The chromophore
formation of S65T-GFP was monitored in vitro, where an ordered reaction consisting of three
distinct steps was observed (Figure 1.6). Protein folding occurs fairly slowly (kf = 2.44×10-3 s-1)
prior to any chromophore modification. Then, an intermediate step occurs including cyclization
of the tripeptide chromophore motif (kc = 3.8×10-3 s-1). The final and slower step (kox = 1.51×10-4
s-1) involves oxidation of the cyclized chromophore (Reid and Flynn 1997). To gain a
comprehensive understanding of the reaction mechanism of GFP chromophore formation, its
biosynthesis is of fundamental scientific interest. In addition, knowledge of the reaction pathway
and identification of intermediates have significant practical and medical implications. Wachter’s
group probed the crystal structure of the Y66L variant of GFP and their results supported the
Cyclization-Oxidation-Dehydration mechanism for chromophore maturation (Wachter, King et
al. 1997). To understand chromophore formation, Enoki and coworkers used pH 2.0 Tris-HCl to
denature GFP and carried out research on kinetic refolding of GFP in vitro. They investigated the
kinetic mechanisms of a mutant (F99S/M153T/V163A) of GFP, which is known to mature more
efficiently than the wild type protein from the acid-denatured state. The kinetics of the refolding
of the mutant suggests at least five kinetic phases (Enoki, Saeki et al. 2004).
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Figure 1. 5. The proposed chromophore formation mechanism of EGFP.
The chromophore of EGFP is formed by a tripeptide (Thr65-Tyr66-Gly67) through folding,
cyclization, dehydration and oxidation processes. It exists in both the neutral state (protonated
form) and the anionic state (deprotonated form) due to effects from the hydrogen bond network.
Modified after (Heim, Prasher et al. 1994).
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Figure 1. 6. Three-step mechanism of GFP chromophore formation.
The three steps of GFP chromophore formation exhibit the formation process of a pre-cyclization
structure, an intermediate structure and the mature chromophore. Modified after (Reid and Flynn
1997; Zhang, Patel et al. 2006).
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Due to the chromophore being buried in the tightly-constructed β barrel, GFP is highly
resistant to denaturation and its fluorescent properties are unaffected in the presence of 6 M
guanidine hydrochloride, 8 M urea or 1% SDS at 90 °C; is stable in a broad range of pH from 5
to 12; and can tolerate various proteases such as trypsin, chymotrypsin, papain, subtilisin,
thermolysin and pancreatin (Ward and Bokman 1982; Ward, Prentice et al. 1982). The tightlyconstructed β barrel protects the chromophore well, which contributes to the overall stability,
temperature- and denaturant-resistance, and prohibition of proteases, oxygen or water molecules
access. Shimomura also analyzed the acid-denatured GFP by proteolysis and deduced the
structure of the chromophore in 1979 and the result indicated that the chromophore is a 4-(phydroxybenzylidene) imidazolidin-5-one attached to the peptide backbone through the 1- and 2positions of the ring (Shimomura 1979). The structure of the chromophore was also confirmed
by X-ray and time-resolved fluorescence analysis. The results indicated that the chromophorecontaining fragment is a cyclized hexapeptide formed from residues Phe64-Ser-Tyr-Gly-ValGln69 of GFP (Perozzo, Ward et al. 1988).

1.4.3 Spectral properties of fluorescent proteins
Although the chromophore is located on the central helix within a couple of angstroms of
the cylinder center, both apolar and polar amino acid side chains such as S202, T203, I167 or
G148 and immobilized water molecules surround the chromophore. The mutations around the
GFP chromophore were shown to alter the optical properties of the protein. Some mutations
result in the loss of the excitation at 475 nm and the preservation of the excitation at 395 nm,
such as S202F and T203I. Moreover, mutation I167T causes a reversed ratio of the sensitivity at
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395 nm to 475 nm. The shift of excitation peaks can provide us multiple color-fluorescent
proteins, such as blue fluorescent protein (BFP), cyan fluorescent protein (CFP), green
fluorescent protein (GFP), yellow fluorescent protein (YFP) and red fluorescent protein (RFP).
The fluorescent protein properties of different GFP variants are shown in Table 1.1 (Piston,
Patterson et al. 2004).
In summary, different mutations resulted in various improved GFP variants with the
characteristics of high intensity, low photobleaching, and high thermo-stability. These variants
also have various excitation or emission wavelengths. Therefore, any proteins tagged with
different GFP variants can be visualized in cells with high light intensities over many hours and
with little photobleaching. This permits intracellular protein pathways or dynamics to be
analyzed in detail. The increased stability and brightness of EGFP also enables the intracellular
fluorescent signal from chimeras to be correlated to standard GFP solution, permitting the
quantification of molecules visualized in cells. Meanwhile, fluorescent proteins can be used for
fluorescence resonance energy transfer (FRET) to monitor intracellular interactions.

1.4.4 Applications of green fluorescent protein
The isolation and cloning of GFP from Aequorea victoria has created a unique new
research tool using GFP as an active or a passive reporter of cell function in molecular and cell
biology. It has been shown that GFP can be used as a gene marker, which can be easily detected
by fluorescence microscopy or flow cytometry. Viable GFP-positive cells have been isolated
through fluorescence-activated cell sorting. Therefore, GFP has served as a versatile tool for the
study of gene expression, gene transfer, protein folding and trafficking, and protein-protein
interactions due to its spectral characteristics, small size, and acquisition of fluorescent activity
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Table 1. 1. Fluorescent protein properties
Protein
(Acronym)

Excitation
Maximum (nm)

Emission
Maximum (nm)

Molar Extinction
Coefficient

Quantum
Yield

In vivo
Structure

Relative Bright
(% of EGFP)

GFP (wt)

395/475

509

21,000

0.77

Monomer

48

Green Fluorescent Protein
EGFP

484

510

56,000

0.60

Monomer

100

Emerald

487

509

57,500

0.68

Monomer

116

Azami Green

492

505

55,000

0.74

Monomer

121

CopGFP

482

502

70,000

0.60

Monomer

125

AcGFP

480

505

50,000

0.55

Monomer

82

ZsGreen

493

505

43,000

0.91

Tetramer

117

Blue Fluorescent Protein
EBFP

383

445

29,000

0.31

Monomer

27

Sapphire

399

511

29,000

0.64

Monomer

55

T-Sapphire

399

511

44,000

0.60

Monomer

79

Cyan Fluorescent Protein
AmCyan1

458

489

44,000

0.24

Tetramer

31

ECFP

439

476

32,500

0.40

Monomer

39

Cerulean

433

475

43,000

0.62

Monomer

79

CoralHue Cyan

472

495

27,300

0.90

Dimer

73

EYFP

514

527

83,400

0.61

Monomer

151

PhiYFP

525

537

130,000

0.40

Monomer

155

Citrine

516

529

77,000

0.76

Monomer

174

Venus

515

528

92,200

0.57

Monomer

156

ZsYellow1

529

539

20,200

0.42

Tetramer
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Yellow Fluorescent Protein

Orange and Red Fluorescent Protein
CoralHue Orange

548

559

51,600

0.60

Monomer

92

mOrange

548

562

71,000

0.69

Monomer

146

DsRed

558

583

75,000

0.79

Tetramer

176

DsRed2

563

582

43,800

0.55

Tetramer

72

DsRed-Express

555

584

38,000

0.51

Tetramer

58

mTangerine

568

585

38,000

0.30

Monomer

34

mStrawberry

574

596

90,000

0.29

Monomer

78

AsRed2

576

592

56,200

0.05

Tetramer

8

mRFP1

584

607

50,000

0.25

Monomer

37

mCherry

587

610

72,000

0.22

Monomer

47

mRaspberry

598

625

86,000

0.15

Monomer

38

HcRed-Tandem

590

637

160,000

0.04

Monomer

19

Modified after (Piston, Patterson et al. 2004).
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in absence of any other cofactors. In vivo, applications of GFP can be divided into two categories
based on its use, as either a tag or an indicator. As a tag, GFP fluorescence reflects levels of gene
expression or sub-cellular localizations of the host proteins to which GFP is fused. As an
indicator, GFP fluorescence is modulated post-translationally by its chemical environment and
protein-protein interactions (Tsien 1998). The first proposed application of GFP was the
detection of gene expression as a tag in vivo by Chalfie (Chalfie, Tu et al. 1994). Currently, GFP
variants are used for determining calcium ion level in various compartments of cells, tissues, or
organs (Zou, Hofer et al. 2007).

1.4.5 Current protease sensors based on GFP
It is well known that green fluorescent protein and its variants play important roles in a
variety of biological process, including dynamic detection of protease activation or inhibition in
vitro or in living cells. The earliest tandem GFP FRET pair, BFP donor and EGFP acceptor, are
connected a linker with 25 amino acid sequence, which exhibited a 4.6-fold change in the ratio of
fluorescence emission from the respective GFPs upon the complete cleavage by trypsin (Heim
and Tsien 1996). Later, a similar GFP-FRET pair was constructed as a tendem BFP-EGFP
substrate for Factor Xa to reveal a three-fold fluorescence emission ratio change between 505
and 405 nm due to the disruption of FRET (Mitra, Silva et al. 1996). Due to the pioneer works
related to protease activity detection with FRET of GFP pairs, FRET-based protease sensors
have been extensively investigated and developed. Currently, many investigators are developing
tandem molecules of green fluorescent protein (GFP) as the genetically encoded sensors to detect
caspase activity and screen caspase triggers or inhibitors both in vitro and in living cells
(Mahajan, Harrison-Shostak et al. 1999; Jones, Heim et al. 2000; Tawa, Tam et al. 2001;
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Karasawa, Araki et al. 2004; Kawai, Suzuki et al. 2005; Ai, Hazelwood et al. 2008; Ray, De et
al. 2008). For example, four-amino-acid recognition sequences, YVAD for caspase-1 and DEVD
for caspase-3 were introduced between CFP and YFP was used for high-throughput screening of
reagents that modulate caspase activity in live mammalian cells (Mahajan, Harrison-Shostak et
al. 1999). Based on various color vesions of the FRET-based probes for caspase activity, a
simultaneous real-time detection of initiator- and effector-caspase activation by double
fluorescence resonance energy transfer analysis was also developed for single living cell (Kawai,
Suzuki et al. 2005) and a new violet-excitable yellow-fluorescing variant of GFP was also used
to construct a dual FRET-based caspase-3 biosensor for living cells (Ai, Hazelwood et al. 2008).
Besides the development of FRET-based biosensors for activity detection trypsin, Factor Xa and
caspases, FRET-based GFP pairs have been also used to design thrombin probe for high
throughput screening of thrombin inhibitors (Zhang 2004) and genetic MMP substrate to
sensitively monitor MMP activation in living cells or high throughput screening of MMP
inhibitors for anti-cancer treatments (Yang, Zhang et al. 2007). Furthermore, several elegant
studies have only reported the on and off measurements of protease activity by linking GFP with
ubiquitin or proteasome cleavage peptide for protein degradation or by using bacterial protease
sequences such as PEST and N-terminal rules (Dantuma, Lindsten et al. 2000; Lee, Beem et al.
2002; Spencer, Theodosiou et al. 2004).

1. 5

Limitations of FRET-based fluorescent protein biosensors
Due to the unique characteristics, different variants of fluorescent proteins have attracted

extensive interest in real-time imaging the spatiotemporal events of living cells. A large number
of FRET-based biosensors based on various fluorescent proteins have been designed and
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developed to detect calcium signaling or track protease activation or inhibition in living cells in
real time. Unfortunately, FRET-based protease sensors are hampered with respect to practical
applications due to the following drawbacks or limitations (Felber, Cloutier et al. 2004; Piston
and Kremers 2007):
(1) The donor and the acceptor of FRET-based GFP pairs exhibit imbalanced
fluorescence intensity due to their 1:1 of stoichiometry. In addition, the quantantive measurement
of protease activity is partially limited by problems associated with photobleaching (Jones, Heim
et al. 2000; Harpur, Wouters et al. 2001; Kohl, Heinze et al. 2002; He, Wu et al. 2004; Karasawa,
Araki et al. 2004; Kawai, Suzuki et al. 2005).
(2) FRET-based fluorophores require spectral overlap between emission wavelength of
the donor and excitation wavelength of the acceptor, which results in the issue of cross-talk in
FRET signal;
(3) FRET-based methods also require the optimal distance between the donor and the
acceptor. Larger fluorescent protein variants with an approximately 40 Å long and 30 Å diameter
barrel occupy much of the useful FRET distance and result in the decrease in practical maximal
FRET efficiencies.
(4) FRET-based methods also need accurate orientation for their FRET efficiency, both
in solution and in a living organism system. In addition, fluorescence energy transfer may be
disrupted due to environmental intruptions or complexities in components. Then, fluorescence
resonance energy transfer efficiency in certain environments may be changed due to poor
orientation. Therefore, empirical optimization on the linker depends on the system of interest.
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(5) The application of this class of protease sensors for in vivo imaging of protease action
may be limited by problems of translocation in vivo due to the typical large size of fluorescent
protein pair.

1. 6 Novel strategy for protease sensor design
It is well known that many physiological or pathological processes are protease
dependent. A novel and effective probe for investigating protease activation pathways or a
diagnostic tool for diseases related to proteases is highly desired to determine protease activity or
to track protease activation or inhibition pathways in living cells or in vivo. Fluorescence
technology is an increasingly appealing strategy for tracking protease activity in living cells.
GFP is one of the best candidates due to its intrinsic fluorescence from the chromophore.
Currently, many protease sensors or probes are based on FRET of GFP pairs, while the protease
sensor based on a single GFP is not reported. In order to develop more effective methods for
studying and monitoring intracellular events, a protease sensor with a specific protease cleavable
linker in a single GFP with high sensitivity and selectivity are highly desired for the monitoring
the real-time dynamic change of protease activity inside living cells. We hypothesize that a
protease specific cleavage linker engineered into the chromophore-sensitive locations of a single
EGFP could provide a significant ratiometric optical signal change in the absorbance or
fluorescence of the chromophore upon the cleavage of this inserted linker, thereby allowing for
the determination of protease activity or the monitoring of protease activation and inhibition
pathways with high sensitivity, specificity and selectivity inside living cells in real time. A
diagram of the grafting approach for developing protease sensors is shown in Figure 1.7.

33

Figure 1. 7. Design of ratiometric EGFP-based protease sensors.
A specific cleavage linker for proteases is grafted into a sensitive location for optical signal
change of the chromophore in EGFP. Following protease cleavage, a ratiometric optical signal
change in absorbance or fluorescence is applied to determine protease activity.
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Recently, EGFP with specific cleavage linkers for proteases have been gained prominence, as a
sensitive protease sensor to monitor different stages of protease activation.

1. 7 Objectives of this dissertation
In this dissertation, several classes of protease sensors, such as trypsin sensors, caspase-3
sensors, caspase-8 sensors and thrombin sensors are systematically designed and studied using a
single EGFP scaffold at its sensitive location for ratiometric optical signal change of the
chromophore. Meanwhile, based on the association capability of both fragments, another
molecular probe based on the split fragments of EGFP was also created for studying calciumdependent protein-protein interactions in living cells.
Chapter 1 presents the basic background of proteases and current methods of protease
activity determination in vitro and in vivo. Based on the drawbacks and limitations of currently
available protease sensors or protease substrate kits, specific criteria for an ideal protease sensor
are proposed and a novel design for sensitive protease probes both in vitro and in living cells is
established. The significance of the sensitive protease sensors built in a single EGFP scaffold is
also described.
Chapter 2 discusses the materials and methods utilized in the overall research of this
dissertation. The molecular biology to obtain the DNA plasmids encoding specific protease
cleavage linkers is detailed. Expression and purification of the designed EGFP-based protease
sensor variants, along with differences between fluorescent and non-fluorescent designed
proteins, and EGFP fragments are described. The analyses of optical properties for protease
sensors before or after protease digestion and fragments of split EGFP are discussed. Mammalian
cell culture, transfection and expression of designed protease sensors or EGFP fragments,

35

protease activation and inhibition measurement in living cells are also illustrated in detail. The
comparison of various protease sensor variants and different cell lines was conducted to examine
the enzymatic response capability or specificity of protease sensors and basal protease activity in
different cell lines.
Chapter 3 discusses the design of sensitive trypsin sensors in detail. Based on the design
of various trypsin sensors, the sensitive location for protease sensor development is identified.
The trypsinogen activation in pancreatic cancer cells is illustrated and their subcellular
compartments are localized. Meanwhile, kinetic studies were used to determine catalytic kinetic
parameters and to optimize their cleavage linkers for improving specificity of various trypsin
sensors.
Chapter 4 discusses the rational design of various caspase-3 and caspase-8 sensors. The
activation or inhibition of caspase-3 and caspase-8 in living cells is probed in detail. The
timescale of caspase-3 activation is confirmed using different currently available caspase-3
substrate kits in vitro and in living cells. The basal caspase-3 activity is tested in different cancer
cell lines.
Chapter 5 describes the design of thrombin sensors based on our developed protease
sensor strategy. The specificity of cleavage linkers in thrombin sensors was investigated through
catalytic kinetic studies to optimize the cleavage linker.
Chapter 6 demonstrates the separation of the EGFP fragments of trypsin sensors
following trypsin digestion, and the accurate cleavage sites of these EGFP-based trypsin sensors
are identified. Optical properties of the large fragment containing the chromophore were studied
to reveal the weak fluorescence and the strong potential for reassociation of the split EGFP
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fragments. A mini-domain with essential sequence for chromophore formation and fluorescence
of EGFP was identified.
Chapter 7 demonstrates a creative strategy for studying calcium-dependent proteinprotein interactions in living cells based on the characteristics of association and fluorescence
complementation of both split EGFP. The calcium-dependent protein-protein interactions is
imaged through the fluorescence complementation of EGFP fragments in living cells and the
calcium effect on the interactions of both fragments is confirmed through purified two fragments
in vitro and calcium triggers in living cells.
Chapter 8 summarizes the analyses and conclusions in this dissertation. Meanwhile, the
major discoveries and future promising are described in this chapter.

37

Chapter 2

2. 1

Materials and methods

Design and construction of protease sensors
In order to design genetic protease sensors, a cleavable linker for specific proteases was

genetically generated in pet28a or pcDNA 3.1 (+) plasmid (Invitrogen) encoding EGFP at three
locations after residues (Glu172, Gln157 or Asn144) using polymerase chain reaction (PCR)
technique. The forward and backward primers of cleavable linkers for various proteases were
designed to be length of about 20 base pairs with approximately 70 °C of anneling temperature
(Tm). The designed primers of the cleavage linkers for various proteases were purchased from
Sigma-Genosys. Before phosphorylation, the primers were dissolved in EB buffer (10 mM Tris,
pH 8.5) to final concentration of 100 μM and allowed for incubation in the room temperature for
2 h. After the incubation at room temperature, phosphorylation reaction of the primers was
conducted by T4 phosphonucleotide kinase (PNK) (Promega) at 37 °C incubator for 30 min
according to the manufacturer’s protocol. Then, the phosphorylation reaction was halted through
putting the mixture of reaction in 65°C water bath for 15 min to inactivate T4 phosphonucleotide
kinase. KOD hot start polymerase (Invitrogen) was used for the amplification of desired protease
sensor DNA plasmids, and the reaction mixture of PCR amplification was prepared following the
manufacturer’s protocols. PCR amplification was completed in a MiniCycler thermocycler
without heated lid (MJ Research) or TC-3000 thermocycler with heated lid (TECHNE) under a
program set up a cycle of activation of polymerase for 2 min at 95 °C; 30-repeated cycles with
denatureation at 95 °C for 30 seconds, anneling for 30 seconds at 58-62 °C based on various
primers and extension with a rate of 20 sec/kbp at 72 °C; and then a cycle of final extension at 72
°C for 10 min. A drop of mineral oil was added to the top of the mixture of PCR reaction to
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prevent evaporation if the reaction was conducted in the MiniCycler thermocycler without heated
lid. Following PCR amplification, the synthesized plasmid DNA products were separated on a
0.8% agarose gel and extracted from the gel using a Qiagen gel extraction kit (Qiagen, Valencia,
USA). The linear plasmid DNA was then ligated with T4 DNA ligase (Promega) following the
manufacturer’s instructions for 22 hours at 4 °C with the addition of approximately 3 mM ATP
to provide energy for the reaction. The resulting circular plasmid DNA was transformed into E.
coli (DH5α) competent cells with a method of heat shock and plated on Luria-bertani (LB) plates
with the appropriate antibiotic for corresponding resistance of host vectors, usually kanamycin
for pet28a vector or ampicillin for pcDNA vector. Plates with transformed cells were incubated
at 37 °C for 16-24 hours to allow for colony growth. A single colony was selected to inoculate in
10 ml LB media with appropriate antibiotic at 37 °C shaker with agitation at 200 rpm and allow
for cell growth. The plasmid DNA was purified from DH5α cells using a Qiagen Miniprep kit
(Qiagen, Valencia, USA). The constructed plasmid DNA was verified through automated DNA
sequencing at Georgia State University (GSU) core facility.
Alternatively, for tracking the protease activation in various subcellular compartments,
the ER retention sequence, KDEL, was connected to the C-terminus, and the ER targeting
sequence of calreticulin (CRsig), MLLSVPLLLGLLGLAAAD, was fused to the N-terminus of
EGFP-based protease sensors via PCR technique. The Kozak consensus sequence was placed at
the N-terminus of the calreticulin sequence for optimal initiation of protein expression in
mammalian cells. Similarly, the sequence of MLSLRNSIRFFKPATRTLCSRYLL for
mitochondria targeting was connected to the N-teriminus of EGFP-based protease sensors via
PCR technique. The commercial marker Mitotracker Red (Invitrogen, Molecular Probe) and
DsRed-ER-marker (BD Bioscience, Clontech) were used as positive markers for mitochondria or
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ER to confirm the right co-localization of our designed protease sensors with signal peptide
sequences.

2. 2

Construction of plasmid DNA EGFP fragments
DNA sequences encoding the large (amino acid residues 1-172) and small (amino acid

residues 173-238) EGFP fragments (not including the engineered EF-hand motif III of CaM)
were fused with the whole EF1 (KSPEELKGIFEKYAAKEGDPNQLSKEELKLLLQTEFPSLLKGP) and
EF2 (STLDELFEELDKNGDGEVSFEEFQVLVKKISQ) motifs of calbindin D9k, or with partial EF1
(KSPEELKG) and partial EF2 motifs (STLDELFE), respectively, and cloned into pcDNA3.1 (+)
vector for mammalian cells. The resulting variants containing whole EF-hand motifs or partial
EF-hand motifs were designated N-EGFP-EF1, C-EGFP-EF2, N-EGFP-EF1p and C-EGFPEF2p. A linker (GGSGSGSS) was interposed to connect the N-EGFP fragment and EF1, or the
C-EGFP fragment and EF2 in order to improve the flexibility of EF-hand motifs. The newlysynthesized plasmid DNAs were ligated with T4 DNA ligase, transformed into DH5α competent
cells grown in Luria-Bertani (LB) media containing kanamycin or ampicillin, and then purified
with a QIAprep Miniprep Kit (Qiagen, USA). The constructed plasmid DNA was verified
through automated DNA sequencing.

2. 3

Competent cell preparation
A glycerol stock of E. coli cell strain is thawed and plated on a fresh LB plate without

antibiotic. The plate with E. coli cells is incubated overnight at 37 °C for cell growth. A single
colony is selected from the plate and inoculated into 10 mL of LB media without antibiotic to
allow for cell growth overnight at 37 °C with shaking at 200 rpm. Following the overnight cell
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growth, 1 ml of the cell suspension is transferred to 100 ml of fresh LB media without antibiotic
and allow to cells grow to an optical density (O.D.) of 0.5 at 600 nm with 200 rpm of shaking at
37 °C. The cell culture is aliquoted to 2 X 50 mL in the prechilled sterile polypropylene tubes
and then standed on ice for 5-10 min. The cells are subjected to centrifugation at 3000 rpm for 7
min at 4 °C. The collected cell pellet is resuspended in 10 mL of 100 mM ice-cold calcium
chloride solution with a gentle swirling. After another centrifugation at 2500 rpm for 5 min at 4
°C, the cell pellet is resuspended in 10 mL of 100 mM ice-cold calcium chloride solution again
and incubated in ice-water bath for 30 min. The cell suspension is subjected to centrifugation at
5500 rpm for 7 min and the cell pellet is then resuspended in 1 mL of 100 mM ice-cold calcium
chloride solution containing 15 % glycerol with a gentle swirling. Finally, 100 μL of competent
cells is transferred to 1.7 mL prechilled sterile polypropylene centrifuge tubes and immediately
freezen at -80°C for later use.

2. 4

Subcloning for protease sensors
In order to obtain plasmid DNA of protease sensors with specific cleavage linkers or

EGFP fragments for the expression in mammalian cells, the plasmid DNA encoding EGFP-based
protease sensors or EGFP fragments in pet28a vector, which contains a kanamycin-resistance
gene and a multiple restriction site, was transferred to pcDNA 3.1 (+) vector through subclone
technology. The plasmid DNA encoding EGFP-based protease sensors or EGFP fragments and
the pcDNA 3.1 (+) vector were subjected to double digestion using BamHI and EcoRI restriction
enzymes under their corresponding optimal digestion buffers at 37 °C for 3-4 hours according to
the manufacturer’s instructions. Following double digestion, the digested DNA and vector were
separated on a 0.8% agarose gel. The bands with desired gene of EGFP-based protease sensor or
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EGFP fragments and the vector were sicized from the gel and purified with a Qiagen gel
extraction kit (Qiagen, USA), respcetively. The desired gene was then ligated to the pcDNA 3.1
(+) vector with T4 DNA ligase through the incubation for 22 hours at 4 °C with the addition of
approximately 3 mM ATP to provide energy for the reaction. The resulting circular plasmid
pcDNA encoding EGFP-based protease sensor or EGFP fragments was then transformed into
DH5α competent cells and allowed to grow in Luria-bertani (LB) plates with ampicillin at 37 °C
overnight. Individual colony was then grown in 10 mL LB media with ampicillin (100 mM/L)
overnight, and the pcDNA enconding EGFP-based protease sensors or EGFP fragments was
purified with the Qiagen Miniprep kit (Qiagen, USA). The sequence of disered pcDNA through
subcloning was verified by automated sequencing at GSU core facility. On the other hand, in
order to obtain plasmid DNA of protease sensors with specific cleavage linkers or EGFP
fragments for the expression in E. coli, the desired pcDNA encoding EGFP-based protease
sensor or EGFP fragments and pet28a vector were subjected to the double digestion, ligation for
subcloning into pet28a in the same manner as the subclone in pcDNA vector.

2. 5

Expression in E. coli and purification with His-tag column
EGFP-based protease sensor variants subjected to insertion of a nucleotide sequence

encoding a cleavage linker were expressed in E. coli BL21 (DE3). A single colony was
inoculated into 20 ml of LB media containing kanamycin with concentration of 30 μg/ml at 37
˚C with agitation at 200 rpm overnight and then transferred to 1 L of LB media containing
kanamycin with a final concentration of 30 μg/ml. The cell culture was induced with 0.2 mM
isopropyl-β-D-thiogalactopyranoside (IPTG) when optical density (O.D.) at 600 nm reached 0.6
and allowed to grow at 30 ˚C for another 16 to 20 hours. To purify the EGFP-based protease
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sensors, cell pellets were resuspended in 10 ml of lysis buffer (20 mM Tris, 10 mM NaCl, 0.1%
Triton X-100, pH 8.8) and sonicated to disrupt the cell membrane. The solution was centrifuged
at 20000 ×g for 20 min, and the supernatant was filtered and injected into a nickel-chelating
column loaded with 0.1 M nickel sulfate solution on fast protein liquid chromatography (FPLC).
After washing with buffer A (50 mM phosphate, 250 mM NaCl, pH 7.4), the bound protein was
eluted with a gradient of imidazole from 0 to 0.5 M in phosphate buffer. The purity of the
fractions was monitored by SDS-PAGE. The protein collected from FPLC was dialyzed in Tris
buffer (10 mM Tris, 1 mM DTT, pH 7.4) to remove imidazole. The concentration of purified
protein was determined by UV-visible absorbance at 280 nm and calculated using Beer’s Law (A
= εcl) with an extinction coefficient of 21,890 M-1 cm-1.

2. 6 Protease sensor purification with Hitrap Q column
EGFP-based protease sensor variants obtained through the purification from His-tag
column were conducted a further purification using an anion exchange column, Hitrap Q
column, to improve their purity. Prior to purification, an Hitrap Q column connected to FPLC
was subjected to sequentially inject 25 ml (5 column volumes) of start buffer (20 mM Tris, pH
8.0), 25 ml of elution buffer (20 mM Tris, 1 M NaCl, pH 8.0), and 25 ml of start buffer again to
equilibrate the column. In order to maintain a similar buffer condition, the EGFP-based protease
sensor sample was diluted with start buffer and then loaded on the column. The continual
injection was preformed until all proteins were bound to the column. Then, the column bound
EGFP-based protease sensors was initially washed with start buffer to remove containminating
proteins, and then eluted using elution buffer with a gradient of NaCl from 0 to 1 M. Usually, the
gradient of approximately 400 mM of NaCl is the optimal condition for the elution of EGFP-
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based protease sensors from column. Following the elution of the desired EGFP-based protease
sensor, the column was kept to wash using elution buffer with 100% gradient of NaCl to remove
any remaining contaminants. The purified EGFP-based protease sensor was concentrated down
to desired concentration based on experimental requirements with the Amicon pressure
concentrator and dialyzed against Tris buffer (10 mM Tris, 1 mM DTT, pH 7.4) to remove NaCl.
The concentration of purified EGFP-based protease sensor was determined by UV-visible
absorbance at 280 nm and calculated using Beer’s Law (A = εcl) with an extinction coefficient of
21,890 M-1 cm-1.

2. 7 Protein refolding with urea
Some EGFP protease sensor variants grafted into cleavage linkers or EGFP fragments
exhibit a tendency to express in inclusion bodies with low solubility, which results in low
efficiency of extraction from cells. In order to improve the solubility, the cell pellet of these
EGFP protein variants was thawed on ice water and 8 M urea was added to dissolve. Once the
cell pellet was dissolved, the mixture was subjected to the refolding through dropwisely adding
to appropriate refolding buffer (10 mM Tris, 10 mM DTT, pH 7.4) with a 10X volume of the
mixture while stirring. The refolded mixture was centrifuged at 17K rpm for 15-20 min to
separate the solubilized protein from the cell pellets or insoluble proteins. The supernatant and
pellet were collected to evaluate the extract efficiceny using SDS-PAGE. The supernatant
containing refolded soluble protein was dialyzed against in a large volume of buffer (10 mM
Tris, 1 mM DTT, pH 8.0) overnight at 4 °C to remove the urea. The dialyzed supernatant
containg the refolded soluable protein was loaded on His-tag column to conduct the purification.
The concentration of purified EGFP-based protease sensor was determined by UV-visible
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absorbance at 280 nm and calculated using Beer’s Law (A = εcl) with an extinction coefficient of
21,890 M-1 cm-1.

2. 8

UV-visible spectroscopy
In order to obtain optical properties of EGFP-based protease sensors, UV-visible spectra

were monitored using a UV-1700 spectrophotometer scanning from 600 to 200 nm. Samples
were buffered in 10 mM Tris, 1 mM DTT, at pH 7.4. The concentrations of the EGFP-based
protease sensors were determined by UV-visible absorbance at 280 nm using the molar
extinction coefficient of 21,890 M-1cm-1 calculated from the contribution from aromatic residues
(1 Trp and 11 Tyr) (5500 and 1490 M-1cm-1 for Trp and Tyr, respectively). The extinction
coefficients at 398 or 490 nm of the EGFP-based protease sensor variants were obtained with
Equation 1, respectively:

⎛

⎞
⎟
⎟
A
⎝ P , 280 nm ⎠

ε P = ε P , 280nm ⎜⎜

AP

Equation 1

In which, εp is the extinction coefficient at 398 or 490 nm of EGFP-based protease sensor
variants, εp,280nm is the extinction coefficient at 280 nm of EGFP-based protease sensor variants,
Ap is the absorption of EGFP-based protease sensor variants at 398 or 490 nm, and Ap,280nm is the
absorption of EGFP-based protease sensor variants at 280 nm. EGFP was used as a reference in
the measurement of the extinction coefficients of the variants.

2. 9

Fluorescence excitation and emission spectroscopy
In order to obtain optical properties of EGFP-based protease sensors, fluorescence spectra

of these EGFP-based protease sensor variants were scanned in the emission range of 410-600 nm
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with an excitation of 398 nm or for emission between 500-600 nm with an excitation of 490 nm.
Samples were buffered in 10 mM Tris, 1 mM DTT, at pH 7.4. A fluorescence cuvette with 1 cm
pathlength was used.

2. 10 MALDI-TOF mass spectroscopy
All MALDI-TOF mass spectra were recorded on a Voyager-DETM Pro biomass
spectrometry Workstation (Applied Biosystems, Foster City, CA) in a linear-positive mode with
delayed extraction. Sinapinic acid in 50% acetontrile with 1% trifluoroacetic acid (TFA) was
used as the matrix. 1 μL of the sample and matrix mixture with various ratios was spotted and
air-dried before the analysis. 25KV was applied as acceleration voltage. Proteins (insulin,
thioredoxin and apomyoglobin) were used as external standards. A mass range from 300 to
35000 Da was scanned and recorded. The spectra were processed with Explore software.

2. 11 Change in optical properties of sensors following protease cleavage
The digestion reactions of protease sensors were performed by adding stock proteases in
their appropriate reaction buffers. The UV-visible spectra of protease sensors following protease
digestion were measured in a 1 cm pathway cuvette and the fluorescence spectra of protease
sensors with excitation at 398 and 490 nm were recorded. Comparisons with and without
protease digestion were conducted to confirm optical changes in the protease sensors following
protease cleavage.
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2. 12 Cleavage identification with SDS-PAGE analysis
The protease sensitivity and cleavage status of EGFP-T1 were monitored and evaluated
by 15% sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE). Trypsin,
chymotrypsin or thrombin was added into 15 μM EGFP-T1 to a final protein: enzyme (w/w)
ratio of 100:1 and the digestion was conducted in each of their respective optimal buffers at room
temperature. Different ratios of protein and trypsin (w/w) (2000:1, 1000:1, 200:1 and 100:1)
were used to investigate the effects of enzyme concentration. Samples were taken at different
time intervals for SDS-PAGE. EGFP-T1, not subjected to protease digestion and stored at -20
˚C, was evaluated in parallel as a control. The optical density for bands with molecular mass of
20 kDa in SDS-PAGE was determined using Scion Image software to analyze the cleavage rate
of EGFP-T1.

2. 13 Separation of EGFP fragments after protease digestion
After natural degradation or protease digestion of EGFP-T1, the mixture of products
retained strong green fluorescence. In order to investigate cleavage sites and the source of
fluorescence, a method combining fast performance liquid chromatography (FPLC) and highpressure liquid chromatography (HPLC) was utilized to separate protein fragments under
denatured conditions. 6 M Urea was added to the digested products of EGFP-T1 and heated in a
90 °C water bath for 5 min to denature protein fragments. The denatured protein fragments were
injected into a prepared FPLC connected to a Hitrap Sephadex 75 size exclusion column and
eluted with 10 mM Tris buffer containing 6 M urea at pH 7.4. The major fragments were
collected and further purified by reversed-phase HPLC equipped with a Whatman C4 column
through gradient elution of mobile phase A (H2O containing 0.1% TFA) and mobile phase B
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(100% acetonitrile containing 0.1% TFA). The fractions with purified protein fragments were
lyophilized for the analyses of protein sequence, mass spectroscopy and spectral properties.

2. 14 Identification of cleavage sites of EGFP-T1
In order to investigate trypsin cleavage sites of EGFP-T1, the molecular mass of digested
products was measured by MALDI-MS at the mass spectroscopy center of Georgia State
University (GSU) and N-terminal sequence analysis was conducted using Edman degradation at
the Centers for Disease Control and Prevention (CDC). The cleavage sites were identified
through the calculation of molecular masses of digested fragments from N-terminal to the
cleavage site and comparison with observed results from MALDI-MS.

2. 15 Optical properties of purified EGFP fragments
The optical properties of P20 were monitored with a UV-1700 spectrophotometer
(Shimadzu Scientific Instruments Inc., Japan) and a fluorescence spectrophotometer (Photon
Technology International Inc., Canada). The UV-visible spectra of the fragments were scanned
from 600 nm to 200 nm in 10 mM Tris, 1 mM DTT, pH 7.4. The UV-visible spectra at different
pH conditions were monitored by gradiently adding 0.5 M NaOH into 1 ml of P20 solution in 10
mM Tris, 1 mM DTT at pH 7.32 to final NaOH concentrations of 1.49, 2.98, 4.46, 5.93, 7.39 and
8.84 μM. The final pH value was 10.82 after addition of NaOH. The UV-visible spectra under
various pH conditions were scanned to investigate the optical properties of P20. Fluorescence
spectra of P20 were measured in the emission region of 410 to 600 nm with an excitation
wavelength of 398 nm, and in the emission region of 500 to 600 nm with an excitation
wavelength of 490 nm, respectively.
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2. 16 Determination of steady-state kinetic parameters of protease sensors
In order to investigate the catalytic kinetic change and to determine the steady-state
kinetic parameters, Michaelis constants (Km), turnover numbers (kcat) and specificity constants
(kcat/Km) for hydrolysis of EGFP-based protease sensors upon the action of proteases, initial rates
of trypsin digestion reaction for EGFP-based protease sesnors at various concentrations were
measured using a time-course model to monitor the change of absorbance at 490 nm for 10 min
on a UV-1700 spectrometer (Shimadzu, Japan), where the initial rate was equivalent to the
resulting slope of absorbance increase. These data were then used to calculate the steady-state
kinetic parameters, kcat, Km and kcat/Km for hydrolysis of EGFP-based protease sensors following
protease digestion, by fitting data to the Michaelis-Menten equation (Equation 2) by nonlinear
regression using KaleidaGraph 3.5 software (Synergy software).
v0
k [S ]
= cat
e K m + [S ]

Equation 2

where v0/e is per mole enzyme initial reaction rate (s-1), kcat turnover number (s-1), [S] substrate
concentration (M), and Km the Michaelis constant (M).

2. 17 Inhibition of protease cleavage
In order to examine the inhibition effects of leupeptin (Sigma, St. Louis), a trypsin
inhibitor, leupeptin at various concentrations (0, 12.5, 25, 50 and 100 nM) was mixed with
EGFP-T1 with various concentrations from 2 to 20 μM buffered in 10 mM Tris, 20 mM CaCl2,
pH 7.4. Subsequently, EGFP-T1 with leupeptin was digested by 5 nM trypsin. Kinetic studies of
EGFP-T1 at various concentrations were performed at each inhibitor concentration level and the
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absorbance changes at 490 nm were monitored using a time course mode. Initial rates and trypsin
sensor concentrations were fitted with built in competitive inhibition equation (Equation 3),
uncompetitive inhibition equation (Equation 4) and Non-competitive inhibition equation
(Equation 5) to obtain a plot to confirm inhibition type and Ki values were calculated with
Enzfitter (Bio-soft, Cambridge).

Competitive inhibition equation

k cat [ S ]
v
=
e [ S ] + K m (1 + [ I ] / K i )

Equation 3

Uncompetitive inhibition equation
Km
1 + [ I ] / Ki
e
=
+
v k cat [ S ]
k cat

Equation 4

Non-competitive inhibition equation
k cat
[S ]
[S ]
1 + [ I ] / Ki
=
Km
+ [S ]
+ [S ]
1 + [ I ] / Ki

app
cat
app
m

k
v
=
e K

Equation 5

where v0/e is per mole enzyme initial reaction rate (s-1), kcat is turnover number (s-1), [S] is
substrate concentration (M), [I] is the inhibitor concentration (M), Km is the Michaelis constant
app
and K mapp are apprant kcat and Km, respectively.
(M), Ki is binding affinity of inhibitor, k cat

2. 18 Cleavage specificity of protease sensors

In order to examine cleavage specificity of EGFP-T1 exposed to different proteases,
thrombin (GE healthcare, USA), cathepsin B, tryptase, tissue plasminogen activator, kallikerin,
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elastase or chymotrypsin (Sigma, St. Louis) was used to digest trypsin sensor, EGFP-T1.
Thrombin, cathepsin B, tryptase, tissue plasminogen activator, kallikrein, elastase or
chymotrypsin was added to 15 µM EGFP-T1, buffered in their optimal reaction conditions (20
mM Tris, 20 mM CaCl2, pH 7.5 for trypsin or chymotrypsin; 20 mM Tris, 150 mM NaCl, 2.5
mM CaCl2, pH 8.0 for thrombin; 50 mM Tris, 120 mM NaCl, 20 µg/ml Heparin for tryptase; 10
mM Tris, 75 mM NaCl, 2 mM EDTA and 2 mM Cysteine for cathepsin B; 20 mM Tris, 5 mM
NaCl, 0.02% NaN3, pH 8.0 for tissue plasminogen activator; 20 mM Tris, 100 mM NaCl, 0.1%
BSA, pH 7.5 for kallikrein and 20 mM Tris, 400 mM NaCl, pH 7.5 for elastase), to a final
concentration of 20 nM, respectively. The cleavage of EGFP-T1 following trypsin, thrombin,
cathepsin B, tryptase, tissue plasminogen activator, kallikrein, or chymotrypsin overnight
digestion was verified using SDS-PAGE. To confirm optimal reaction buffer conditions for
EGFP-T1 cathepsin B digestion, a fluoresncent substrate (Z-Phe-Arg-7-amino-4-methyl
coumarin or Z-FR-AMC) was used for test its cleavage in identical buffer condition by cathepsin
B. The fluorescence signal change of Z-FR-AMC at 460 nm was detected by fluorescence
spectrophotometer with excitation of 380 nm following cathepsin B digestion.

2. 19 Extinction coefficient calculation of cleaved products

In order to determine the concentrations of cleaved products following trypsin digestion,
5 μL of 40 μM trypsin was added to trypsin sensor samples to conduct overnight digestion.
Following the complete digestion of trypsin sensor samples, the absorbance at 490 nm of
digested trypsin sensors was measured using a UV-1700 spectrometer. Extinction coefficient
constants of cleaved products from trypsin sensors were calculated using Beer-Lambert law.
Based on the calculated extinction coefficient constants and absorbance change, the cleaved
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product concentrations of trypsin sensors following trypsin digestion can be obtained for initial
rate calculations.

2. 20 Relative signal change calculation

In order to evaluate the optical signal change of our designed trypsin sensors, the relative
signal change for absorbance or fluorescence change upon trypsin digestion is calculated by
Equation 6:
or

D = ( A490 a / A398 a ) /( A490b / A398b )
D = ( F490 a / F398 a ) /( F490b / F398b )

Equation 6

where A490a and A398a are the absorbances at 490 and 398 nm following trypsin cleavage; A490b
and A398b are the absorbances at 490 and 398 nm before trypsin cleavage; F490a and F398a are the
fluorescence intensities at excitation of 490 and 398 nm following trypsin cleavage; and F490b
and F398b are the fluorescence intensities at excitation of 490 and 398 nm before trypsin cleavage,
respectively.

2. 21 Mammalian cell culture

The HeLa cell line was purchased from the American Type Culture Collection (ATCC).
The MIA PaCa-2 cell line, a pancreatic cancer cancer line, was provided by Dr. Lily Yang at
Emory University. Both cell lines are adherent, and stocks are grown on 100 mm cell culture
dishes containing their optimal cell culture media in a 37 °C humidified incubation chamber
equipped with 5% CO2. The cell culture media for HeLa cells is Dulbelcco’s Modified Eagle’s
Medium (DMEM, Sigma Chemical Co., St. Louis, MO) with 1 g/L glucose and L-glutamine,
sodium bicarbonate, supplemented with 10% fetal calf serum (FCS), and 100 U/ml penicillin and
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0.1 mg/ml streptomycin (Pen-Strep or PS). The cell culture media for MIA PaCa-2 cells has the
same components as the media for HeLa cells except the glucose is 4.5 g/L. When the cells are
reached the confluence of approximately 95%, the passage is required to reduce the confluence
for allowing to the continuing growth of the cells. As for the passage procedure, 10 ml of Hank’s
Balanced Salt Solution without calcium chloride and magnesium sulfade (HBSS--) (Sigma
Chemical Co., St. Louis, MO) was used to replace the cell culture medium in the dish and wash
the cells for 2 times. Following the washing of HBSS-- buffer, 1 mL of 0.05% trypsin-EDTA
solution is added to the cell dish to detach the cells. After the cell detaching, the cells with
trypsin solution are diluted with 9 ml of HBSS-- buffer and mix the cells well to fully suspend.
One miniliter of the diluted cell suspension solution was peptited out and plated plate back to the
cell dish with the addition of 9 ml of fresh cell culture media for regular cell growth. The rest of
diluted cell suspension solution is discarded. The passaged cells are placed back into a 37 °C
humidified incubation chamber equipped with 5% CO2 until they reach confluence again. In
general, the cell passage is required every 2-3 days.
To prepare the cell culture media for HeLa or MIA PaCa-2 cells, 13.4 g DMEM (Sigma
Chemical Co., St. Louis, MO) powder with 1 or 4.5 g/L glucose and glutamine was dissolved in
800 mL of ddH2O. 3.7 g of NaHCO3 was added to the media to a final concentration of 44 mM.
6 M HCl was applied to adjust pH to 7.2-7.3. The prepared media was brought to 1 L with
ddH2O. The media was filtered in the laminar flow hood with a Sterivex 0.22 μm filter and
stored in an autoclaved glass bottle at 4 °C. Before cell culture, 500 mL of the cell culture media
were supplemented with 10% FCS, 100 U/ml penicillin and 0.1 mg/ml streptomycin.
To prepare the HBSS-- buffer, 9.7g Hank’s Balanced Salt Solution without divalent
cations (Sigma Chemical Co., St. Louis, MO) was dissolved in 800 mL of ddH2O. Additionally,
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0.0238 g of HEPES, 0.42 g of NaHCO3, and 0.38 g of EGTA were also dissolved into the buffer
solution to final concentrations of 10 mM, 5 mM and 1 mM, respectively. Once all reagents were
dissolved, the pH of the buffer was adjusted between 7.2 and 7.3 with 5 M NaOH. Finally, the
volume of the buffer was brought to 1 L with ddH2O and filtered with a Sterivex 0.22 μm filter
into an autoclaved glass bottle for storage at 4 °C.

2. 22 Preparation of cell plates and transfection of protease sensors

For transfection, the cell plates were prepared one or two days in advance. The cells were
grown on glass coverslips (0.5 - 1.0 × 106 cells/dish) in 35 mm culture dishes in DMEM (Sigma,
St. Louis, MO) with 44 mM NaHCO3, pH 7.2, and supplemented with 10% FCS, 100 U/ml
penicillin and 0.1 mg/ml streptomycin (Pen/Strep) at 37 °C with 5% CO2 in a humidified
incubation chamber. After the cells were seeded for 24-48 hours, the desired DNA plasmids were
transfected to the cells. During the transfection, 2 μl of liposome, lipfectamine-2000, (Invitrogen
Life Technologies) was mixed with 1 ml of serum-free Opti-MEMI media (Gibco Invitrogen
Corporation) and allowed to equilibrate for 5 min at room temperature. 2 μg of desired plasmid
DNA was then mixed well with Opti-MEMI media containing liposome. The mixture of DNA
and liposome solutions was allowed to equilibrate for 20 min in a light-exclusion environment at
room temperature. During the equilibrium, the cell plates were washed twice with 1-2 ml OptiMEMI. The DNA-liposome mixture was then transferred to the cell plates. The additional OptiMEMI was supplied to cell plates to 2 ml of the final volume. The cell plates were incubated for
4-5 hours in an incubator supplied with 5% CO2 at 37 °C. Following 4-5 hours incubation, the
Opti-MEMI media was replaced with fresh DMEM cell culture media for protein expression at
30 °C for 24-48 hours.
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2. 23 Transfection of EGFP fragments

HeLa cells were grown on glass coverslips (0.5 - 1.0 × 106 cells/dish) in 35 mm culture
dishes in Dulbecco’s Modified Eagles Medium (DMEM) (Sigma Chemical Co., St. Louis, MO)
with 44 mM NaHCO3, pH 7.2, and supplemented with 10% FCS (v/v), 100 U/ml penicillin and
0.1 mg/ml streptomycin (Pen/Strep) at 37 °C with 5% CO2 in a humidified incubation chamber.
After the cells were seeded and grown overnight, N-EGFP-EF1 and C-EGFP-EF2 were cotransfected into HeLa cells with lipofectamine-2000 (Invitrogen Life Technologies) and serumfree Opti-MEM (Gibco Invitrogen Corporation) according to the manufacturer’s instructions.
During the transfection, 2 μl of liposome, lipfectamine-2000, (Invitrogen Life Technologies) was
mixed with 1 ml of serum-free Opti-MEMI media (Gibco Invitrogen Corporation) and allowed
to equilibrate for 5 min at room temperature, then 2 µg of N-EGFP-EF1 and 2 µg of N-EGFPEF2 plasmid DNA were added to the serum-free Opti-MEMI media containing lipofectamine2000, respectively. Following overnight incubation at 37 °C, the serum-free Opti-MEMI media
containing DNA and lipofectamine complex was replaced by fresh DMEM cell culture media
enriched with FCS and Pen/Strep. The cells were then grown 24 to 48 hours in a humidified
chamber with 5 % CO2 at 30 °C before fluorescence microscope imaging. Individual transfection
of N-EGFP-EF1 or C-EGFP-EF2 or co-transfection of N-EGFP-EF1p and C-EGFP-EF2p were
used as controls.

2. 24 Fluorescence imaging

Cells were transfected with protease sensors or EGFP-wt, and then allowed to grow for
24-48 hours before imaging. EGFP-wt was used as the control. Cells were imaged on a Zeiss
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Axiovert 200 Inverted Microscope with a 40x oil objective lens and a CCD camera (AxioCam
HRc). Ratiometric emission imaging was acquired through a FITC filter set (excitation
wavelength: 480 ± 10 nm; emission wavelength: 510 ± 10 nm) and 395 nm filter set (excitation
wavelength: 400 ± 10 nm; emission wavelength: 510 ± 10 nm) from a light source (FluoArc,
Zeiss) in a time course mode using Axiovision software. During image acquisition, protease
activation triggers or calcium triggers were added to the cell plate to an appropriate final
concentration for inducing protease activation or opening calcium channels in the subcellular
membrane to adjust calcium concentration in different subcellular compartments. The ratiometric
change between fluorescence emission for excitation at 488 nm and 398 nm was calculated at
different time intervals to detect protease activation in living cells and average ratio values were
calculated from individual cells (Hanson, McAnaney et al. 2002). All fluorescence emissions at
different time intervals were normalized by dividing the initial fluorescence intensity to set the
basal ratio to 1 (Allen, DiPilato et al. 2006).
The fluorescence ratiometric change (R) is expressed by equation 7:

Rt −488 / 398 =

NFt −488
NFt −398

Equation 7

where NFt-488 is the normalization fluorescence intensity of various time points at 488 nm
excitation, and NFt-398 is the normalization fluorescence intensity of various time points at 398
nm excitation.
However, while investigating calcium-dependent protein-protein interactions, calcium
ion channel triggers were applied to activate the calcium influx of cellular compartments and
examine the calcium effect on dimerization of EF1 and EF2 from calbindin D9k. During imaging
acquisition, the signal change in fluorescence intensity under 488 nm excitation was used to an
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indicator of calcium dependent protein-protein interaction when ionomycin and calcium were
added to stimulate the cells co-transfected N-EGFP-EF1 and C-EGFP-EF2 to final
concentrations of 1 μM and 5 mM, respectively.

2. 25 Immunofluorescence

In order to identify the same subcellular location of trypsinogen activation and EGFPbased trypsin sensor expression, immunofluorescence was used to confirm the localization of
typsinogen activation following induction with 10 nM caerulein in MIA PaCa-2 cells transfected
EGFP-T1. EGFP-T1 was transfected into MIA PaCa-2 according to above statement for its
expression 48 hrs. Following protein expression, MIA PaCa-2 cells was conducted to induction
using caerulein in a final concentration of 10 nM for 1 hr. The cell culture media was removed
and the cells were washed one time using PBS buffer (140 mM NaCl, 2.7 mM KCl, 20 mM
Na2HPO4, 2 mM KH2PO4, pH 7.4). After the washing, 500 μl of 3.7% paraformaldyhe was
added in the cell chamer to fix the cells for 30 min at room temperature and then the fixed cells
were incubated with 0.1% Triton X-100 for 15 min at room temperature. The fixed cells were
washed with TBS buffer three times for 15 min each time. 500 μl of TBS buffer with 5% BSA
was added in the cell chamber to block the cells for 3 hrs, and then primary antibodies, rabbit
polyclonal to α-antitrypsin and goat polyclonal to GFP conjugated with FITC (Abcam Inc.) was
added into cell chamber with TBS buffer containing 2.5% BSA with 1:200 dilutions and then
incubated with fixed cells for another 3 hrs at room temperature. Following the incubation with
primary antibodies, the cells were washed with TBS buffer three times for 15 min each time.
Secondary antibody, rabbit IgG antibody conjugated with Texas Red (Abcam Inc.) was used to
against the primary antibody, rabbit polyclonal antitrypsin for incubating 1 hr at room
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temperature. After the incubation, the extra secondary antibody was removed through the
washing three times with TBS buffer for 15 min each time. One drop of mounting regent was
added on the glass coverslip and then covered for cell imaging.

2. 26 Confocal microscope imaging

The cells transfected with protease sensors were transferred from DMEM cell culture
media to Ringer solution (10 mM HEPES, 0.4 mM KH2PO4, 2.4 mM K2HPO4, 120 mM NaCl, 1
mM CaCl2, 1 mM MgCl2, 10 mM Glucose, pH 7.4), and the living cell imaging experiments
were conducted on an LSM 510 laser confocal microscope (Carl Zeiss Inc., Thornwood, NY)
using a 100Χ oil-immersion objective (Zeiss, Fluar, 1.30 NA). Prior to imaging, the cells and
solutions were allowed to equilibrate to room temperature. The localization of EGFP-based
protease sensors was visualized by excitation of EGFP with the 488 nm line of an argon laser,
and the narrowest bandpass filter (505-530 nm) was employed for emission. Mitotracker Red and
DsRed-ER marker were excited with the 543 nm line of a He-Ne laser, and emission was
detected through a long-pass filter (emission above 560 nm). Zeiss LSM 510 software (Carl
Zeiss, Inc.) was used to control the image acquisition parameters. All images were acquired at
high resolution (1024 × 1024).

2. 27 Protease assay in cell lysates

To examine the protease and confirm the protease activation pattern in living cells,
protease activity was determined using chromogenic or fluorogenic peptide substrates in cell
lysates following protease inducer stimulation. HeLa Cells or MIA PaCa-2 cells (1 × 106) were
cultured in 100-mm cell culture dishes for 24 h and then treated with 1 μM staurosporine (STS)
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or 10 nM caerulein to activate caspase-3 or trypsinogin, respectively. The cell pellets from each
cell line at 80% confluence following STS or caerulein induction at various interval times were
harvested and lysed with lysis buffer (10 mM Tris, 10 mM NaH2PO4/NaHPO4, 150 mM NaCl,
1% Triton X-100, 10 mM Na2P2O7·10H2O, pH 7.5) containing phosphatase inhibitors (1 mM
sodium orthovanadate, 30 mM NaF, 1 mM phenyl methylsulfonyl fluoride). The supernatant
containing protein was obtained through centrifugation at 13000 ×g. The total protein
concentration was determined using BSA protein assays (Bio-Rad, USA) according to the
protocol of the manufacturer. The cell lysates containing 100-μg protein of each sample at
various time intervals were mixed with trypsin substrate (Z-Arg-pNA) or caspase-3 substrate kit
(Z-DEVD-AFC) in the indicated substrate reaction buffer (10 mM Tris, 20 mM CaCl2, pH 7.5)
for trypsin activity assays or (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 10 mM DTT, 0.1%
CHAPS, 10% sucrose, pH 7.4) for caspase-3 activity assays, and then incubated under light-free
conditions for 1 hour at 37 ˚C. The absorbance or fluorescence results of each sample at various
induction time intervals were measured using a fluorescence microplate reader. Relative
fluorescence units (RFU) were to express the trypsin or caspase-3 activity. To normalize the
activated trypsin or caspase-3 amount in cell lysates, active trypsin or caspase-3 was used as a
positive control. The amount of trypsin or caspase-3 activation can be estimated at various time
points following caerulein or STS induction in living cells.

2. 28 Western blot

To confirm the caspase-3 activation pattern in living cells, caspase-3 activation was
examined using western blot in cell lysates. HeLa Cells and MIA PaCa-2 cells (1 × 106) were
cultured in 100-mm cell culture dishes for 24 h and then treated with 1 μM STS. Cells were
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harvested at various time points (0, 30, 60 and 120 min) following STS stimulation and then
lysed in RIPA buffer (50 mM Tris, 150 mM NaCl, 1.0% NP4O, 0.5% deoxycholic acid, 0.1%
SDS, pH 8.0) containing phosphatase inhibitors (1 mM sodium orthovanadate, 30 mM NaF, 1
mM phenyl methylsulfonyl fluoride). The total amount of protein of each cell lysate supernatant
was measured with BSA protein assays. 100 μg of protein from each sample was electrophoresed
through a polyacrylamide-SDS gel for 3 h at 60 V and electroblotted onto nitrocellulose
membranes in transfer buffer (50 mM Tris, 100 mM glycine, and 20% methanol) for 4 h at 100
mA. The membrane with proteins was blocked overnight at 4 ºC using block buffer (20 mM Tris,
150 mM NaCl, 0.1% Tween-20, 5% BSA, pH 7.5). Then the proteins on the membrane were
exposed to a monoclonal primary antibody, anti-mouse caspase-3 (Cell Signaling, USA), for 4 h
at room temperature, which can interact with the full length of caspase-3 and the large fragment
of cleaved caspase-3. Following the washing of primary antibody, HRP-conjugated secondary
antibody was added to interact with primary antibody for 2 h at room temperature. The
interaction between primary and secondary antibody was detected with the enhanced
chemiluminescence (ECL) system after the addition of anti-mouse or anti-rabbit IgG (Cell
Signaling, USA). Meanwhile, the primary antibody, anti-β-actin was used as the loading control.

2. 29 Detection of half-time for maximum casapse-3 activation in living cells

Cells were transfected with EGFP-based caspase-3 sensors and then allowed to grow for
24-48 hours before imaging. In order to detect the rate of caspase-3 activation in living cells
following 1 μM STS stimulation, the half-time maximum for caspase-3 activation was used to
evaluate. Cells were imaged on a Zeiss Axiovert 200 Inverted Microscope with a 40x oil
objective lens and a CCD camera (AxioCam HRc). Ratiometric emission imaging was acquired
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through a FITC filter set (excitation wavelength: 480 ± 10 nm; emission wavelength: 510 ± 10
nm) and 395 nm filter set (excitation wavelength: 400 ± 10 nm; emission wavelength: 510 ± 10
nm) from a light source (FluoArc, Zeiss) in a time course mode using Axiovision software.
During image acquisition, STS was added to the cell plate to a final concentration of 1 μM for
inducing caspase-3 activation. The fluorescence ratiometric change between excitation at 398
and 488 nm was calculated at different time intervals to detect protease activation in living cells.
The time point of 50% change between minimum and maximum fluorescence ratiometric change
is designated as half-time for maximum caspase-3 activation. The average half-time for
maximum caspase-3 activation is calculated using individual half-time for maximum caspase-3
activation from various cells (at least 12 cells), which can also used to compare the potential
caspase-3 activation capability of different cell lines.

2. 30 pH change examination in living cells

In order to determine whether inducers for trypsinogen or caspase-3 activation have an
effect on pH change in living cells, one of the pH probes, 2', 7’-bis-(2-carboxyethyl)-5-(and-6)carboxyfluorescein, acetoxymethyl ester (BCECF-AM) (Invitrogen, Molecular Probe, USA) was
used to examine the pH change following protease trigger stimulation. HeLa or MIA PaCa-2
cells were grown on glass coverslips (0.5 - 1.0 × 106 cells/dish) in 35 mm culture dishes in
Dulbecco’s Modified Eagles Medium (DMEM) (Sigma Chemical Co., St. Louis, MO) with 44
mM NaHCO3, pH 7.2, and supplemented with 10% FCS (v/v), 100 U/ml penicillin and 0.1
mg/ml streptomycin (Pen/Strep) at 37 °C with 5% CO2 in a humidified incubation chamber.
After the cells were seeded and grown overnight, the cells were incubated with BCECF-AM pH
probe to a final concentration of 10 μM in modified Ringer solution at 37 °C for 45 min. Then
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the fresh modified Ringer solution was added to the cell dishes and incubated for another 20 min
at 37 °C to ensure complete hydrolysis of the probe and release of the fluorescent group in living
cells. Cells were imaged on a Leica Inverted Microscope (Leica Microsystem, Germany) with a
40x oil objective lens and an EM CCD camera (Hamamatsu Corporation, Japan). Ratiometric
emission imaging was acquired though a monochromater set (excitation wavelength: 490 ± 10
nm and 440 ± 10 nm; emission wavelength: 535 ± 10 nm) from a light source in a time course
mode under the control of SimplePCI software (Hamamatsu Corporation, Japan). During image
acquisition, protease activation triggers (10 nM caerulein for trypsinogen activation and 1 μM
STS for caspase-3 activation) were added to the cell plate to an appropriate final concentration
for inducing protease activation. The ratiometric change between fluorescence emission for
excitation at 490 and 440 nm was calculated at different time intervals to express pH change due
to effects of protease inducers in living cells.

2. 31 Fluorescence spectral scanning of protease sensors in living cells

The living cells cultured on glass coverslips with transfected protease sensors were
transferred from DMEM cell culture media to Ringer solution (10 mM HEPES, 0.4 mM
KH2PO4, 2.4 mM K2HPO4, 120 mM NaCl, 1 mM CaCl2, 1 mM MgCl2, 10 mM Glucose, pH
7.4). The glass coverslip with living cells containing transfected protease sensors was vertically
placed in a cuvette with 1 cm of pathway. Two miniliter of Ringer solution was added into the
cuvette to make the solution level over the glass coverslip for maintaining cells under normal
culture conditions. Fluorescence excitation spectra and emission spectra of protease sensors in
living cells were measured using a fluorescence photospectrometer (Photon Technology
International Inc., Canada). The fluorescence excitation spectra ranging from 300 to 500 nm
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were scanned with an emission wavelength of 508 nm, while the fluorescence emission spectra
ranging from 500 to 600 nm were scanned with excitation wavelengths of 398 and 490 nm. In
order to track the fluorescence spectral change of caspase-3 sensors in living cells following
stimulation with 1 μM STS, fluorescence emission spectra of caspase-3 sensors were measured
at various time intervals of 0, 5, 10, 20, 30, 45, and 60 min following STS induction. The
fluorescence spectrum change of EGFP-wt in living cells was also monitored in parallel under
identical conditions as a control. The relative change in maximum fluorescence intensity at 508
nm with excitations at 398 and 490 nm was calculated and normalized to reveal relative
percentage change following protease activation through equation 8:

NFt =

Ft
F0

Equation 8

where NFt is the normalization fluorescence intensity at various time points; Ft is the
fluorescence intensity of various time points and F0 is the initial fluorescence intensity.
Meanwhile, the ratiometric change of fluorescence emission between excitations at 398
and 470 nm was calculated at different time intervals to detect protease activity in living cells.
The fluorescence ratiometric change (R) is expressed by equation 9:

Rt −398 / 490 =

NFt −398
NFt −490

Equation 9

where NFt-398 is the normalization fluorescence intensity at 508 nm for various time points with
398 nm of excitation; NFt-490 is the normalization fluorescence intensity at 508 nm for various
time points with 490 nm of excitation.
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2. 32 Statistical analysis

The data for normalization of fluorescence intensity and fluorescence ratio change of
living cells transfected with EGFP-based protease sensors and EGFP-wt are represented as
means ± SD with at least 6 living cells. Student’s t-test analysis was performed to determine the
statistical significance between EGFP-based protease sensors and EGFP-wt. Differences were
considered statistically significant at P < 0.05.
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Chapter 3

3. 1

Design sensitive EGFP-based trypsin sensors for living cell imaging

Introduction

3.1.1 Trypsin function

Digestive proteases are produced as inactive proenzymes inside the membrane-bound
zymogen granules (Thrower, Diaz de Villalvilla et al. 2006). The proenzyme becomes active
after enzymatic maturation during exocytosis (Raraty, Ward et al. 2000; Sherwood, Prior et al.
2007). Usually protease inhibitors coexist with proteases at concentrations sufficient to prevent
autodigestion (Hirota, Ohmuraya et al. 2006). Fatal human diseases such as acute pancreatitis
result from autodegradation of trypsin, chymotrypsin and elastase derived from pancreatic
tissues. Trypsin is one of the major digestive enzymes that are responsible for regulating protein
degradation (Hirota, Ohmuraya et al. 2006). Intracellular misbalanced trypsinogen activation,
inhibition, turnover and secretion can result in acute and chronic pancreatic diseases (Goldberg
2000). Approximately 35000 new cases of pancreatic cancer related to serine proteases,
including trypsin, are reported annually, which ranks as the fourth leading cause of cancer deaths
in the United State (Sarkar, Banerjee et al. 2006). The overall survival rate for pancreatic cancer
patients is less than 4%, but diagnosis at an early stage may significantly improve these odds
(Shaib, Davila et al. 2006). Clearly, finding an effective approach to investigate pathological
mechanisms, improve early diagnosis and develop new treatment strategies for pancreatic cancer
would have significant medical value.
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3.1.2 Substrate specificity of trypsin

Examination of the three-dimensional structures of the enzyme-inhibitor and enzymepseuosubstrate complexes can reveal important information on hydrogen bonds, van der Waals
interactions, and electrostatic interactions. Intensive investigations of trypsin have resulted in
significant achievements in elucidating the amino acid and nucleotide sequences, threedimensional structures, and kinetic and thermodynamic constants for trypsin substrates and
trypsin inhibitors over the past four decades. Long-term investigation into this enzyme and its
family members has thus far produced spectacular achievements. Much attention is also drawn to
crystallographic studies or to site-directed mutagenic studies, which can narrow, broaden or
change protease specificity in a predictable way.
Based on the interaction between substrate recognition sites and the subsites of trypsin
(c.f. Figure 1.1), trypsin is a proteolytic enzyme showing substrate specificity for Arg or Lys
with high preference at the P1 position. A negatively charged amino acid at the base of the
catalytic binding pocket of tryspin is important for catalytic activity (Graf, Jancso et al. 1988;
Evnin, Vasquez et al. 1990). According to the available crystal structures for trypsin complexes,
Asp189 is a crucial amino acid residue in the pocket and always contributes a cyclic network of
hydrogen bonds with the guanidinium group of Arg, as also indicated in Figure 3.1 (Perona and
Craik 1997). In order to examine the significance of Asp189 in trypsin, extensive investigations
were conducted using both site-directed mutagenesis (Graf, Craik et al. 1987; Graf, Jancso et al.
1988; Wilke, Higaki et al. 1991) and genetic selection (Evnin, Vasquez et al. 1990). The mutant
of trypsin, D189K, displays no catalytic activity on lysyl or arginyl substrates. Approximately
105-fold decrease in the catalytic efficiency toward peptidyl substrates containing the Arg or Lys
residue at the P1 position can be observed following replacement of Asp189 with different
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Figure 3. 1. Interaction between substrate and catalytic binding pocket in trypsin.
A cyclic network of hydrogen bonds is formed between the guanidinium group of P1 Arg in
substrate and Asp189 at the catalytic binding pocket in trypsin. Modified after (Perona and Craik
1997).
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residues, such as Asn, Ala, or Tyr (Graf, Craik et al. 1987; Graf, Jancso et al. 1988). The
catalytic activity with respect to arginine and lysine substrates can also be partially restored by
either the presence of Asp or Glu at position 189 or 190 due to the electrostatic
complementarities. The amino acid residue at position 190 also has a regulatory effect on the
catalytic specificity of trypsin (Evnin, Vasquez et al. 1990). Surprisingly, the activity of the
D189S mutant can also be partly rescued using a high concentration of acetate (up to 3 M)
(Perona, Hedstrom et al. 1994). In this case, the restored activity may result from the negative
potential provided by the acetate molecule, which appears to cause up to 300-fold rescue of the
catalytic rate.
The contributions from acidic residues in the catalytic binding pocket to the catalytic
activity or efficiency were also intensively probed through charge relocation. The side chain of
Gly226 in trypsin may potentially protrude into the pocket, based on the analysis of the crystal
structure of G226A (Wilke, Higaki et al. 1991). Charge relocation was fulfilled through sitedirected mutagenesis, and high-level catalytic efficiency was revealed in a D189G/G226D
variant for substrates with P1 positively-charged side chains. Similar kinetic enhancements were
obtained for P1 Arg and Lys substrates in the case of genetically-selected variants with Asp
relocated to position 190 (Evnin, Vasquez et al. 1990). Therefore, electrostatic availability
through charge interactions can contribute to more interaction between the enzyme and substrate
than the direct hydrogen bond interactions involving Asp226, or can modify the hydrogen bond
arrangement between the enzyme and substrate. Such hypotheses can also explain the
importance for the conservation of Asp189 in trypsin-like serine proteases.
Taken into consideration the characteristics of the catalytic binding pocket in trypsin, a
growing body of methods is used to evaluate substrate specificity for trypsin and to develop
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sensitive substrates or probes for determining trypsin activity. Since the P1 position of the
substrates for trypsin selectively prefers Arg or Lys, the P2 and the P3 sites were first found to
exhibit high preference to Ala and Pro residues at the P2 site and Gln at the P3 site based on the
comparison of kinetic parameters of Boc-X-X-Arg-Mec substrate (Kawabata, Miura et al. 1988).
The trypsin chromogenic substrate selection using combinatorial chemistry approach was used to
design an optimal substrate with high specificity (Zablotna, Dysasz et al. 2004) and obtained the
most sensitive substrate Phe-Val-Pro-Arg-Anb-NH2 with 125-fold more activity than BAPNA,
(Bz-D, L-Arg-pNA). Peptide microarray and peptide-profiling library were also applied to assay
protease substrate specificity (Gosalia, Salisbury et al. 2005; Thomas, Francis et al. 2006).
Taking into consideration substrate specificity for trypsin, the kinetic parameter, kcat/Km, of most
substrates conjugated to preferable amino acid residues and chromogenic or fluorogenic dyes,
ranged from 103 to 106 M-1s-1.

3.1.3 Trypsin measurements

The study of protease actions in living systems requires sensitive probes capable of realtime monitoring the activation or inhibition of proteases in various cellular locations. Although
proteases and protease inhibitors can be monitored through real-time PCR and Western blot,
quantitative methods to measure protease activity and its inhibition in living cells in real time are
highly desired. The actions of most proteases are typically measured using chromogenic or
fluorogenic dyes such as p-nitroaniline, AFC, AMC or rhodamine conjugated to short
peptides/peptide mimics encompassing the P1 to Pn cleavage sites (usually up to P4) in cell
lysates, or using fluorescence antibody detection of the cleaved product in fixed cells (Abe, Baba
et al. 2000; Zablotna, Dysasz et al. 2004). Although some of these peptide probes are able to
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diffuse into cells by passive diffusion through the membrane, they cannot provide continuous
dynamic imaging of enzyme actions due to limited cellular lifetime, nor are they capable of
detecting reactions at targeted cellular locations (Miyawaki 2003; Giepmans, Adams et al. 2006).
Fluorescent proteins with self-encoded chromophores are capable of monitoring numerous
cellular events in living cells or organisms via real-time imaging (Chalfie, Tu et al. 1994).
Currently, several protease probes using fluorescent protein pairs have been developed, which
utilize fluorescence resonance energy transfer (FRET) change upon protease actions (Luo, Yu et
al. 2003; Zhang 2004; Allen, DiPilato et al. 2006; Wu, Simone et al. 2006; Vinkenborg, Evers et
al. 2007; Yang, Zhang et al. 2007). Meanwhile, fluorescent complementation techniques based
on ligand-induced chromophore formation by protein fragments have also been applied to
develop sensors to detect calcium, kinase and protein-protein interactions in various cellular
processes (Nagai, Sawano et al. 2001; Kawai, Sato et al. 2004). Calpain proteolytic activity in
living mice muscle can be monitored through FRET-based methods using multiphoton
microscopy (MPM) (Stockholm, Bartoli et al. 2005). However, the practical application of these
FRET-based protease probes is limited by FRET efficiency due to cross-talk in FRET signals,
sensitivity to photobleaching and cellular environmental perturbation (Felber, Cloutier et al.
2004; Piston and Kremers 2007; Vinkenborg, Evers et al. 2007). Therefore, the study of protease
actions in living systems is frequently hindered by the lack of ideal tools or probes capable of
monitoring dynamic processes of proteases in various cellular locations. The capability of
assessing the functional roles of proteases by quantitative, real-time methods to measure protease
activity and its inhibition in living cells is highly desired (Boonacker, Elferink et al. 2003).
Investigations on mechanisms and diagnosis of chronic pancreatic diseases are largely restricted
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to later stages of the illness, partly due to inherent limitations in the currently available peptide
kits designed for the detection of trypsin activity in cell lysates.

3.1.4 Objectives

In this chapter, we first report a novel strategy to develop trypsin sensors by grafting an
enzymatic cleavage site into a sensitive location for chromophore optical property change of
EGFP. The ratiometric optical signal change of designed trypsin sensor variants will be
examined. Their high enzymatic selectivity and kinetic responses for enzyme activation and
inhibition will be investigated. The application of developed trypsin sensors to cellular activation
of trypsinogen and the effects of inhibitors in living pancreatic cells will be examined.

3. 2

Design and construction of trypsin sensors

To design protease sensors for monitoring cellular processes related to protease activation
and inhibition with fluorescence signaling, trypsin sensor variants were engineered by grafting
an enzymatic cleavage sequence onto EGFP, as seen in Figure 3.2A. We hypothesized that
proteolytic cleavage occurring within designed sequences at sensitive locations near the
chromophore could result in a chromophore signal change due to local conformational change.
Based on cited criteria for optimal design of a protease sensor, three grafting sites on the wild
type EGFP (EGFP-wt) scaffold were selected to confer these essential sensor properties. The
three sites are immediately following Glu172 within loop-9, Gln157 within loop-8, and Asn144
within loop-7. Trypsin demonstrates a strong preference to cleave the peptide bond immediately
following an Arg or Lys residue in a solvent-accessible region. Consequently, we selected a
trypsin cleavage sequence derived from EF-hand motif loop-III of calmodulin as the basic
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Figure 3. 2. Grafting location selection and cleavage linker for the design of trypsin sensors.
(A) The diagram demonstrates three EGFP-based trypsin sensors grafted the cleavable linker for
trypsin at positions Asn144, Gln157 and Glu172. Trypsin cleavage occurs following residues R
or K underlined in sequence. (B) The model structure shows insertion locations for the grafting
of trypsin linker in the EGFP scaffold.
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grafted structure because it contains three Arg and one Lys residues in the loop and flanking
helices, and has good solvent accessibility based on the model structure shown in Figure 3.2B.
Three potential trypsin sensors were obtained through a grafting approach using PCR techniques,
which are named after EGFP-T1, EGFP-T2 and EGFP-T3 based on location 172, 157 and 144,
respectively.

3. 3

Optical properties of trypsin sensors

The genetically engineered trypsin sensors EGFP-T1, EGFP-T2 and EGFP-T3 along with
wild type EGFP in the pet28a vector were successfully expressed in E. coli. Following grafting
of trypsin cleavage sites, EGFP-T1 and EGFP-T2 retained strong fluorescence both in bacteria
and as purified proteins, but EGFP-T3 did not. The UV-visible absorption spectra of the three
classes of purified trypsin sensors are shown in Figure 3.3A. EGFP-T3 did not exhibit strong
absorption peaks in the range 350-500 nm. Compared to the absorption spectra of EGFP-wt,
EGFP-T2 exhibited a similar maximum absorption wavelength at 490 nm due to its deprotonated
form of the chromophore. In contrast, EGFP-T1 had two strong absorption peaks at 490 and 397
nm, where the peak at 397 nm corresponds to the protonated form of the chromophore (Tsien
1998). The insertion of the EF-loop at position 172 in EGFP increased the population of the
protonated form of the chromophore while correspondingly decreasing the deprotonated form of
the chromophore observed at 490 nm. The maximum emission wavelengths of EGFP-wt, EGFPT1 and EGFP-T2 were 508, 508 and 506 nm, respectively, resulting from excitation at 398 nm,
as shown in Figure 3.3B. However, it should be noted that part of the fluorescence emission
signal at 508 nm of EGFP-T1 also originated from excitation at 490 nm. Furthermore, such
alteration of the ionic state of the chromophore is related to the addition of the flanking helices.
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Figure 3. 3. Optical properties of designed trypsin sensors.
UV-visible absorption (A) and fluorescence (B) spectra of EGFP-wt (○), EGFP-T1 (□), EGFPT2 (◊) and EGFP-T3 (●) were measured in 10 mM Tris, 1 mM DTT, pH 7.4. EGFP-wt and
EGFP-T2 showed the similar absorption peak at the wavelength of 490 nm. On the other hand,
EGFP-T1 exhibited two strong absorption peaks at 398 and 490 nm. However, no strong
absorption peaks were observed in EGFP-T3. Fluorescence maximum emission peaks of EGFPwt (○), EGFP-T1 (□), EGFP-T2 (◊) occurred at 508 nm while excited 398 nm.
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The EGFP-based trypsin sensor variants with both flanking helices exhibited a greater absorption
ratio of A397nm/A490nm than trypsin sensor variants having only a single flanking helix, or no
flanking helix in the inserted loop (Figure 3.4). The absorption ratio of A397nm/A490nm of different
trypsin sensor variants was shown in Table 3.1. According to the absorbance and fluorescence
properties, EGFP-T2 has optical properties similar to that of EGFP-wt where the dominant
species has a protonated chromophore, whereas the insertion of a cleavage linker for trypsin
following position 172 results in a population reduction of deprotonated chromophore species
and a corresponding increase of the protonated species. This result suggests that position 172 in
EGFP is a sensitive location at which the ionic states of the chromophore species can be altered
by the addition of the grafting sequence.

Table 3. 1. Ratio of deprotonated and protonated chromophore of trypsin sensors
Ratio

Trypsin sensors

E-helix

Loop

F-helix

EGFP-T1

EEEIREAFRVF

DKDGNGYISAAE

LRHVMTNL

0.75

DKDGNGYISAAE

LRHVMTNL

0.64

EGFP-T1Fa
EGFP-T1Ea
EGFP-T1L
EGFP-wt

EEEIREAFRVF

(A397nm/A490nm)

DKDGNGYISAAE

0.40

DKDGNGYISAAE

0.31
0.15
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The dual chromophore forms in GFP has been demonstrated in previous reports (Tsien
1998). A complicated hydrogen bond network allowing for proton transfer between the
chromophore and its neighboring side chains provides a great contribution to the equilibrium
between protonated and deprotonated chromophore forms (Brejc, Sixma et al. 1997). The
predominant protonated form of the chromphore exhibits its maximum absorbance at 397 nm,
which is governed by the carboxylation of Glu222 through electrostatic repulsion and hydrogen
bonding between a bound water molecule and Ser205. In contrast, the maximum absorbance
peak of the deprotonated form of the chromophore is observed at 490 nm. Under this condition,
the charge of Glu222 was proposed to donate to the chromophore through proton abstraction and
a hydrogen bond network, involving in Ser205 and bound water. In order to stabilize the
deprotonated state, a rearrangement of the side chains of Thr203 and His148 may be involved in,
as shown in Figure 3.5. Besides the proton relay between Ser205 and Glu222, the side chains of
Asp117, Thr118, Glu172 and Asp190 were also proposed to be involved in the alteration of
different conformations of the chromophore under the observation of electron density of crystal
structure (Brejc, Sixma et al. 1997). Our observation of the switch of dual chromophore forms
following the insertion of cleavage linker at position 172 is likely due to a result from the
alteration of ionization state of the chromophore. Following the insertion of the cleavage linker
at position 172 of EGFP, the population of both states of the chromophore may be significantly
altered through the proton relay between Ser205 and Glu222 and arrangement of hydrogen bond
networks due to the environmental change of Glu172 (Brejc, Sixma et al. 1997).
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Figure 3. 4. Effects from inserted linkers on spectral change of EGFP-based trypsin sensors.
Compared to EGFP-wt, the ratio (A397nm/A490nm) of absorbace of deprotonated and protonated
chromophore forms was exhibited as an increased order, EGFP-T1 (■) containing loop flanked
both E-helix and F-helix, EGFP-T1-Fa (▲) containing loop flanked alone F-helix, EGFP-T1-Ea
(♦) containing loop flanked alone E-helix, EGFP-T1L (▼) containing a loop without helices, and
EGFP-wt (●).
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Figure 3. 5. Switch between protonated and deprotonated forms of chromophore in EGFP.
Proton relay between Ser205 and Glu222 of EGFP results in two chormophore forms,
deprotonated and protonated forms, which provides dual excitation states or maximum
absorption peaks of EGFP. The side chains of Asp117, Thr118, Glu172 and Asp190 also
involved in the alteration of different conformations of the chromophore through under the
observation of electron density of crystal structure. Modified after (Brejc, Sixma et al. 1997).
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3. 4

Optical change of trypsin sensors following the action of trypsin

To evaluate optical signal changes related to the action of trypsin cleavage, the UVvisible absorption spectra of EGFP-T1 were measured before and after trypsin cleavage in
trypsin digestion buffer (10 mM Tris, 10 mM CaCl2, pH 7.4). Following trypsin cleavage, the
maximum absorption of EGFP-T1 at 490 nm increased by 82% and concurrently decreased by
53% at 398 nm (Figure 3.6A). Similarly, EGFP-T1 exhibited a ratiometric fluorescence change
with a 51% decrease in maximum fluorescence emission intensity at 508 nm at an excitation
wavelength of 398 nm (Figure 3.6C) and a corresponding 36% increase at an excitation
wavelength of 490 nm (Figure 3.6D). In contrast, the maximum absorption of EGFP-T2 showed
no obvious change although it was cleaved by trypsin under identical digestion conditions
(Figure 3.6B). As expected, EGFP-wt, which was not cleaved, exhibited no optical signal
change. This result suggests that position 172 in EGFP is a sensitive location at which the ionic
states of the chromophore species can be altered by the addition of the grafting sequence. The
observed optical changes in the maximum absorption and fluorescence emission intensities may
be due to the recovery of proton relay between Ser205 and Glu222 with the dissection of original
interaction of Glu172, thereby recovering relative proportions of the two chromophoric species
of EGFP-T1 following cleavage by trypsin, which revealed that the insertion at position Glu172
should be an optically sensitive location with respect to chromophore properties.
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Figure 3. 6. Optical signal change of trypsin sensors following trypsin digestion.
Absorption spectra of EGFP-T1 (A) and EGFP-T2 (B) were measured after trypsin digestion at
various times from 0 min (solid line) to 120 min (dashed line) in trypsin digestion buffer (10 mM
Tris, 20 mM CaCl2, at pH 7.4). Absorbance of EGFP-T1 exhibited a decrease at 397 nm and an
increase at 491 nm following trypsin digestion at different digestion time intervals. In contrast,
Absorbance of EGFP-T2 exhibited no change following trypsin digestion at different digestion
time intervals. Fluorescence spectra of EGFP-T1 with excitation at 398 nm (C) and excitation at
490 nm (D) were measured following trypsin digestion from 0 min (solid line) to 120 min
(dashed line) in trypsin digestion buffer. Fluorescence of EGFP-T1 decreases when excited at
398 nm and increases when excited at 490 nm following trypsin digestion at different digestion
time intervals.
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3. 5 Verification of trypsin sensor cleavage

To verify the cleavage status of EGFP-based trypsin sensors, digestion reactions with 15
μM EGFP-T1 and EGFP-T2 were performed by adding stock trypsin from bovine pancreas
(Sigma, St. Louis) up to a final concentration of 20 nM in trypsin reaction buffer (10 mM Tris,
10 mM CaCl2, pH 7.4). The UV-visible spectra of trypsin sensors following trypsin digestion
were measured in a 1 cm pathway cuvette at different time intervals (0, 1, 3, 5, 10, 20, 30, 60, 90
and 120 min) and fluorescence spectra of trypsin sensors with excitation at 398 and 490 nm were
recorded at identical time intervals. Similarly, EGFP-wt was subjected to identical digestion as
the control. The resulting cleavage products were systematically examined using SDS-PAGE and
MALDI-MS. EGFP-T1 and EGFP-T2 were found to specifically cleave into two major
fragments by trypsin at the grafted cleavage sites, approximately 20 and 8 kDa from EGFP-T1
(Figure 3.7A), and 18 and 10 kDa from EGFP-T2 (Figure 3.7B) in SDS-PAGE. As a function of
increasing digestion time, these two major fragments remain unchanged until digestion up to 24
hours. In contrast, EGFP-wt exhibited only a minor decrease in mass (Figure 3.7C) resulting
from the removal of His-tag upon incubation with trypsin based on the SDS-PAGE assays. The
cleaved mixtures were subjected to further analysis by MALDI-MS (Dr. Siming Wang provided
the spectroscopy data). The results revealed that fragments produced from EGFP-T1 have
molecular masses of 20840.79 and 7969.20 Da (Figure 3.7D), and fragments from EGFP-T2
have molecular masses of 18542.65 and 9759.08 Da (Figure 3.7E), which corresponds to the
calculated mass values of 20844.68 Da and 18551.00 Da for the large fragments of EGFP-T1
and EGFP-T2, and is consistent with cleavage occurring in the cleavage linker. On the other
hand, EGFP-T3, which exhibited no fluorescence, was not suitable as a sensor due to its apparent
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Figure 3. 7. Cleavage verification of trypsin sensors using SDS-PAGE and MALDI-MS.
SDS-PAGE gels show cleavage products of EGFP-T1 (A), EGFP-T2 (B), and EGFP-wt (C) at
different digestion time intervals. M is protein marker. Lanes 1, 2, 3, 4, 5, 6, 7, 8 and 9 are
samples following trypsin digestion for 0 min, 1 min, 5 min, 10 min, 30 min, 60 min, 2 h, 6 h,
and 24 h at room temperature, respectively. The product fragments of EGFP-T1 (D) and EGFPT2 (E) cleaved by trypsin were identified using MALDI-MS. (F) To block the trypsin cleavage
site, all Arg and Lys in the cleavage linker of EGFP-T1 were mutated into Ala to obtain EGFPT1m. This mutation prevented the cleavage in the inserted linker of EGFP-T1m. M is the protein
marker. Lane 1, 2 and 3 are samples of EGFP-T1m without trypsin digestion, EGFP-T1m with
trypsin digestion and EGFP-T1 with trypsin digestion, respectively.
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unfolded structure revealed by far UV circular dichroism, and its possible digestion into multiple
fragments was suggested by the lack of distinct bands in SDS-PAGE. Furthermore, we created a
negative control EGFP variant (EGFP-T1m), lacking trypsin cleavage sites, through mutation of
Arg and Lys within the designed cleavage linker into Ala. Upon addition of trypsin, EGFP-T1m
was not observed to be cleaved into small fragments at the inserted linker region in SDS-PAGE
(Figure 3.7F) although a similar minor decrease in mass was observed, as with EGFP-wt, due to
removal of the His-tag. The absorption and fluorescence signals of this EGFP variant are also not
altered upon addition of trypsin. These results clearly demonstrated that cleavage occurred
specifically at the designed cleavage linker in EGFP-T1 and EGFP-T2.

3. 6 Kinetic study of trypsin sensors

Kinetic studies of EGFP-T1 were compared with results from three commercially
available trypsin substrates, Bz-DL-Arg-pNA (BAPNA), Bz-DL-Arg-AMC and Boc-Gln-AlaArg-AMC under identical trypsin digestion buffer conditions. All of these commerciallyavailable substrates exhibit optical signal changes at a single wavelength (i.e. non-ratiometric)
upon trypsin cleavage. Kinetic parameters, turnover number (kcat), the Michaelis constant (Km),
and the specificity constant (kcat/Km) for our trypsin sensors (Figure 3.8) and those of commercial
trypsin substrates were calculated through fitting with the Michaelis-Menten equation, as listed
in Chapter 2.16. Kinetic parameters are shown in Table 3.2. The EGFP-T1 sensor exhibited a
750-fold decrease in Km and a 150-fold increase in the substrate specificity constant (kcat/Km)
compared to the BAPNA colorimetric kit. Similarly, an approximately 20-fold decrease in Km
and a 20-fold increase in kcat/Km were observed in comparison with Bz-DL-Arg-AMC. Boc-GlnAla-Arg-AMC, with preferable residues at positions P2 and P3, exhibited 2.3-fold larger Km and
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Figure 3. 8. Kinetic studies of EGFP-T1 conducted in trypsin digestion buffer.
Kinetic studies of EGFP-T1 were conducted to monitor the absorbacnce signal change of EGFPT1 at 490 nm following trypsin digestion in trypsin reaction buffer with 10 mM Tris, 10 mM
CaCl2, pH 7.4 at room temperature. The catalytic kinetic parameters, kcat, Km, and kcat/Km, are
-1 -1
0.26 ± 0.01/s, 4.0 ± 0.4 μM, and 65000 ± 5000 M s through Michaelis-Menten equation fitting,
respectively. The data presented in mean ± SD, are fitting kinetic parameters and fitting errors.
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5.4-fold smaller kcat than EGFP-T1. Since trypsin demonstrates a strong preference to cleave the
peptide bond immediately following an Arg or Lys residue in a solvent-accessible region, a
trypsin cleavage sequence derived from EF-hand motif loop III of calmodulin was selected as the
basic graft structure, which contains highly-accessible Arg and Lys residues in the loop and
flanking helices. To eliminate the contribution of calcium binding, Glu at the EF-loop position
12 was replaced by Ala to obtain EGFP-T1nb variant. Consequently, kcat/Km of EGFP-T1nb for
trypsin improved, and was higher than that of Boc-Gln-Ala-Arg-AMC due to the addition of
preferable residues for trypsin at P2 and P3 positions before the trypsin cleavage site. On the one
hand, based on previous report (Ma, Tang et al. 2005), two loops outside the binding pocket of
trypsin plays a critical role in substrate sepecificity through the cooperative motions between
loops and substrate-binding sites for improving the activity and substrate specificity of trypsin.
On the other hand, the helix-loop-helix structure of the cleavage linker in EGFP-based trypsin
sensors also provides the high flexibility to match the cooperative motion and improve the
binding affinity between trypsin and EGFP-based trypsin sensors. Therefore, compared to the
commercially available trypsin substrates, a smaller Km value is contributed by high cooperation
and optimal binding between helix-loop-helix linker and trypsin binding pocket, which exhibits a
larger kcat/Km value to reveal a higher substrate sepecificity of trypsin. Overall, the substrate
specificity constants, kcat/Km of EGFP-based trypsin sensor variants are comparable to that of
Boc-Gln-Ala-Arg-AMC.
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Table 3. 2. Comparison of kinetic parameters between trypsin sensors and commercial kits
-1

-1 -1

Trypsin sensors or kits

kcat (s )

Km (μM)

kcat/Km (M s )

EGFP-T1

0.26 ± 0.01

3.99 ± 0.38

(6.52 ± 0.50) × 10

EGFP-T1nb

0.85 ± 0.06

4.21 ± 0.71

(2.01 ± 0.21) × 10

Bz-DL-Arg-pNA

1.33 ± 0.17

(3.00 ± 0.50) × 10

(4.44 ± 0.41) × 10

Bz-DL-Arg-AMC

0.25 ± 0.01

77.44 ± 8.46

(3.22 ± 0.21) × 10

Boc-Gln-Ala-Arg-AMC

1.41 ± 0.05

9.27 ± 0.95

(1.52 ± 0.12) × 10

4
5

3

2
3
5

Conditions: 10 mM Tris, 10 mM CaCl2, pH 7.4, 25˚C. The data presented in mean ± SD, are fitting kinetic parameters and fitting
errors.

3. 7

Inhibition of trypsin sensors

In order to ensure that the developed sensor is able to directly monitor the catalytic step,
the inhibition effect of leupeptin on trypsin was examined by monitoring absorbance signal
change at 490 nm during the digestion of EGFP-T1 with various leupeptin concentrations (0,
12.5, 25, 50 and 100 nM) in trypsin digestion buffer (10 mM Tris, 10 mM CaCl2, pH 7.4). The
rate of the absorbance signal change due to cleavage was found to decrease with increasing
leupeptin concentrations (Figure 3.9A). The rates of EGFP-T1 with various leupeptin
concentrations were fitted to reveal a competitive inhibition with Ki value of 31 ± 2 nM (Figure
3.9B). This clearly demonstrates that the optical signal change of EGFP-T1 sensor is directly
related to the enzymatic cleavage action rather than the binding process, and can be applied to
monitor inhibition processes for drug screening.
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Figure 3. 9. Inhibition effect on the cleavage of EGFP-T1.
Effects of different concentrations of trypsin inhibitor, leupeptin, on the cleavage of EGFP-T1
trypsin digestion were examined in a time course mode (A). EGFP-T1 samples containing
leupeptin with 0 nM (○), 12.5 nM (□), 25 nM (∆), 50 nM (∇), 100 nM (⊠) were digested using 5
nM trypsin in 10 mM Tris, 20 mM CaCl2, pH 7.4. Absorbance was monitored at 490 nm using a
time course model. EGFP-T1 with trypsin inhibitor, leupeptin with 0 nM (○), 12.5 nM (□), 25
nM (Δ), 50 nM (∇), 100 nM (⊠) is evaluated (B) to reveal the competitive inhibition to trypsin,
with Ki value of 31 ± 2 nM.

87

3. 8

Selectivity of trypsin sensors

One of the major challenges in developing protease probes is to achieve strong specificity
for different proteases(Tung, Mahmood et al. 2000). To examine the enzymatic specificity of
EGFP-T1, thrombin, cathepsin B, tryptase, tissue plasminogen activator, kallikrein, elastase and
chymotrypsin with different substrate specificities (Table 3.3) were incubated with this sensor at
room temperature. Lysosomal cathepsin B was shown to be responsible for the trypsinogen
activation (Greenbaum, Hirshkowitz et al. 1959; Hofbauer, Saluja et al. 1998; Criddle,
McLaughlin et al. 2007). Neither cathepsin B nor tryptase, as well as thrombin or tiusse
plasminogen activator was able to cleave EGFP-T1 as monitored by SDS-PAGE (Figure 3.10A).
By contrast, cathepsin B substrate, z-FR-AMC, was cleaved in identical buffer condition by
cathepsin B monitored by fluorescence signal change (Figure 3.10B). Although EGFP-T1 can be
slowly cleaved by kallikerin, elastase and chymotrypsin, which will be examined in more detail
in the future. Overall, the designed protease sensor with a specific cleavage linker still exhibited
strong enzymatic specificity. Such strong enzymatic selectivity is very exciting since cathepsin B
and tryptase are known to cleave the residues after Arg, which are involved in one of the
mechanisms of trypsinogen activation. Thus, our developed sensor is ideal for cellular
application to understand mechanisms of trypsinogen activation.
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Table 3. 3. Substrate specificity of selected proteases

Proteases

Amino acid sequence of cleavage site
Pn---P4-P3-P2-P1-↓-P1’-P2’-P3’-P4’---Pm’

Trypsin

-X-X-R-↓-X-X- or -X-X-K-↓-X-X-

Thrombin

-X-X-R-↓-G-X-

Cathepsin B

-X-X-R-↓-E-X- or -X-X-V-↓-E-X- or -X-X-G-↓-K-X-

Tryptase

-X-X-R-↓-X-X- or -X-X-K-↓-X-X-

Tissue plasminogen activator

-X-X-R-↓-V-X-

Kallikrein

-X-X-R-↓-X-X- or -X-X-M-↓-X-X- or -X-X-L-↓-X-X-

Elastase

-X-X-A-↓-X-X-

Chymotrypsin

-X-Y-↓-X-X- or -X-F-↓-X-X- or -X-W-↓-X-X-

3. 9

Trypsinogen activation in living cells

Caerulein is the most commonly used inducer for trypsinogen activation (Kruger,
Albrecht et al. 2000; Thrower, Diaz de Villalvilla et al. 2006). We monitored trypsinogen
activation in pancreatic cells using commercially available trypsin MCA peptide substrate BocGln-Ala-Arg-AMC. Trypsin activities in cell lysates of MIA PaCa-2 cells, after induction with
10 nM caerulein at different time points, were examined by monitoring the change in relative
fluorescence signal of trypsin MCA substrate at 450 nm under the excitation of 380 nm. The
results indicated that the highest level of trypsinogen activation was achieved following caerulein
induction for 60 to 120 min based on relative fluorescence unit change of trypsin substrate.
Using 4 nM trypsin as a positive reference, trypsinogen was activated to reach a trypsin level of
6 nM following caerulein induction for 1 h (Figure 3.11).
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Figure 3. 10. The selectivity of EGFP-T1 for proteases.
SDS-PAGE (A) exhibited no cleavage bands of EGFP-T1 following 20 nM thrombin, cathepsin
B, tryptase or tissue plasminogen activator overnight digestion, but EGFP-T1 can be slowly
cleaved by kallikerin, elastase and chymotrypsin. M is protein marker. Lane 1 is EGFP-T1
without digestion. Lanes 2, 3, 4, 5, 6, 7, 8 and 9 are EGFP-T1 following overnight digestion with
trypsin, thrombin, cathepsin B, tryptase, tissue plasminogen activator, kallikerin, elastase and
chymotrypsin, respectively. To confirm optimal reaction buffer for EGFP-T1 cathepsin B
digestion, Z-FR-MAC for cathepsin B (B) was cleaved under identical digestion buffer
conditions to reveal fluorescence emission signal increase at 460 nm following digestion time
increase at 0 (○), 1 (□), 5 (◊), 10 (∆), 20 (●), 30 (■), 60 (♦), 120 (▲) and 180 min (▼) through
detection by fluorescence spectrophotometer at the excitation of 380 nm.
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Figure 3. 11. Trypsin activity determination in cell lysates using trypsin peptide substrate.
The cultured MIA PaCa-2 cells following 10 nM caerulein at various time intervals (0, 10, 20,
30, 60, 120, 240 min and 20 h) were subjected to cell lysis to extract trypsin. Trypsin activity
was detected through incubation with trypsin substrate kit, Boc-Gln-Ala-Arg-AMC, at various
time points following induction, which revealed that the highest level of trypsinogen activation
was reached following caerulein induction for 1 or 2 h based on relative fluorescence emission
unit change at 460 nm of trypsin substrate under the excitation of 380 nm. Using 4 nM trypsin as
a positive reference, trypsinogen was activated to reach a trypsin level of 6 nM following
caerulein induction for 1 h. The change in relative fluorescence units is also observed to be a
linear correlation with active trypsin concentrations.
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3. 10 Fluorescence imaging of trypsin sensor

In order to track trypsin activity in living cells, our trypsin sensors were transfected into a
pancreatic cancer cell line, MIA PaCa-2 cell line using an established method with lipofectamine
(Zou, Ye et al. 2005). After transfection, the cells transfected with EGFP-T1 and the controls
(EGFP-wt or EGFP-T1m) exhibited strong fluorescence in fluorescence microscopy, following
16 to 48 hours of expression. Upon zymogen activation by 10 nM caerulein, the fluorescence
emission signal at 510 nm for EGFP-T1 gradually decreased at 398 nm excitation while
concurrently increasing at 488 nm excitation (Figure 3.12A, 3.12B and 3.12C), resulting in a
ratiometric fluorescence emission change greater than 25% (Figure 3.12D). In contrast, the
fluorescence emission ratio of EGFP-wt or EGFP-T1m remained unchanged. The ratiometric
fluorescence change of EGFP-T1 sensor is significantly different from that of EGFP-wt (*P <
0.05). Trypsinogen activation using 10 nM caerulein induction in living cells (n = 12) exhibited a
half-time for maximum caspase-3 activation of 15-20 min, which was in excellent agreement
with the results obtained using the peptide substrate, Boc-Gln-Ala-Arg-AMC, to monitor trypsin
activity in cell lysates. On the other hand, prior to the imaging, the MIA PaCa-2 cells transfected
with EGFP-T1 gene was incubated with cell-permeable trypsin inhibitors such as soybean
trypsin inhibitor or leupeptin for 30 mins. During the cell imaging acquisition, 10 nM caerulein
was applied to the cell plate for the induction of trypsinogen activation. Fluorescence signal of
MIA PaCa-2 cells transfected EGFP-T1 following incubation with trypsin inhibitors and
caerulein induction didn’t exhibit any change when excited at both wavelengths (398 and 488
nm). Therefore, no change in fluorescence ratiometric signal was also observed either. These
results demonstrated that trypsinogen activation or trypsin activity in the living cells could be
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Figure 3. 12. Fluorescence imaging and signal change of EGFP-T1 in living cells.
The representative images of MIA PaCa-2 cells transfected with EGFP-T1, emitted at 510 nm
with excitation of 398 nm (A) and 488 nm (B) before and after incubation with 10 nM caerulein.
Normalized fluorescence (NF) intensity change (C) at 510 nm increased with excitation at 488
nm and decreased with excitation at 398 nm upon activation by caerulein induction at different
times. The arrow indicates the time point of caerulein induction. Relative fluorescence change
ratio (D) at 510 nm with excitation of 488/398 nm of MIA PaCa-2 cells transfected with EGFPT1 following induction with 10 nM caerulein (●) or 5 nM caerulein (♦) exhibited significant
increase, whereas the controls, EGFP-wt (○), EGFP-T1m (∆) and EGFP-T1 incubated with 100
µM leupeptin (◊) exhibited no change following 10 nM cearulein stimulation. After induction
with 10 nM caerulein for 45 min, the ratiometric change in fluorescence signal of EGFP-T1 was
significantly different from that of the control, EGFP-wt (*P < 0.05).
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successfully inhibited. By comparing trypsin activity at different time points following caerulein
induction, trypsinogen activation in pancreatic cancer cells reached to the highest level
(approximately 6 nM) at 1 hr following stimulation with 10 nM caerulein. The trypsinogen
activation is strongly dependent on caerulein concentration (Figure 3.12D). Therefore, our
trypsin sensor also has the capability of detecting enzymatic activation/inhibition in living cells
in real time, which will facilitate further research aimed at understanding the activation or
inhibition mechanisms and pathways of protease activation receptors (PAR) (Riewald, Petrovan
et al. 2002).
Moreover, our developed trypsin sensor have been specifically targeted to the
endoplasmic reticulum (ER) and mitochondria by adding the signal peptide sequence, ER
retention

sequence,

KDEL,

and

ER

targeting

sequence

of

calreticulin,

MLLSVPLLLGLLGLAAAD (Zou J, Hofer AM et al. 2007), and by fusing to mitochondria
signal peptide, PLLRGRCPARRH, from cytochrome C oxidase subunit VIII (COX 8)
(Huttemann, Schmidt et al. 2003), respectively. The mitochondrial-targeted sensor (EGFP-T1Mito) and ER-targeted sensor (EGFP-T1-ER) nicely overlap with commercial marker
Mitotracker Red (Invitrogen, Molecular Probe) and DsRed-ER-marker (BD Bioscience,
Clontech), respectively (Figure 3.13A and 3.13B). These exciting results indicated that our
trypsin sensor provides the potential to map dynamic activation/inhibition processes in specific
subcellular environments. Since our trypsin sensor is based on a single EGFP unit, it should not
encounter problems with translocation in cellular compartments, as is observed with larger
FRET-based sensors. Additionally, our trypsin sensor does not exhibit a tendency towards
photobleaching or poor orientation, which is also common with FRET-based sensors.
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Figure 3. 13. Subcellular location targeting of EGFP-T1-Mito and EGFP-T1-ER.
The subcellular location targeting of EGFP-T1-Mito and EGFP-T1-ER was confirmed using
mitotracker Red and DsRed-ER. Our trypsin sensors, EGFP-T1-Mito (A) and EGFP-T1-ER (B)
exhibited a well overlap with commercial mitotracker Red and DsRed-ER, respectively. The
fluorescence emission of EGFP-T1-Mito and EGFP-T1-ER was obtained by using a bandpass
emission filter (505-530 nm) under an excitation at 488 nm of an argon laser. The fluorescence
emission of mitotracker and DsRed-ER was obtained by using a long-pass emission filter above
560 nm under an excitation at 543 nm of a He-Ne laser.
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3. 11 Trypsinogen activation in pancreatic cancer cells

Caerulein is the most commonly-used inducer of trypsin activation in living pancreatic
acinar cells (Kruger, Albrecht et al. 2000; Thrower, Diaz de Villalvilla et al. 2006). It is widely
accepted that zymogen is packed into granules of acinar cells. However, the location of
trypsinogen activation has not been conclusively identified despite substantial studies with
various methods. Several studies have suggested that zymogen activation might be initiated in
zymogen granules (Mithofer, Fernandez-del Castillo et al. 1998; Raraty, Ward et al. 2000).
Using antibodies against trypsinogen activation peptide in confocal and immunoelectronic
microscopy, initial zymogen activation was observed in a vesicular non-zymogen granule
compartment (Hofbauer, Saluja et al. 1998; Otani, Chepilko et al. 1998). The activation of
trypsinogen in the large endocytic vacuole was also proposed to be the initiation of acute
pancreatitis (Sherwood, Prior et al. 2007). Currently, the pancreatic cancer cell line, MIA PaCa2, derived from the human pancreatic tumor (Ulrich, Schmied et al. 2002), has been extensively
used in developing cancer therapy based on protease-induced apoptosis (Basu, Castle et al. 2006;
Rosetti, Tesei et al. 2006). Differing from acinar cells, pancreatic cancer cells such as MIA
PaCa-2 do not have a granule structure (Madden, Heaton et al. 1989). However, a high mRNA
level of trypsinogen and secretory trypsin inhibitor were reported in this cancer cell line (Ogawa,
Matsuura et al. 1987; Swarovsky, Steinhilber et al. 1988). To date, it is still unknown whether
pancreatic cancer cells such as MIA PaCa-2 have any elevation of trypsin activity. It is also not
clear due to limitations of current commercially available trypsin probes, whether trypsinogen
activation of pancreatic cells occurs in the cytosol. The developed trypsin sensors demonstrate
strong enzymatic specificity, especially to cathepsin B and tryptase, which are essential for
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examining the mechanisms of zymogen activation. Furthermore, the direct observation of
trypsinogen activation was first exhibited in MIA PaCa-2 cancer cells by caerulein stimulation
even though this cell line lacks zymogen granules or cytosolic vacuole structures (Madden,
Heaton et al. 1989). These results correlate well with previous reports related to the high mRNA
levels of trypsinogen (Ogawa, Matsuura et al. 1987) and trypsin inhibitors (Swarovsky,
Steinhilber et al. 1988). Moreover, the location of trypsinogen activation occurs in the cytosol of
this cancer cell, which further adds to new insight regarding zymogen activation and inhibition.
Zymogen granules, vacuoles or the combination of cytosol and cellular organelles of pancreatic
acinar cells were previously reported to function trypsinogen generation and activation
(Hofbauer, Saluja et al. 1998; Mithofer, Fernandez-del Castillo et al. 1998; Otani, Chepilko et al.
1998; Raraty, Ward et al. 2000). Currently, this developed sensor to further investigate the
dynamic process and mechanisms for trypsinogen activation was successfully applied at different
cellular locations and further development and application of EGFP-based sensors with strong
enzymatic specificity will facilitate the understanding of protease actions in living systems.
Finally, since MIA PaCa-2 cancer cells have been widely used for understanding cell death,
cancer metastasis and drug effects, knowledge gained from zymogen activation and inhibition is
expected to impact future development of cancer drugs, especially against pancreatic cancers.

3. 12 Localization of trypsinogen activation

The direct observation of trypsinogen activation in MIA PaCa-2 cancer cells by caerulein
stimulation was first reported even though this cell line lacks zymogen granules or cytosolic
vacuole structures and the activated trypsin can perform the cleavage of EGFP-T1 to result in the
ratiometric optical signal change in living cells, which is used for the real-time monitoring of
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trypsinogen activation or inhibition. In order to identify whether trypsinogen activation and
expression of EGFP-based trypsin sensors in the same subcelluar location to accomplish the
cleavage of EGFP-based trypsin sensors, immunofluorescence was used to confirm the
localization of trypsinogen activation following induction with 10 nM caerulein in MIA PaCa-2
cells transfected with EGFP-T1 according to experimental procedures descried in the section of
Materials and Methods. On the other hand, the MIA PaCa-2 cells transfected with EGFP-T1
without stimulation using 10 nM caerulein were also conducted immunofluorescence
determination as the control. Strong red fluorescence in the cytoplasm of the cells was observed
in the confocal fluorescence microscope with an excitation of 560 nm due to the interaction
between primary antitrypsin and the secondary antibody (Figure 3.14A), which clearly indicated
that a large amount of trypsin was activated in the cytoplasm of the cells following the
stimulation with 10 nM caerulein. Similarly, the strong green fluorescence was also observed in
the confocal fluorescence microscope with an excitation of 488 nm (Figure 3.14B), which
indicated large amount of EGFP-T1 sensor also expressed in the cytoplasm of cells. The well
overlap (Figure 3.14C) between the red and the green fluorescence in the cytoplasm of cells
demonstrated the same subcelluar location between trypsionogen activation and EGFP-T1
expression. All of these results provide us a further confirmation that the real-time optical signal
change of EGFP-T1 in living cells following caerulein induction was really resulted in the
cleavage of EGFP-T1 sensor by activated trypsin.
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Figure 3. 14. Localization of trypsin activation and expression of EGFP-based trypsin sensor.
Fluorescence signal of trypsin (A) against anti-trypsin antibody and EGFP-T1 (B) against antiGFP antibody exhibited a well overlap (C) in the cytoplasm of MIA PaCa-2 cells following 10
nM caerulein stimulation using immunofluorescence, which suggests EGFP-T1 cleavage due to
trypsin activation in the same subcelluar compartment. The fluorescence emissions of GFP and
Texas Red are determined under the excitation of 488 nm and 543 nm, respectively.
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3. 13 Plasmid DNA construction of trypsin sensors with optimal cleavage linkers

Through the extensive investigation, the position 172 of EGFP has been identified as a
sensitive location for chromophore conformation change upon the action of trypsin and a trypsin
sensor (EGFP-T1) has been successfully developed for imaging trypsin activation or inhibition in
living cells. However, the insertion of optimal cleavage linker at this sensitive location to
improve the response rate to trypsin, enlarge the relative signal response and offer a better
specificity to trypsin digestion is still an important goal. In order to develop sensitive trypsin
sensors with optimal cleavage linkers for imaging trypsinogen activation in living cells, the P
region (P1, P2, P3 and P4 positions) and P’ region (P1’, P2’ and P3’ positions) around the cleavage
site in trypsin sensors were systematically studied. Based on the bovine trypsin inhibitor or some
natural trypsin substrates, the recognition sites of trypsin substrates was desgined to be Gly-ProAla-Arg-Leu-Ala-Ile in the specific cleavage linkers for trypsin. In order to evaluate effects from
different positions in P region or P’ region, various cleavage linkers for trypsin with Leu-Arg,
Gly-Pro-Arg-Leu, Gly-Pro-Ala-Arg-Leu or Gly-Pro-Ala-Arg-Leu-Ala-Ile were designed and
grafted at the identified position 172 in EGFP to obtain different trypsin sensor variants, which
are shown in Table 3.4.

3. 14 Optical properties of trypsin sensors with optimal cleavage linkers

All variants of our designed EGFP-based trypsin sensors have been expressed in E. coli
and exhibit strong fluorescence. Through nickel-chelating column purification, all trypsin sensor
variants exhibit two strong absorption peaks at 397 and 490 nm, as shown in Figure 3.15. The
two strong absorption peaks result from a population distribution between the ionic and neutral
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Table 3. 4. Designed trypsin sensors with different cleavage linkers
Trypsin sensor name

Cleavage linker sequences
E-helix

loop

F-helix

EGFP-T1

EEEIREAFRVF

DKDGNGYISAAE

LRHVMTNL

EGFP-T1EFa

EEEIREAFRVF

DKDGNGYISAA

GPRLVMTNL

EGFP-T1EFb

EEEIREAFRVF

DKDGNGYISAA

GPARLVMTNL

EGFP-T1EFc

EEEIREAFRVF

DKDGNGYISAA

GPARLAITNL

EGFP-T1Ma

EEEIAEAFAVF

DADGNGYISAAE

LRHVMTNL

EGFP-T1Mb

EEEIAEAFAVF

DADGNGYISAA

GPRLVMTNL

EGFP-T1Mc

EEEIAEAFAVF

DADGNGYISAA

GPARLVMTNL

EGFP-T1Fa

DKDGNGYISAAE

LRHVMTNL

EGFP-T1Fb

DKDGNGYISAA

GPRLVMTNL

EGFP-T1Fc

DKDGNGYISAA

GPARLVMTNL

EGFP-T1Fd

DKDGNGYISAA

GPARLAITNL

EGFP-T1Ea

EEEIREAFRVF

DKDGNGYISAAE

EGFP-T1Eb

EEEIAEAGPARLF

DKDGNGYISAAE

EGFP-T1L

DKDGNGYISAAE
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Figure 3. 15. UV-visible spectra of EGFP-based trypsin sensor variants.
Through insertion of various cleavage linkers into EGFP, the neutral chromophore form of these
trypsin sensor variants with a concentration of 10 μM was partially switched to the ionic
chromophore form, which exhibited a decrease of absorption at 490 nm and a concurrent
increase of absorption at 397 nm in Tris buffer (10 mM Tris, 1 mM DTT, pH 7.4). The
population ratio index of both chromophore forms is reduced according to the order: EGFP-wt
(○), EGFP-T1Eb (◇), EGFP-T1Fc (▲ ), EGFP-T1EFb (▷), EGFP-T1Mc (●) and EGFP-T1
(□ ).
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forms of the chromophore. Due to the insertion of cleavage linkers in these trypsin sensor
variants, the neutral form of the chromophore is partially converted to the ionic form, resulting in
various populations between two chromophore forms. A ratio index between neutral and ionic
forms of the chromophore can be expressed by the maximum absorption at 490 nm dividing the
maximum absorption at 397 nm to indicate various populations of two states. The linkers
containing intact E-III-F hand motif produced the smallest ratio index of chromophore
population, where the levels of the chromophore populations were nearly equivalent, such as
EGFP-T1. The other trypsin sensor variants, however, with modified or partial E-III-F motifs,
exhibited a decrease in neutral chromophore population and an increase in ionic chromophore
population due to the length and properties of cleavage linkers.

3. 15 Kinetic parameters for trypsin sensors with optimal cleavage linkers

Steady-state kinetic parameters kcat, Km, and kcat/Km for trypsin hydrolysis of EGFP-based
trypsin sensors can be used for evaluating the optimization of cleavage linkers. When
determining catalytic kinetic parameters, kcat, Km, and kcat/Km, initial rates were measured at
various EGFP-based trypsin sensor concentrations in trypsin reaction buffer (10 mM Tris, 20
mM CaCl2, pH 7.4). The initial rate data were fitted through the Michalis-Menten equation to
obtain the catalytic kinetic parameters of trypsin sensor variants. Since our first trypsin sensor
(EGFP-T1) was constructed on EGFP with a grafted EF-hand motif from calmodulin as the
cleavage linker, we also grafted partial or modified EF-hand motifs onto EGFP to obtain
different EGFP-based trypsin sensors to test the accessibility for trypsin in the loop or flanking
helices regions. The kinetic catalytic parameters of these trypsin sensors are shown in Table 3.5.
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EGFP-T1L was not cleaved by trypsin, which is possibly due to less flexibility of the inserted
cleavable linker. However, EGFP-T1Fa exhibited the fastest cleavage.

Table 3. 5. Kinetic parameters for first generation of trypsin sensors
-1

4

-1 -1

Trypsin sensors

kcat (s )

Km (μM)

kcat/Km (× 10 M s )

EGFP-T1

0.26 ± 0.01

3.98 ± 0.74

6.52 ± 0.45

EGFP-T1Fa

0.82 ± 0.12

11.80 ± 1.91

5.18 ± 0.98

EGFP-T1Ea

0.70 ± 0.05

5.90 ± 1.31

11.12 ± 2.09

EGFP-T1Ma

0.09 ± 0.01

2.22 ± 0.06

4.18 ± 0.08

EGFP-T1L

No cleavage

Conditions: 10 mM Tris, 10 mM CaCl2, pH 7.4, 25˚C. The data presented in mean ± SD, are fitting kinetic parameters and fitting
errors.

Due to the fast response to trypsin of EGFP-T1Fa, the various cleavage linkers for
extending with preferable residues at P and P’ regions were grafted in the identified location of
EGFP to obtain different trypsin sensor variants. The results indicated EGFP-T1Fc, with GlyPro-Ala-Arg-Leu as a cleavage linker, exhibited the fastest cleavage rate based on the kcat value,
whereas, EGFP-T1Fa with Leu-Arg as the linker exhibited the slowest cleavage rate. Similarly,
the specificity constant (kcat/Km) of the trypsin sensor with recognition site, Gly-Pro-Ala-ArgLeu, had the largest value among these trypsin sensor variants. The results clearly demonstrated
that P2, P3 and P4 positions with Ala, Pro and Gly and P1’ position with Leu provided strong
binding affinity, a fast cleavage rate and better cleavage specificity for trypsin. Although P2’ and
P3’ positions were designed to have Ala and Ile, kcat/Km of these trypsin sensor variants was not
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significantly different from those of trypsin sensor variants with cleavage linker, Gly-Pro-AlaArg-Leu, which are shown in Table 3.6.

Table 3. 6. Optimization of residues in the P and P’ region of cleavage linkers
-1

4

-1 -1

Trypsin sensors

kcat (s )

Km (μM)

kcat/Km (× 10 M s )

EGFP-T1Fd

1.30 ± 0.08

6.16 ± 0.94

21.18 ± 2.07

EGFP-T1Fc

1.80 ± 0.08

8.16 ± 0.87

22.05 ± 1.42

EGFP-T1Fb

1.03 ± 0.04

9.17 ± 0.95

11.21 ± 0.76

EGFP-T1Fa

0.82 ± 0.12

11.80 ± 1.91

5.18 ± 0.98

Conditions: 10 mM Tris, 10 mM CaCl2, pH 7.4, 25˚C. The data presented in mean ± SD, are fitting kinetic parameters and fitting
errors.

Taking into consideration the preferable residues in P and P’ region for trypsin, EGFPT1Fc, EGFP-T1Eb, EGFP-T1EFb and EGFP-T1Mc were also designed and constructed. Kinetic
parameters, kcat, Km and kcat/Km of these designed trypsin sensor variants and commercial trypsin
kits under identical buffer conditions were determined and calculated through fitting with the
Michaelis-Menten equation. The kinetic catalytic parameters are shown in Table 3.7. All of these
commercially-available trypsin kits exhibit optical signal changes at a single wavelength (i.e.
non-ratiometric) upon trypsin cleavage. Among these trypsin sensor variants or commercial
trypsin kits, the EGFP-T1EFb sensor exhibited the smallest value in binding affinity (Km) and the
highest substrate specificity constant (kcat/Km), which revealed almost a 750-fold decrease in Km
and a 600-fold increase in kcat/Km compared to the BAPNA colorimetric kit. Similarly, an
approximately 20-fold decrease in Km and a 75-fold increase in kcat/Km were observed in
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comparison with Bz-DL-Arg-AMC. Boc-Gln-Ala-Arg-AMC with preferable residues at
positions P2 and P3 exhibited 2.3-fold larger Km and 1.6-fold smaller kcat/Km than EGFP-T1EFb.
Consequently, the substrate specificity constant (kcat/Km) of EGFP-T1nb for trypsin improved,
and was higher than that of Boc-Gln-Ala-Arg-AMC due to the addition of preferable residues for
trypsin at P and P’ region around the trypsin cleavage site. Overall, the substrate specificity
constants (kcat/Km) of EGFP-based trypsin sensor variants were comparable to that of Boc-GlnAla-Arg-AMC.

Table 3. 7. Comparison of catalytic parameters between trypsin sensors amd commercial kits
-1

4

-1 -1

Trypsin sensors

kcat (s )

Km (μM)

kcat/Km (× 10 M s )

EGFP-T1Fc

1.80 ± 0.08

8.16 ± 0.87

22.05 ± 1.42

EGFP-T1Eb

0.87 ± 0.12

6.14 ± 0.98

14.17 ± 1.64

EGFP-T1EFb

0.98 ± 0.04

4.12 ± 0.45

23.80 ± 1.72

EGFP-T1Mc

0.85 ± 0.06

4.21 ± 0.71

20.13 ± 2.14

Bz-DL-Arg-pNA

1.33 ± 0.17

3000 ± 500

0.04 ± 0.004

Bz-DL-Arg-AMC

0.25 ± 0.01

77.44 ± 8.46

0.32 ± 0.02

Boc-Gln-Ala-Arg-AMC

1.41 ± 0.05

9.27 ± 0.95

15.20 ± 1.20

Conditions: 10 mM Tris, 10 mM CaCl2, pH 7.4, 25˚C. The data presented in mean ± SD, are fitting kinetic parameters and fitting
errors.

3. 16 pH effects on trypsin sensors

In order to examine buffer pH effect on trypsin cleavage, kinetic parameters of our designed
trypsin sensors were analyzed following trypsin digestion in PIPES buffer (20 mM PIPES, 20
mM CaCl2, pH 6.7) and Tris buffer (10 mM Tris, 20 mM CaCl2, pH 7.4 and pH 8.0),
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respectively. The kinetic parameters of EGFP-based trypsin sensor variants (EGFP-T1 and
EGFP-T1Fa) in three pH buffer conditions are shown in Table 3.8. The results indicated that Km
values under different pH conditions did not change, and kcat and kcat/Km exhibited only a modest
increase due to the pH increase. Based on the kcat value of both EGFP-based trypsin sensor
variants, the cleavage of EGFP-based trypsin sensors for trypsin was determined to be pH
dependent in the range 6.7-8.0.

Table 3. 8. Catalytic parameters for trypsin under various pH conditions
Trypsin sensors

EGFP-T1

EGFP-T1Fa

-1

4

-1

-1

pH

kcat (s )

Km (μM)

kcat/Km (× 10 M s )

6.7

0.14 ± 0.01

3.55 ± 0.25

4.16 ± 0.21

7.4

0.26 ± 0.01

3.98 ± 0.74

6.52 ± 0.45

8.0

0.28 ± 0.01

3.76 ± 0.43

7.45 ± 0.38

6.7

0.50 ± 0.02

6.22 ± 0.69

7.95 ± 0.67

7.4

0.82 ± 0.12

11.80 ± 1.91

5.18 ± 0.98

8.0

0.87 ± 0.12

6.03 ± 1.98

14.46 ± 1.51

Conditions: 10 mM Tris, 10 mM CaCl2, pH6.7, 7.4 and 8.0, 25˚C respectively.
The data presented in mean ± SD, are fitting kinetic parameters and fitting errors.

3. 17 Extinction coefficient constants of products after trypsin sensor cleavage

The quantity of trypsin sensors cleaved or the product can be used to establish the
evaluation of the turnover number of trypsin sensors in unit time during trypsin digestion. Due to
the monitoring of the change in absorbance of trypsin sensors at 490 nm, the increase in
absorbance at this wavelength can be used to calculate the amount of products. Therefore,
extinction coefficient constants are necessary. After trypsin sensor samples were cleaved
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completely through trypsin overnight digestion, the absorbance of products at 490 nm was
measured and then extinction coefficient constants were calculated using Beer-Lambert law. The
extinction coefficient constants of the designed trypsin sensor variants differed slightly due to the
various cleavage linkers, which are shown in Table 3.9. The extinction coefficients of cleavage
products from EGFP-T1Fa, EGFP-T1Fb, EGFP-T1Fc and EGFP-T1Fd after cleavage are
similar, revealing that these trypsin sensor variants exhibit similar behavior during trypsin
cleavage.

Table 3. 9. Extinction coefficients of cleavage products from trypsin sensors
Trypsin sensor

Extinction coefficients
(ε) (μM-1cm-1)

EGFP-T1

0.038 ± 0.002

EGFP-T1Ea

0.033 ± 0.004

EGFP-T1Fa

0.037 ± 0.003

EGFP-T1Ma

0.031 ± 0.005

EGFP-T1Fb

0.037 ± 0.005

EGFP-T1Fc

0.037 ± 0.003

EGFP-T1Fd

0.037 ± 0.004

EGFP-T1EFb

0.038 ± 0.002

EGFP-T1EFc

0.042 ± 0.002

EGFP-T1Mc

0.023 ± 0.002

Conditions: 10 mM Tris, 10 mM CaCl2, pH 7.4, 25˚C. The data presented in mean ± SD, are extinction coefficients and stardard
deviations from different samples at various concentrations (2-20 μM) following trypsin complete digestion, n = 6.
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3. 18 Relative signal change calculation of trypsin sensors

In order to evaluate the response of trypsin sensors to trypsin, the relative optical signal
change in absorbance or fluorescence of different trypsin sensor variants before trypsin cleavage
and after trypsin cleavage was measured. Following trypsin digestion, EGFP-T1 has the biggest
relative signal change, however, other EGFP-based trypsin sensor variants exhibit the smaller
relative signal change. The main reason is possibly due to a similar population of netural and
ionic chromophore forms in EGFP-T1, which provides a larger space for the absorption decrease
at 397 nm and increase at 490 nm resulting from the population distribution between the neutral
and ionic chromophore forms at both wavelengths. In contrast, the less space for population
distribution of the chromophore forms in other trypsin sensor variants resulted in the smaller
relative signal change. The relative signal changes of the trypsin sensor variants are shown in
Table 3.10. Based on the above analyses, the complete E-III-F motif insertion in EGFP can be
attributed to the close level in population between the neutral and ionic chromophore forms of
the chromophore and provide the high accessibility for enzymes to enhance the relative signal
change.

3. 19 Optical signal change EGFP-T1 upon the action of chymotrypsin

Since EGFP-T1 can be slowly cleaved by chymotrypsin during the specificity
determination for various proteases, this strategy also has the potential to develop the
chymotrypsin sensors. In order to evaluate optical signal changes related to the action of
chymotrypsin cleavage, the UV-visible absorption spectra of 15 μM EGFP-T1 were measured
before and after chymotrypsin cleavage in chymotrypsin digestion buffer (10 mM Tris, 10 mM
CaCl2, pH 7.4). Following chymotrypsin cleavage, the maximum absorption of EGFP-T1 at 490
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nm increased by 102% and concurrently decreased by 55% at 398 nm (Figure 3.16A). In
contrast, the maximum absorption of EGFP-T2 showed no obvious change although it was
cleaved by chymotrypsin under identical digestion conditions (Figure 3.16B). This result further
confirms that position 172 in EGFP is a sensitive location at which the ionic states of the
chromophore species can be altered by the addition of the grafting sequence and can be used for
the development of different biosensors for proteases. In addition, compared to trypsin digestion
of EGFP-T1 with an 83% increase in absorbance change at 490 nm and the relative signal
change of 3.76 following trypsin digestion, an enhanced absorbance increase at 490 nm of
EGFP-T1 and following chymotrypsin digestion was observed so that resulting in the relative
signal change of 4.51. The improved relative signal change is possible due to multiple cleavage
sites (following residues Met, Leu, Tyr and Thr) on the helix-loop-helix structure, which is
different with the cleavage sites with positively-charged residues Arg and Lys.

Table 3. 10. Relative signal changes of trypsin sensor variants
Trypsin sensor

Relative signal change (RD)

EGFP-T1

3.76 ± 0.22

EGFP-T1EFb

3.57 ± 0.36

EGFP-T1Eb

2.12 ± 0.17

EGFP-T1Fc

2.06 ± 0.08

EGFP-T1Mc

1.80 ± 0.29

Conditions: 10 mM Tris, 10 mM CaCl2, pH 7.4, 25˚C. The data presented in mean ± SD, are relative signal cahnges and stardard
deviations from different samples at various concentrations (2-20 μM) following trypsin complete digestion, n = 6.
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Figure 3. 16. Optical signal change of EGFP-T1 following chymotrypsin digestion.
Absorption spectra of EGFP-T1 (A) and EGFP-T2 (B) were measured after chymotrypsin
digestion at various times from 0 min (●) to 120 min (□) in chymotrypsin digestion buffer (10
mM Tris, 20 mM CaCl2, at pH 7.4), respectively. Absorbance of EGFP-T1 exhibited a decrease
at 397 nm and an increase at 491 nm following chymotrypsin digestion at different digestion
time intervals. In contrast, Absorbance of EGFP-T2 exhibited no any change following
chymotrypsin digestion at different digestion time intervals.
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3. 20 Conclusions and significance

Based on the investigation of trypsin sensor variants, a novel strategy is established to
develop protease sensors by grafting an enzymatic cleavage linker on an EGFP scaffold at
various locations hypothesized to be sensitive to the EGFP chromophore. The sensitive location,
position 172, for the signal change of EGFP chromophore, is confirmed to be suitable location
for the development of protease sensors. The designed EGFP-based trypsin sensors are capable
of tracking trypsinogen activation and inhibition in various subcellular compartments in living
cells in real time. Although several elegant studies reported the on and off measurement of
protease activity by linking GFP with ubiquitin or proteasome cleavage peptide for protein
degradation or by using bacterial protease sequences such as PEST and N-terminal rules
(Dantuma, Lindsten et al. 2000; Spencer, Theodosiou et al. 2004), our developed trypsin sensors
exhibit a large ratiometric change which allows for quantitative measurement of enzymatic
actions. The substrate specificities our protease sensors are better or comparable than those of
currently-available peptide probes. Meanwhile our trypsin sensors exhibit both strong enzymatic
selectivity and significant ability to monitor enzymatic inhibition. Moreover, this novel strategy
for trypsin sensors is the first example where the dynamic activation or inhibition of trypsin
action and function in pancreatic cancer cells via living cell imaging can be determined. This
novel approach can also be applied to develop other sensors for real time probing of enzymatic
mechanisms, tracking the progress of diseases related to protease activity and monitoring the
effects of protease inhibitors in drug development (Roberts, Martin et al. 1990).
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Chapter 4

Developing caspase sensors for imaging apoptosis at early stage in living
cells

4. 1

Introduction

4.1.1 Apoptosis, caspase actions and tumors

Apoptosis, or programmed cell death, is responsible for many essential physiological
processes that play a critical role in excluding damaged or harmful cells for tissue development
and maintaining homeostasis in a biological system. Many human diseases can also be attributed
directly or indirectly to a derangement of apoptosis, resulting in either cell accumulation, cell
eradication, cell turnover impairment, or cell loss (Fadeel and Orrenius 2005). It is increasingly
clear that apoptosis plays a central role in the pathogenesis of various human diseases including
cancers, autoimmune diseases and neurodegenerative diseases. The progress of apoptosis is
regulated by activation of a series of multiple caspases in a stringently temporal and spatial order
under certain circumstances. Caspases, closely associated with apoptosis, are aspartate-specific
cysteine proteases. The activation and function of caspases, involved in the delicate caspasecascade system, are regulated by various kinds of molecules, such as inhibitors of apoptosis
protein, Bcl-2 family proteins, calpain, and calcium ions (Zhang, Haskins et al. 2004; Fan, Han
et al. 2005). Therefore, the caspase-cascade system plays vital roles in the induction, signal
transduction and amplification of intracellular apoptotic signals. For example, an increase in
apoptosis leads to cell loss accompanied by neurodegenerative diseases (Alenzi 2005). While the
relationship between apoptosis and caspases has been demonstrated among some diseases, the
apoptosis mechanisms by which caspase activity is mediated are not fully understood. One of the
major challenges in monitoring apoptosis pathways is the involvement of series of caspases and
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their activation or inhibition mechanisms. Initiator caspases (caspase 8, 9 and 10) and effector
caspases (caspase 3 and 7) have different pathways and also share substrate specificity to some
extent. On the other hand, progress in this area has been limited due to the lack of a convenient
and reliable system to quantify these protease activities and quantitatively detect caspase activity
in real time in living cells or in vivo (Gurtu, Kain et al. 1997). Therefore, there is a strong need to
develop specific caspase sensors for monitoring activation and inhibition in living systems in
real-time.

4.1.2 Apoptosis pathways

During the last decades, a great deal of attention has been paid to the apoptosis pathways
and its regulation in governing survival and death of cells (Cohen 1993; Eischen and Leibson
1997; Burns and El-Deiry 1999; Cummings, Ward et al. 2004; Jegathesan, Liebenthal et al.
2004; Oberst, Bender et al. 2008). Although it is clear that apoptosis is a process with typical
morphological characteristics including plasma membrane blebbing, cell shrinkage, chromatin
condensation and fragmentation, its pathways and regulation are still being extensively
investigated (Sedlakova, Kohut et al. 1999; Kanduc, Mittelman et al. 2002; Elmore 2007).
Caspases are key proteins for the signal transduction and the apoptotic signals induced by several
stimuli. These proteins are present within the cell as inactive precursors that require proteolytic
cleavage for activation. There are two main caspase groups, initiators and executors (Boatright
and Salvesen 2003). The former are activated by autoproteolysis when translocated to specific
cell compartments or through the coupling of adapters and/or activators. Therefore, although the
activation or inhibition of a series of caspases is tightly regulated by other factors, caspases are
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still the central component for apoptosis response, protein degradation, chromatin fragmentation
and final cell death.
Currently, three pathways are reported for apoptosis. As shown in Figure 4.1, two major
apoptosis pathways, the intrinsic pathway (mitochondria-mediated apoptotic pathway) and the
extrinsic pathway (receptor-mediated apoptotic pathway) were well demonstrated and
established. Both apoptosis pathways had close relationships with the activation or inhibition of
caspase-cascade system (Budihardjo, Oliver et al. 1999; Shi 2002; Boatright and Salvesen 2003;
Wang, Liu et al. 2005; Logue and Martin 2008). As for the mitochondria-mediated apoptotic
pathway, mitochondria participation is the major characteristic of this apoptotic pathway to
mediate the interactions among various cytoplasmic organelles, including the endoplasmic
reticulum, Golgi apparatus and lysosomes (Ferri and Kroemer 2001). Meanwhile, within this
apoptotic pathway, Bcl-2 family proteins have pivotal roles in regulating the behavior of some
small molecules, such as cytochrome C, Smac/Diablo, and apoptosis-inducing factor, resulting in
apoptosome formation or to activate caspase cascades (Schuler and Green 2001; Harada and
Grant 2003; Antonsson 2004). The receptor-mediated apoptotic pathway is initiated to form a
death-inducing signal complex through the recruitment and ligation of a death ligand to its
transmembrane death receptor (Sartorius, Schmitz et al. 2001; Falschlehner, Emmerich et al.
2007). FasL and other TNF superfamily ligands are instrumental in activating the caspasecascades by inducing the trimerization of cell-surface death receptors and perturbing the release
of cytochrome C from mitochondria or neutralizing the inhibitors of apoptotic protein or
activators of casapses. Because Fas and TNF superfamily ligands have an indirect effect on the
release of cytochrome C, cross-talk between the intrinsic and extrinsic pathways has also been
extensively investigated (Khosravi-Far and Esposti 2004; Basu, Castle et al. 2006). For example,
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Figure 4. 1. Diagram of caspase-3 activation and apoptosis pathways.
The activation of caspase-3, one of the major players during apoptosis, can be accomplished
through two main pathways, death receptor-mediated pathway and mitochondria-mediated
pathways. In the receptor-mediated pathway, procaspase-8 can be activated through the binding
between death ligands and death receptors and the formation of death inducing signaling
complex (DISC). The activated caspase-8 cleaves procaspase-3 to result in caspase-3 activation
and apoptosis. In the mitochondria-mediated pathway, inducers or extracellular stress can
promote the release of cytochrome C from mitochondria and then form the apoptosome through
cytochrome C, Apaf-1 and caspase-9. The activated caspase-9 performs the cleavage of procaspase-3 to achieve caspase-3 activation and induce apoptosis.
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the BH3-domain of protein BID is only cleaved by the activation of pro-caspase-8 through the
extrinsic pathway, and then translocates to the mitochondrion to promote cytochrome C release
(Li, Zhu et al. 1998; Tan, Tan et al. 1999).
In addition to the above well-characterized apoptotic mechanisms, another mechanism of
the apoptotic process was also suggested where the calcium or endoplasmic reticulum (ER)regulated pathway made a significant contribution to activation or inhibition of caspase-cascade
system (Jimbo, Fujita et al. 2003; Tantral, Malathi et al. 2004; Murakami, Aizu-Yokota et al.
2007). The ER provides storage for Ca2+ and is essential for calcium signaling. Ca2+ dynamics
can also be modulated through Bcl-2 family proteins, one of the crucial factors in the apoptotic
pathway, which results in apoptosis due to the massive accumulation of Ca2+ (Oakes, Opferman
et al. 2003; Bassik, Scorrano et al. 2004). Since Ca2+ dynamics can also be mediated by
mitochondria to result in apoptosis, some calcium-binding proteins should also have significant
effects on the activation or inhibition of the caspase-cascade system and apoptotic pathways
(Heath-Engel and Shore 2006). On the other hand, due to the complicated caspase-cascades
system and apoptosis networks, a caspase-independent apoptotic process also has been
demonstrated (Assefa, Vantieghem et al. 2000; Bidere and Senik 2001; Ajiro, Bortner et al.
2008). Hence, comprehensive investigation and understanding of activation or regulation of
apoptotic pathways is essential for developing therapeutic strategies or novel and effective drugs
to treat autoimmune diseases, cancers and neurodegenerative diseases.
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4.1.3 Inducers for caspase-3 activation

The central contribution of the activation or regulation of caspase-cascade system in the
apoptotic process has been well recognized. Since caspase-3 is a pivotal enzyme in the execution
stage of the apoptotic pathway, this effector caspase is a good biomarker of apoptosis. In order to
understand the contributions and regulations of caspase-3 activation in the apoptotic process, the
inducers or triggers for caspase-3 activation are also extensively investigated. The following list
is the brief summary of commonly-used inducers for caspase-3 activation through different
apoptotic pathways.

Inducers for caspase-3 activation through mitochondria-mediated pathway
1) Staurosporine (STS) (Figure 4.2A) is a small molecule anticancer drug and has been
used as a broad-spectrum inhibitor of protein kinases (Feng and Kaplowitz 2002). It has been
well-established and widely-used to promote intracellular apoptosis through protein kinase C
inhibition to result in caspase-3 activation, the alteration of mitochondrial function to promote
the release of cytochrome C (Deshmukh and Johnson 2000), the loss of mitochondrial membrane
potential (Matsuyama, Llopis et al. 2000; Rego, Vesce et al. 2001; Smaili, Hsu et al. 2001), the
increase of ATP concentration (Shiraishi, Tatsumi et al. 2001), the decrease of extracellular pH
(Matsuyama, Llopis et al. 2000) and production of reactive oxygen species (ROS) (Kruman, Guo
et al. 1998; Li, Maasch et al. 1999; Gil, Almeida et al. 2003).
2) Etoposide (Figure 4.2B) is a drug for inducing DNA damage to treat cancers, which is
mainly focused on the inhibition of topoisomerase activity (Kim, Emi et al. 2005; Karpinich,
Tafani et al. 2006).
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3) UV irradiation is an approach for inducing the inactivation of mitogen-activated
protein kinase or extracellular signal-regulated kinase to result in apoptosis (Franklin, Srikanth et
al. 1998; He, Huang et al. 2004; Sethi and Sodhi 2004).
4) Tributyltin (TBT) (Figure 4.2C) can rapidly activate caspase-3 by damaging the
functions of mitochondria, increasing free calcium concentration in the cytosol, inducing the
production of ROS, improving the release of cytochrome C, and promoting mRNA expression of
TNFα and c-jun (Stridh, Kimland et al. 1998; Stridh, Gigliotti et al. 1999; Gennari, Viviani et al.
2000; Tiano, Fedeli et al. 2003).
5) Artemisinin and its derivatives are well-known antimalarial drugs and particularly
useful for the treatment of infection of malaria parasites resistant to traditional antimalarials
(Klayman 1985; Balint 2001; Liu, Zhao et al. 2006). Currently, dihydroartemisinin (DHA)
(Figure 4.2D), a water-soluble active metabolite of artemisinin derivatives, is used to induce
apoptosis in many cancer cell lines like leukemia HL60 cells or MD-DBA-451 cells through the
expression of caspase-3 (Lu, Meng et al. 2008; Zhou, Wang et al. 2008). The mechanism of
apoptosis or caspase-3 activation is reported to downregulate transferin receptor (TfR)
expression through mitochondrial pathway (Nakase, Lai et al. 2008). In addition, the report
demonstrated that DHA-induced apoptosis was an iron-dependent process and reactive oxygen
species (ROS) was contributed little to DHA-induced apoptosis in HL-60 cells (Lu, Meng et al.
2008). Moreover, DHA time-dependently activates mitogen-activated protein kinases (MAPKs)
(Lu, Meng et al. 2008; Mu, Zhang et al. 2008).

Inducers for caspase-3 activation through death receptor-mediated pathway
1) TNFα (tumor necrosis factor type 1) superfamily is a well-defined caspase trigger
through death receptor pathway. Caspase activation is initiated by the binding between death
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Figure 4. 2. The molecular structures of inducers for caspase-3 activation.
Four different small molecules, staurosporine (A), etoposide (B), tributyltin chloride (C) and
dihydroarteminsinin (D) were used for triggering apoptosis and caspase-3 activation in living
cells.
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ligands belonging to the tumor necrosis factor superfamily and its corresponding death receptor,
followed by the ligation and the formation of a multiprotein complex, death inducing signaling
complex (DISC), which promotes the caspase-8 activation in upstream followed by downstream
caspase-3 or caspase-7 activation (Boatright and Salvesen 2003; Philchenkov, Zavelevich et al.
2004). In addition, TNFα also functions to increase the expression level of p53 and p53associated proapoptotic genes and indirectly stimulates the caspase cascade in cells (Menon,
Lombardi et al. 2002). Moreover, since TNFα is an autocrine growth factor for a series of tumors
and performs critical functions for tumorigenesis, extensive investigations have also indicated
that it exhibits a strong capability to activate receptor-interacting kinase (RIP), resulting in the
activation of NF-кB and the MAPK family members such as JNK, p38 and MAPK, which
regulate the caspase pathways (Higashimoto, Panopoulos et al. 2006). Furthermore, it has also
been reported that chromosomal abnormalities can be induced by TNFα independent of the
mediations from ROS, JNK and p38; however, a clear mechanism for this is still being probed.
2) Anti-Fas exhibits similar functions and regulation modes as TNFα superfamily
members for caspase-cascade systems. The best-characterized death-receptor signaling pathway
is triggered through interaction between Fas and its ligand FasL, followed by the production of
DISC to accomplish the caspase-cascade. Currently, typical anti-Fas ligands for caspase
activation are anti-CD95 and anti-APO-1 (Boatright and Salvesen 2003; Philchenkov,
Zavelevich et al. 2004).
3) TRAIL (tumor necrosis factor (TNF)-related apoptosis-inducing ligand) is an
important member of TNF family of cytokines for promoting caspase activation and apoptosis.
TRAIL is specific to a wide variety of tumor cells, but not normal cells for caspase activation
and apoptosis induction through the mediation of death receptors such as DR4 and DR5
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(Philchenkov, Zavelevich et al. 2004). The assembly of the signaling complex of DR4/DR5 can
be achieved through the binding of TRAIL, followed by initiation of caspase-8 activation. In
addition, activation of caspases can be initiated via TRAIL, which also have been reported to
have relationships with the mitochondria pathway, such as the loss of mitochondrial
transmembrane potential, the cleavage of BID, and the redistribution of mitochondrial
cytochrome C (Suliman, Lam et al. 2001; Nencioni, Wille et al. 2005). Therefore, TRAILinduced caspase activation and apoptosis can be accomplished via both mitochondria-dependent
and -independent pathways.

4.1.4 Structure and substrate specificity of caspases

Caspases are synthesized in relatively large amounts as inactive precursors within the
cytoplasm. As shown in Figure 4.1 and 4.3, these precursors contain three domains: an extended
N-terminal prodomain, a large subunit (~17-20 kDa) and a small subunit (~10 kDa). In an
initiator caspase, the prodomain is generally larger, with more than 90 amino acid residues,
whereas an effector caspase frequently contains 20-30 residues in its prodomain sequence
(Chang and Yang 2000). The long prodomains in initiator caspases are composed of death
effector domains (DED), which are found in caspase-8 and caspase-10, or the caspase
recruitment domains (CARD), which are found in caspase-9 and caspase-2. These domains can
mediate specific protein-protein interactions between procaspases and their adapters to promote
the formation of a multimeric complex that is necessary to bring two caspase precursors together
for procaspase activation (Stennicke and Salvesen 1998; Donepudi and Grutter 2002; Shi 2002;
Shi 2004). On the other hand, the short prodomains in executioner caspases do not mediate
protein-protein interactions. Following a proapoptotic stimulus, they are sequentially processed
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into a precursor, noncatalytic domain and two catalytic subunits: a large subunit containing the
active site Cys, and a smaller 10 kDa subunit.
The three-dimensional structures of active caspases have been determined and shown in
Figure 4.4, which are composed of a tetramer formed from two heterodimers of these two
subunits with molecular masses of 20 kDa and 10 kDa, respectively (Concha and Abdel-Meguid
2002). Two small subunits are surrounded by two large subunits (Chang and Yang 2000). This
catalytic tetramer is arranged in opposite direction and each heterodimer has an active site, which
is characterized by a deep pocket for binding the Asp (P1) at the cleavage site in its specific
substrate and a broader, shallower irregular pocket to bind the preceding three amino acid
residues (P2-P4) (Stennicke and Salvesen 1999). The proteolytic process for the activation of
procaspases to produce the active caspase tetramers is shown in Figure 4.3. Each caspase has a
conserved active site, pentapeptide QACXG (X is always R, Q, or G) containing the active Cys
residue that is necessary for the proteolytic activity of caspases. Therefore, caspases have an
essential requirement for cleavage after an aspartate residue (D). Both the large and the small
subunits contribute to form the substrate-binding pockets, which recognize at least four amino
acids (P4P3P2P1) as the cleavage site in the substrates. In the S1 site, the amino acid residues,
which form the Asp substrate-binding pocket, are R179, Q283, R341 and S347, with the first two
residues from the large subunit and the latter two residues from the small subunit. R179 and
R341 can form hydrogen bonds with the Asp residue in the P1 site of the substrate. The major
interactions in the active site are shown in Figure 4.5 (Nicholson 1999). The amino acids from
the small subunit forming the S2 and S3 sites can be varied considerably (Cohen 1997; Donepudi
and Grutter 2002). Therefore, caspases have less strict requirement at the P2 and P3 locations in
substrates. However, the high specificity of substrates is mainly due to the significant difference

123

Figure 4. 3. The process from procaspase to active caspase tetramer.
The pro-caspase composed of prodomain, large subunit and small subunit was proteolytically
cleaved at the Asp-X cleavage sites to obtain large and small subunits, respectively. The large
subunit (α chain) and small subunit (β chain) are connected to form a heterodimer. Two
heterodimers then form a tetramer to produce an active caspase. The active site is composed of
four residues, R179, H237, C285 and R341.
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Figure 4. 4. The three-dimensional structure of active caspase-3 (PDB, 2J30).
The active caspase-3 tetramer is composed of two heterodimers, which are formed by the large
subunit (highlighted in green and cyan color) and the small subunit (highlighted in red and
purple color).
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Figure 4. 5. Interactions between the substrate and residues in the active site of caspase-3.
The residues at P1 and P3 position of caspase-3 substrates provide the critical interactions
between substrate and active sites of caspase-3. The Glu residue at the P3 position of substrate
forms the bident hydrogen bonds with Arg341 in the active site of caspase-3. Arg179 and
Arg341 are also involved in hydrogen network formation with the Asp residue at the P1 position
of caspase-3 substrates. Modified after (Nicholson 1999).
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in the S4 site. For example, the large and shallow hydrophobic depression contributes to caspase1 specificity due to correct accommodation with Tyr or Trp in the P4 site. The narrow and
hydrophilic pocket accounts for caspase-3 recognition specificity because of the interaction with
the side chain of Asp residue (Earnshaw, Martins et al. 1999). Hence, a unique pocket for each
caspase member was recognized, and the specific recognition sites are shown in Table 4.1.

Table 4. 1. The specific recognition sites of various caspases
Specificity group

Group I

Group II

Group III

Caspase name

Optimal recognition motif
(P4-P1)

Caspase-1

WEHD

Caspase-4

WEHD

Caspase-5

WEHD

Caspase-13

WEHD

Caspase-2

DEHD

Caspase-3

DEVD

Caspase-7

DEVD

Caspase-6

VEHD

Caspase-8

LETD

Caspase-9

LETD

Caspase-10

LEXD

Modified after (Nicholson 1999).

Consensus motif

WEHD

DEXD

(I/V/L)EXD
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One of the most attractive features for caspases is that these enzymes have high substrate
specificity. Peptide substrates are named by designating the amino acid extending from the
cleaved peptide bond to N-terminal side as P1, P2, P3, P4, etc and the amino acid residues
extending following the cleaved peptide bond to the C-terminal side as P1’, P2’, P3’, P4’, etc.
Initial studies have shown that caspases have very high P1 specificity. The rate of catalysis
decreases more than 100-fold when the P1 aspartic acid residue is substituted by any other amino
acid (Stennicke and Salvesen 1999). To examine the substrate specificity at other positions,
caspase-1 substrates were synthesized, and then analyzed to determine their Vmax/Km (Howard,
Chartrain et al. 1991). Amino acids spanning P1 to P4 were proven to be critical for substrate
recognition by caspase-1, as deletions of these amino acid residues diminished substrate activity.
No significant reduction in catalysis was observed when C-terminal deletions were examined
except for the P2’ position. It is important to note that the P5 deletion significantly reduced the
relative rate of hydrolysis, but placing an acetyl group on the N-terminus of P4 restored optimal
activity. In addition, the activity investigations on caspase-3 and caspase-7 indicated caspase-3
prefers hydrophobic residues, such as Leu or Val, at the P5 site, however, there is no obvious
requirements for the P5 site of caspase-7 substrates (Fang, Boross et al. 2006). Although
extensive investigations indicated that DEVD in substrates is the optimal sequence residues for
caspase-3 recognition and cleavage, proteins with less optimal sequences like DKVDV, DGFDS,
DMPDG and DNIDA from zebrafish or the nucleobindin-2 protein with sequence of TDGLDP
also have high potential to be cleaved by caspase-3 (Valencia, Bailey et al. 2007; Valencia,
Cotten et al. 2008). Therefore, investigating the highly-conserved recognition sequence and the
specificity for caspase-3 in these natural caspase-3 substrates should provide important
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information for highly-specific caspase-3 sensor development, which will enhance our ability to
monitor caspase-3 activation or inhibition in real time in living systems.

4.1.5 Current methods for detection of caspase activity and their limitations

The majority of caspase actions are mainly monitored in semi-quantified or indirect
modes. Antibody against caspases by Western blot is a common method with high sensitivity,
which provides a qualitative rather than quantitative assay for caspases of apoptosis pathways in
apoptotic cells, tissues or organs. Caspase inhibitors or affinity labels to monitor caspase actions
are limited by their relatively low specificity for each individual caspase and toxic effects
especially during long-time measurement in living cells or in vivo (Lee, Long et al. 2000; Tawa,
Tam et al. 2001; Kohler, Orrenius et al. 2002). The current majority of caspase-3 sensors or
probes for monitoring caspase actions are also composed of chromogenic or fluorogenic dye
conjugated cleavage linkers for caspase-3, which can be summarized under the following major
classes. The first class, that is commercially available, is chemical synthetic substrates linked to
chromphores, which utilizes a synthetic tetrapeptide, Asp-Glu-Val-Asp (DEVD), labeled with a
fluorescent molecule, 7-amino-4-trifluoromethyl coumarin (AFC), or a colorimetric molecule, pnitroanilide (pNA) as substrates. DEVD-dependent protease activity is assessed by the detection
of the free AFC or pNA cleaved from substrates for rapid quantification of caspase-3 activity
during the onset of apoptosis (Gurtu, Kain et al. 1997). To analyze caspase activity with this
method, apoptotic cells are required to be lysed and then subjected to enzymatic action. Although
some caspase peptide probes can be diffused into living cells, caspase activity cannot be wellquantified due to difficulties in delivery, especially in the desired sub-cellular compartments
such as mitochondria and ER. Quantification of caspase activity in living cells is also affected by
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background interference. In addition, specificity of these commercial substrates for caspases is
poor due to lack of defined structure and in inability to insert the preferable amino acid residues
in both P region and P’ region of the cleavage linkers (Liu, Bhalgat et al. 1999; Kohler, Orrenius
et al. 2002; Kawai, Suzuki et al. 2004; Kawai, Suzuki et al. 2005). Another class of fluorescence
probes with a fluorophore and a quencher was developed and applied to on-chip detection of
caspase-3 activity. This probe is non-fluorescent in the absence of caspase-3. However, when it
is treated with active caspase-3, the fluorescence intensity increases dependent on the caspase-3
activity due to the cleavage of the quencher-containing moiety on a glass slide (Han, Sonoda et
al. 2006).
To date, real-time determination of caspase-3 pathway in vivo or in living cells has been
largely elusive. Due to the limitations of the above methods for caspase-3 activity assay in living
cells, and the unique capability of GFP to be expressed in many organisms without the
requirement of cofactors, GFP has attracted extensive attention for developing novel and
effective methods to determine caspase-3 activity in vitro or in vivo in real time. The amino acid
peptide linker containing caspase-3 recognition sequence (DEVD) for linking fluorescence
protein pairs, such as GFP and BFP, ECFP and EYFP, has been used for monitoring the
apoptosis processes by FRET assay (Luo, Yu et al. 2001; Zhang, Haskins et al. 2004). Dual color
fluorescence cross-correlation spectroscopy (FCCS) has also been used to directly detect
caspase-3 activation in a single live cell using a fusion protein comprised of enhanced green
fluorescent protein (EGFP) and monomeric red fluorescent protein (mRFP). Several reports have
also been presented the FRET resulting in the fusion fluorescent protein pairs for monitoring
protease activity with flow cytometry, fluorescence microplate reader in apoptotic cells (Jones,
Heim et al. 2000; He, Wu et al. 2004; Wu, Simone et al. 2006). Another reported method
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allowing for real-time observation of caspase activation in situ in living cells was based on FRET
measurement using the prism and reflector imaging spectroscopy system (PARISS) (Zhang,
Haskins et al. 2004). These FRET-based methods have advantages of monitoring the dynamic
processes of caspase activation in vitro or targeting the right locations in vivo. Unfortunately, as
discussed in Chapter 1 (Section 1.5), practical applications for in vivo imaging of protease
actions with FRET-paired protease probes are limited due to the relatively small change in
signal, problems associated with photobleaching, imbalance in fluorescence intensity between
the donor and the acceptor, cross-talk in the FRET signal due to spectral overlap between the
donor and the acceptor, and the restriction of optimal distance for FRET efficiency due to the
large size of the fluorescent proteins (Felber, Cloutier et al. 2004; Piston and Kremers 2007).

4.1.6 Objectives to the development of caspase sensors

It is well known that caspase-cascade system has a pivotal function to cell survival and
cell death in the cell cycle. The generation, activation, inhibition and regulation of caspases in
living systems are complicated, which presents difficulties for real-time monitoring of pathways
and mechanisms of apoptosis. On the other hand, due to caspase activation, homeostasis
alteration like acidification or alkalization of different subcellular compartments during the late
stage of apoptosis, a sensitive genetic caspase probe with a ratiometric measurement mode that
circumvents the effect from background and normalizing the alteration of cellular contents is
highly desired.
The insertion of EF-hand motifs at position Glu172 of the EGFP is sensitive to proteases,
such as trypsin, as is reported in Chapter 3. According to the high sensitivity and large relative
signal change of trypsin sensors in vitro or in living cell studies, we hypothesized that EGFP can
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be applied to design the protease-susceptible molecules for monitoring specific proteolytic
activities in vitro, in living cells and in vivo, and to understand mechanisms of protease-related
diseases.
In this chapter, we would like to extend the design and application of the strategy for
protease sensors. Herein, we have presented our strategy to develop caspase-3 and caspase-8
sensors by grafting a caspase-3-specific or caspase-8-specific cleavage linker at the identified
chromophore-sensitive location 172 in a single EGFP. The optical and kinetic properties of these
sensors were first examined using purified proteins under different buffer conditions. Because
EGFP exhibits high resistance to various proteases and presents the possibility of cleavage with
adding a cleavable linker for proteases at the inserted loop region of EGFP, the insertion of
caspase-3-specific or caspase-8-specific cleavable linkers in EGFP was conducted to develop
sensors for detecting initiator caspase, caspase-8 and effector caspase, caspase-3 activation and
inhibition in living cells in real time. In addition, the fluorescence ratiometric changes of
caspase-3 at 398 and 490 nm for excitations were also examined using both fluorescence
microscopy and fluorimeter assays in several different cell lines. Furthermore, the performance
of developed sensors in monitoring caspase-3 activation was compared with peptide kits.
Moreover, the data in living cells were compared with the data in vitro using purified proteins.

4. 2

Design and construction of caspase-3 sensors

In order to develop EGFP-based caspase sensors, different cleavage linkers containing
caspase-3 recognition sequence (DEVD) were grafted into the identified location Glu172, a
sensitive position on EGFP for optical signal change of the chromophore, through PCR
techniques, to obtain various caspase-3 sensors, as summarized in Table 4.2. Due to the
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resistance of EGFP to proteases and the characteristics of better flexibility of EF-hand motifs in
the trypsin sensors reported in Chapter 3, the recognition sequence (DEVD) as the cleavage site
for caspase-3 was extended with an E-helix and F-helix on both sides to improve the exposure
area of the cleavage site and increase accessibility to proteases. The caspase-3 recognition
sequence (DEVD) with flanking EF-hand motifs was grafted in EGFP to produce a caspase-3
sensor, designated EGFP-C3A. Meanwhile, in order to improve the possibility of exposure or
accessibility for caspase-3 cleavage and to compare the cleavage efficiency of EGFP-based
caspase-3 sensors containing one cleavage site and two cleavage sites, another recognition
sequence unit of caspase-3 (DEVD) was further grafted into EGFP-C3A to obtain another
caspase-3 sensor with double cleavage sites, designated as EGFP-C3B. Both cleavage sites for
caspase-3 were linked through a short glycine linker (GG). Based on the investigation of trypsin
sensors, the cleavage sites on F-helix can offer fast response to trypsin and produce a large
relative signal change. Therefore, the caspase-3 recognition sequence (DEVD) was also located
on F-helix to evaluate caspase-3 cleavage efficiency and relative signal change of our designed
caspase-3 sensors. Since the preferred residues, Leu or Val on P5 and Gly or Ser on P1’ positions
of substrates have an important effect on caspase-3 cleavage, the preferred residues at P5 and P1’
positions, in recognition linkers for caspase-3 have been also considered to provide high
specificity to caspase-3 digestion while designing caspase-3 sensors with a cleavage site on Fhelix. The designed EGFP-based caspase-3 sensors with preferred residues at P5 and P1’
positions were designated as EGFP-C3C and EGFP-C3D. On the other hand, in order to further
confirm the effects of helix-loop-helix motifs on caspase-3 cleavage, caspase-3 sensors without
helix-loop-helix motifs were also designed. The alone caspase-3 recognition sequence (DEVD)
and the alone caspase-3 recognition sequence (DEVD) extended with the linker (GGSGG) on
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both sides were grafted into the identified sensitive location, Glu172 of EGFP to obtain EGFPbased caspase-3 sensors, EGFP-C3E and EGFP-C3F, respectively. A linker without recognition
sequence was also designed and inserted onto EGFP to obtain a control, EGFP-C3N.

Table 4. 2. Designed caspase sensor variants and their cleavage linker sequences
Caspase sensor name

Cleavage linker sequences

EGFP-C3A

EEEIREAFRVFDEVDLRHVMTNL

EGFP-C3B

EEEIREAFRVFDEVDGGDEVDLRHVMTNL

EGFP-C3C

EEEIREAFRVFDKDGNGYISAAEVDEVDGVMTNL

EGFP-C3D

EEEIREAFRVFDKDGNGYISAAELDEVDSVMTNL

EGFP-C3E

DEVD

EGFP-C3F

GGSGGDEVDGGSGG

EGFP-C3N

EEEIREAFRVFDKDGNGYISAAEVGVMTNL

EGFP-C8A

EEEIREAFRVFDKDGNGYISAAELLETDGVMTNL

EGFP-C8B

EEEIREAFRVFDKDGNGYISAAELLETDSVMTNL

Because caspase-3 activation is a landmark event in apoptosis, assaying caspase-3
activity in living cells has been extensively applied as an effective tool or a powerful biomarker
for detecting programmed cell death, and understanding comprehensive mechanisms or
pathways of apoptosis. However, caspase-3, an effector caspase, is first generated from an
inactive procaspase-3 which is proteolytically activated by initiator caspase, caspase-8.
Therefore, an EGFP-based caspase-8 sensor should also have its significance in visualization of
caspase-8 activation and inhibition to study apoptosis mechanisms or pathways. A similar
method is exploited to construct caspase-8 sensors. Caspase-3 and caspase-8 sensors were
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successfully designed and amplified with PCR in pcDNA 3.1 (+) and pET28a vectors, for
mammalian cell expression and bacterial expression systems, respectively. All cleavage linker
sequences for our designed caspase-3 and caspase-8 sensors are listed in Table 4.2.

4. 3

Optical properties of caspase sensors

The genetically engineered EGFP-based caspase-3 and caspase-8 sensors in the pET28a
vector were successfully expressed in E. coli. Following the grafting of the cleavage linkers in
EGFP, all of these caspase sensors, EGFP-C3A, EGFP-C3B, EGFP-C3C, EGFP-C3D, EGFPC3E, EGFP-C3F, EGFP-C8A and EGFP-C8B reveal strong fluorescence both in bacteria and as
purified proteins. The purified caspase-3 and caspase-8 sensor variants show two chromophore
forms, deprotonated and protonated chromophores, resulting in strong absorption peaks at 490
and 398 nm, respectively, as shown in Figure 4.6. Like trypsin sensors, the insertion of the
caspase-3 or caspase-8 cleavage linker at position Glu172 onto EGFP increases the proportion of
the protonated form of the chromophore and reveals a strong absorption at 397 nm while
correspondingly decreasing the deprotonated form of the chromophore with a strong absorption
observed at 490 nm. Furthermore, such alteration of the ionic state of the chromophore is also
related to the properties of cleavage linkers that are inserted. The EGFP-based caspase-3 or
caspase-8 sensor variants with both flanking helices exhibit a greater absorption ratio
(A398nm/A490nm) than caspase sensor variants that did not have a flanking helix in the inserted
loop. The maximum fluorescence emission wavelengths of all caspase sensor variants were
approximately 508 nm resulting from excitation at 398 or 490 nm, respectively, as shown by the
representative variant, EGFP-C3B, in Figure 4.7. Consistent with our results from the developed
trypsin sensors, as shown in Chapter 3, the close population level between deprotonated
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Figure 4. 6. Spectral characteristics of EGFP-based caspase-3 sensors.
Compared to EGFP-wt ( ○ ), spectra of EGFP-C3A ( ◇ ), EGFP-C3B ( ● ), EGFP-C3C ( ■ ),
EGFP-C3D (□ ) and EGFP-C3E (△) buffered in 10 mM Tris, 1 mM DTT, pH 7.4, have both
protonated and deprotonated chromophore forms. The different lengths and net charge of the
cleavage linkers have significant effects on the population of both chromophore forms. All
caspase-3 sensors with concentration of 10 μM are buffered in Tris buffer (10 mM Tris, 1 mM
DTT, pH 7.4).

136

Figure 4. 7. Fluorescence emission spectra of representative caspase-3 sensors.
The fluorescence emission spectra of EGFP-C3B were scanned in the range 500 to 600 nm with
excitation of 398 (●) and 490 nm (■ ) in Tris buffer (10 mM Tris, 1 mM DTT, pH 7.4). The
maximum emission peak is observed at 508 nm when excited at both wavelengths.
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chromophore form and protonated chromophore form provides a large relative signal change.
Therefore, EGFP-C3B, EGFP-C3C and EGFP-C8A have the larger relative signal change
following the digestion of caspases.

4. 4 Optical signal change following caspase digestion

In order to examine the spectral characteristics of various caspase-3 sensors, all of the
caspase-3 sensors with 15 μM in caspase reaction buffer (20 mM HEPES, 100 mM NaCl, 1 mM
EDTA, 10 mM DTT, 0.1% CHAPS, 10% Sucrose, pH 7.4) were monitored to observe
absorbance or fluorescence spectral changes following caspase-3 digestion at a final
concentration of 31.25 nM. Following caspase-3 digestion, the maximum absorption of EGFPC3B at 490 nm increased and concurrently decreased at 398 nm, as shown in Figure 4.8A.
Similarly, EGFP-C3B exhibited a ratiometric fluorescence signal change with a decrease in
maximum fluorescence intensity at 508 nm at an excitation wavelength of 398 nm (Figure 4.8B)
and a corresponding increase at an excitation wavelength of 490 nm (Figure 4.8C). Meanwhile,
EGFP-C3C exhibited similar absorbance and fluorescence signal change trends as EGFP-C3B
following caspase-3 digestion under identical reaction buffer conditions. In contrast, other
EGFP-based caspase-3 sensors, EGFP-C3A, EGFP-C3E and EGFP-C3F exhibited very little
optical signal change in absorbance or fluorescence following caspase-3 digestion, and EGFPC3E, EGFP-C3F and EGFP-C3N exhibited no optical signal change following the addition of
caspase-3, which clearly indicated that EGFP-C3B and EGFP-C3C are suitable for the
development of caspase-3 sensors, but not EGFP-C3E and EGFP-C3F in spite of the caspase-3
recognition sites in the linkers. These results demonstrated that the larger exposure or high
accessibility of recognition sites for caspase-3 could be improved through the extension of helix-
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loop-helix structure in the cleavage linker to result in faster response to caspase-3 action, or
provide a larger relative optical signal change following caspase-3 digestion.
In order to form an active caspase-3, a tetramer is generated through interaction between
the heterodimers composed of a large subunit and small subunit of pro-caspase-3. Therefore, the
optimal compositions of caspase-3 reaction buffers play a pivotal role in caspase-3 activation and
its cleavage efficiency for substrates. According to previous investigations for the digestion of
caspase substrates (Thornberry, Bull et al. 1992; Stennicke and Salvesen 1997; Okun, Malarchuk
et al. 2006), the removal of CHAPS in caspase reaction buffers resulted in the loss of more than
40% caspase activity (Stennicke and Salvesen 1997). In order to improve the interaction between
heterodimers, 10% glycerol or 10% sucrose was added in the reaction buffers (Kohler, Orrenius
et al. 2002). In addition, because the caspases are proteases of the cysteine family, a relatively
high concentration of DDT is required for full activity of caspases to avoid oxidation of catalytic
cysteine (Nobel, Kimland et al. 1997; Okun, Malarchuk et al. 2006). Meanwhile, EDTA
incorporated into caspase reaction buffers is also reported to avoid to the inactivation of trace
metals in the buffer systems and NaCl is used to maintain the consistent ionic strength or pH
change (Stennicke and Salvesen 1997; Feeney and Clark 2005). In order to obtain an optimal
caspase-3 reaction buffer for our EGFP-based caspase-3 sensors, we have conducted caspase-3
digestion of 15 μM EGFP-C3B through the addition of stock caspase-3 (Sigma, St. Louis) up to
a final concentration of 31.25 nM in 7 different reaction buffer conditions with the abovementioned important compositions and mostly-used caspase-3 reaction buffer conditions in
literature (Stennicke and Salvesen 1997; Shin, Okada et al. 2003; Du, Wang et al. 2004; Okun,
Malarchuk et al. 2006), which are summarized in Table 4.3. Based on overnight digestion, SDSPAGE examination indicated EGFP-C3B is specifically cleaved by active caspase-3 into two
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Figure 4. 8.
Spectral change of EGFP-C3B under the caspase-3 reaction buffer system
containing 10% sucrose following caspase-3 digestion.
The maximum absorption (A) of EGFP-C3B exhibited a decrease at 398 nm and an increase at
490 nm following caspase-3 digestion in the caspase-3 reaction buffer (20 mM HEPES, 100 mM
NaCl, 1 mM EDTA, 10 mM DTT, 0.1% CHAPS, 10% Sucrose, pH 7.4). The maximum
fluorescence emission at 508 nm exhibited a decrease when excited at 398 nm (B) and an
increase when excited at 490 nm (C) after caspase-3 cleavage. The spectra of EGFP-C3B before
and after caspase-3 digestion are in solid and dashed lines, respectively.
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major fragments approximately 25 and 8 kDa in mass (Figure 4.9) in 7 various caspase-3 buffer
conditions. The UV-visible spectra of EGFP-C3B following caspase-3 digestion were measured
in a cuvette with 1 cm pathlength and fluorescence spectra of EGFP-C3B with excitation of 398
and 490 nm were recorded. The largest relative signal change for caspase-3 digestion of EGFPC3B was observed in reaction buffer 4 (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 10 mM
DTT, 0.1% CHAPS, 10% Sucrose, pH 7.4), as also summaried in Table 4.3.

Table 4. 3. Composition of various reaction buffers for caspase-3
Composition

Buffer-1

HEPES (mM)

20

PIPES (mM)

Buffer-2

Buffer-3

Buffer-4

Buffer-5

Buffer-6

Buffer-7

20

20

20
20

Tris (mM)

20
20

NaCl (mM)

100

100

100

100

100

100

100

DTT (mM)

10

10

10

10

10

10

10

EDTA (mM)

1

1

1

1

1

1

1

CHAPS (%)

0.1

0.1

0.1

0.1

0.1

0.1

Glycerol (%)

10

Sucrose (%)

10
10

10
10

10

10

pH

7.5

6.8

7.5

7.5

6.8

7.5

7.5

Relative
signal change

1.50

1.85

1.44

2.10

1.84

1.75

1.51
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Figure 4. 9. The cleavage confirmation of EGFP-C3B following caspase-3 digestion.
In order to investigate optimal buffer conditions for caspase-3 digestion, the digestion of 20 μM
EGFP-C3B was conducted by active caspase-3 in 7 buffers with various compositions.
Following caspase-3 digestion with the contration of 20 nM, EGFP-C3B is specifically cleaved
in two major fragments with approximately 25 kDa and 8 kDa molecular masses, respectively. M
is the protein marker; C3B is the sample of EGFP-C3B sensor; B1, B2, B3, B4, B5, B6 and B7
are the samples of EGFP-C3B following caspase-3 digestion under 7 different reaction buffer
conditions listed in Table 4.3.
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4. 5

Verification of caspase sensors cleavage

Although EGFP-C3B can be cleaved into major fragments in 7 various different reaction
buffer conditions, the accurate cleavage locations still need to be verified. The cleaved fragments
for EGFP-C3B were subjected to further analysis by MALDI-MS (Dr. Siming Wang provided
the mass spectroscopy), which revealed molecular masses for intact EGFP-C3B and the two
major fragments of 34440.02 (Figure 4.10A), 25607.73 (Figure 4.10B) and 8226.51 Da (Figure
4.10C), respectively, where the latter two mass values correspond to the calculated mass values
of 25494.56 and 8211.15 Da for the major fragments of EGFP-C3B. This result is in good
agreement with the analysis of SDS-PAGE. Both mass spectrometry and SDS-PAGE analyses
reveal that the molecular masses of the cleavage fragments are consistent with cleavage at the
desired caspase-3 cleavage location. When examining the selectivity for different members of
caspase family, both purified EGFP-C3B and EGFP-C3C at concentration of 20 μM were
specifically cleaved by 20 nM caspase-3 into two major fragments in optimal caspase-3 reaction
buffer (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 10 mM DTT, 0.1% CHAPS, 10%
Sucrose, pH 7.5) following overnight digestion at room temperature, as revealed by SDS-PAGE
(Figure 4.10D). In contrast, wild type EGFP (EGFP-wt) and EGFP-C3N that both lack caspase-3
recognition sites did not exhibit similar cleavage upon overnight incubation with caspase-3.
Moreover, our caspase-3 sensors can not be cleaved by 20 nM caspase-6, caspase-7, caspase-8
and caspase-9 (These enzymes are provided by Rihe Liu from The University of North Carolina
at Chapel Hill); however, under identical buffer conditions, 20 nM caspase-8 cleaves its substrate
EGFP-C8A. Although there is considerable similarity between recognition sites for various
caspases, our EGFP-C3B and EGFP-C3C offer a high selectivity and specificity for caspase-3,
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Figure 4. 10. Cleavage of EGFP-C3B following evaluation by MALDI-MS and SDS-PAGE.
20 μM EGFP-C3B was subjected to 20 nM caspase-3 digestion overnight at room temparture in
its optimal reaction buffer (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 10 mM DTT, 0.1%
CHAPS, 10% Sucrose, pH 7.5) and the cleavage status was determined using MALDI-MS. The
molecular mass of intact EGFP-C3B, cleaved major large fragment and major small fragment are
34440.02 (A), 25607.73 (B) and 8226.51 Da (C), respectively, suggesting a specific cleavage at
the recognition site of caspase-3 in the inserted linker. The specificity and selectivity of caspase3 sensors for different caspases was examined in SDS-PAGE (D). Lanes M, 1, 2, 3, 4, 5, 6, 7, 8,
9, 10, 11, 12, 13, 14 and 15 are: protein marker, EGFP-C3B, EGFP-C3B with caspase-3
digestion, EGFP-C3B with caspase-8 digestion, EGFP-C3C, EGFP-C3C with caspase-3
digestion, EGFP-C3C with caspase-8 digestion, EGFP-wt, EGFP-wt with caspase-3 digestion,
EGFP-C8A with caspase-8 digestion, EGFP-C3B with caspase-6 digestion, EGFP-C3B with
caspase-9 digestion, EGFP-C3B with caspase-7 digestion, EGFP-C3C with caspase-6 digestion,
EGFP-C3C with caspase-9 digestion and EGFP-C3C with caspase-7 digestion, respectively. All
caspase sensors at the concentration of 20 μM are buffered in optimal reaction buffer conditions
and subjected to overnight digestion with 20 nM caspases at room temperature.
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which may be due to the preferred residue extension outside P1 and P4 position in our EGFPbased sensors. Moreover, the grafting cleavage linker inside the EGFP β-barrel structural
environment possibly provides an improved match to the caspase-3 active pocket. Such
enzymatic specificity is very important for further application in monitoring caspase-3 action in
live systems.

4. 6

Kinetic study of caspase sensors

In order to evaluate the enzymatic response and the specificity of caspase-3 sensors
through catalytic kinetic parameters, kinetic studies of EGFP-based caspase-3 sensors at various
concentrations from 2 to 30 μM supplemented the addition of active caspase-3 were conducted in
the optimal caspase-3 reaction buffer (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 10 mM
DTT, 0.1% CHAPS, 10% Sucrose, pH 7.5) to obtain the turnover number (kcat), the Michaelis
constant (Km), and the specificity constant (kcat/Km). The initial rates of EGFP-based caspase-3 at
various concentrations following caspase-3 cleavage were determined using a time course mode
to monitor absorbance changes at 490 nm. Kinetic studies of our designed caspase-3 sensors
were compared with results from a commercially-available caspase-3 substrate, Ac-DEVD-pNA
colorimetric caspase-3 substrate, under identical buffering conditions. Kinetic catalytic
parameters, kcat, Km and kcat/Km were determined through fitting with the Michaelis-Menten
equation (Chapter 2), as summarized in Table 4.4. Although our designed caspase-3 sensors have
smaller kcat values, EGFP-C3B exhibited a 2.7-fold smaller Km and a 6.7-fold higher kcat/Km than
commercial caspase-3 substrates, Bz-DEVD-pNA and Z-DEVD-AMC, respectiviely, based on
previous reports (Fang, Boross et al. 2006). EGFP-C3C exhibited a 3-fold larger kcat and 0.4-fold
smaller Km with overall substrate specificity 4.8-fold better than that of EGFP-C3B, which is due
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either to better solvent accessibility of the cleavage site or a longer linker. Moreover, the
substrate specificity kcat/Km of EGFP-C3C exhibited 21.8 and 4.5-fold larger than those of
commercial caspase-3 substrates, Bz-DEVD-pNA and Z-DEVD-AMC, respectively, due to its
smaller Km value. It is important to note that the same DEVD sequence in two different
commercial probes were 2.5 folds difference in Km, suggesting the influence of chromophore on
the kinetic property. These results indicate that our designed EGFP-based caspase-3 is
comparable or better than currently available commercial caspase-3 substrates without
unnecessary influence like the small chromphore. Although fluorescent protein FRET-based
caspase-3 probes are extensively investigated for the studies in living cells or in vivo, and this
technology has made great achievements in living system detection, no catalytic kinetic
parameters corresponding to this method have been reported.

Table 4. 4. Catalytic kinetic parameters of caspase-3 sensors
-1

-1 -1

Trypsin sensors

kcat (s )

Km (μM)

kcat/Km (M s )

EGFP-C3B

0.13 ± 0.01

10.03 ± 1.19

12500 ± 150

EGFP-C3C

0.39 ± 0.03

6.55 ± 1.53

59600 ± 9300

Bz-DEVD-pNA

0.73 ± 0.02

26.91 ± 1.20

2730 ± 120

Z-DEVD-AMC

0.88 ± 0.01

67.1 ± 4.3

13100 ± 790

FRET-based sensors

No catalytic kinetic parameters reported

Conditions: 20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 10 mM DTT, 0.1% CHAPS, 10% Sucrose, pH 7.5, 25 ˚C
The data presented in mean ± SD, are fitting kinetic parameters and fitting errors.
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4. 7

Fluorescence imaging of caspase-3 sensors

In order to real-time track caspase-3 activity in living cells, our EGFP-C3B sensor was
transfected into HeLa cells. After transient transfection, HeLa cells with EGFP-C3B gene and
the control (EGFP-wt) exhibit strong fluorescence via fluorescence microscopy, following 16 to
48 hours of expression. Upon caspase-3 activation by 1 μM staurosporine (STS), the
fluorescence emission signal at 510 nm of EGFP-C3B significantly increased by approximately
100% at 398 nm of excitation while concurrently decreasing by 70 % at 488 nm of excitation
(Figure 4.11A, 4.11B, 4.11C and 4.11D), resulting in a relative signal change of 3.2 expressed in
a ratiometric fluorescence emission change, determined by Equation 3, using the fluorescence
intensity at 398 nm dividing the fluorescence intensity at 488 nm (Figure 4.11E). During the
fluorescence signal change, no obvious change in cell morphology was observed, which suggests
that caspase-3 activation can be sensitively detected in the early stage of apoptosis prior to the
cell morphology changes and nucleus fragmentation. In contrast, the fluorescence signal change
of EGFP-wt at 510 nm with excitation of 398 and 488 nm exhibited no significant change
(Figure 4.12A, 4.12B, 4.12C and 4.12D). Moreover, no changes were observed in the ratiometric
fluorescence signal of EGFP-wt, as shown in Figure 4.12E. Similarly, the cells transfected with
EGFP-C3N that also lacked cleavage sites exhibited no fluorescence signal change at either
excitation wavelengths or ratiometric fluorescence signal change.
In order to screen the caspase-3 activity in different cell lines, EGFP-C3B sensor was
transfected into a pancreatic cancer cell line, MIA PaCa-2, which is commonly-used for
apoptosis research and reported to have high caspase-3 activity based on the analysis of cell
lysates. The imaging of the cells transfected with EGFP-C3B was acquired under identical
excitation wavelengths and induction via 1 μM STS. The fluorescence emission signal at 510 nm
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Figure 4. 11. Fluorescence imaging and signal change of EGFP-C3B in HeLa cells following
STS induction.
Representative images of HeLa cells transfected with EGFP-C3B, emitted at 510 nm with
excitation of 398 nm (A) and 488 nm (B) before and after induction with 1 μM STS for 32 min
on a Zeiss Axiovert 200 Inverted Microscope. The relative fluorescence signal change at 510 nm
exhibited an increase with excitation at 398 nm (C) and a decrease with excitation at 488 nm (D)
upon caspase-3 activation by STS induction at different times. The arrows show the time of STS
induction. The ratiometric fluorescence signal change (F398nm/F488nm) (E) at 510 nm of HeLa cells
transfected with EGFP-C3B following 1 μM STS induction with excitation of both wavelengths
revealed an increase with a relative signal change of 3.2.

148

Figure 4. 12. Fluorescence imaging and signal change of EGFP-wt in HeLa cells following STS
induction.
The representative images of HeLa cells transfected with EGFP-wt, emitted at 510 nm with
excitation of 398 nm (A) and 488 nm (B) before and after induction with 1 μM STS for 32 min.
The relative fluorescence signal change at 510 nm exhibited a similar pattern, with a slight initial
increase followed by a decrease with excitation at 398 nm (C) and 488 nm (D) upon caspase-3
activation by STS induction at different time intervals. The arrows show the time of STS
induction. The fluorescence ratiometric change (F398nm/F488nm) (E) at 510 nm of HeLa cells
transfected with EGFP-wt following 1 μM STS induction with excitation of both wavelengths
revealed no change.
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Figure 4. 13. Fluorescence imaging and signal change of EGFP-C3B in MIA PaCa-2 cells
following STS induction.
The representative images of MIA PaCa-2 cells transfected with EGFP-C3B, emitted at 510 nm
with excitation of 398 nm (A) and 488 nm (B) before and after induction with 1 μM STS for 32
min. The relative fluorescence signal change at 510 nm exhibited a significant increase with
excitation at 398 nm (C) and a slight increase with excitation at 488 nm (D) upon caspase-3
activation by STS induction at different time intervals. The arrows show the time of STS
induction. The fluorescence ratiometric change (F398nm/F488nm) (E) at 510 nm of HeLa cells
transfected with EGFP-C3B following 1 μM STS induction with excitation of both wavelengths
revealed an increase with a relative signal change of approximately 8.
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of EGFP-C3B revealed a significant increase under 398 nm of excitation and a concurrent
decrease at 488 nm of excitation. The relative fluorescence signal exhibited a 12-fold increase at
398 nm of excitation while exhibited a slight increase at 488 nm (Figure 4.13A, 4.13B, 4.13C
and 4.13D), resulting in a relative signal change of approximately 8 expressed in a ratiometric
fluorescence emission change, determined by Equation 3 (Figure 4.13E). Compared to cell
imaging results from HeLa cells, the relative signal change of EGFP-C3B in MIA PaCa-2 cells is
nearly 3-fold larger than in HeLa cells.

4. 8

Caspase-3 inhibition tracking in living cells

In order to understand the activation or inhibition of caspase-3 in living cells, an
inhibition study of caspase-3 in living cells was conducted with our designed EGFP-based
caspase-3 sensors. After HeLa cells were transfected with EGFP-C3B following 24-48 hours
expression, a caspase-3 inhibitor, Ac-DEVD-CHO (Sigma, St. Louis) was added into the cell
culture plates to a final concentration of 20 μM and incubated with the transfected HeLa cells for
12 h prior to cell imaging. Fluorescence imaging of HeLa cells treated with caspase-3 inhibitor
exhibited a slight increase at excitation with both wavelengths (398 and 488 nm) (Figure 4.14A,
4.14B, 4.14C and 4.14D), which was possibly due to shrinkage and condensation from the cells
following 1 μM STS induction, but the ratiometric fluorescence signal (F398nm/F488nm) did not
exhibit obvious change (Figure 4.14E). Since the caspase-3 inhibitor, Ac-DEVD-CHO, is a
competitive inhibitor to caspase-3, it can competitively bind caspase-3 and inhibit its activity
when caspase-3 is activated following STS induction, which resulted in no cleavage of casapse-3
sensor expressed in cells to maintain intact form. Taken together, caspase-3 activity in living
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cells following treatment by STS induction can also be effectively inhibited using caspase-3
inhibitor, AC-DEVD-CHO.

4. 9

Shorter half-time for maximum caspase-3 activation in MIA PaCa-2 cells

A comprehensive comparison on ratiometric fluorescence signal change among EGFPwt, EGFP-C3N, EGFP-C3B and EGFP-C3B incubated with caspase-3 inhibitor, Ac-DEVDCHO, in both cell lines (HeLa and MIA PaCa-2 cells) was conducted, as shown in Figure 4.15.
The ratiometric fluorescence signal change of EGFP-C3B in HeLa cells or MIA PaCa-2 cells
following 1 μM STS induction at 45 mins exhibited a significant difference (P < 0.05), compared
to the controls, EGFP-wt, EGFP-C3N or EGFP-C3B with inhibition. Moreover, caspase-3
activation using 1 μM STS induction in living MIA PaCa-2 cells exhibited a shorter half-life
time, compared to living HeLa cells under identical stimulation conditions, which suggested a
higher basal caspase-3 activity or higher potential for caspase-3 activation in MIA PaCa-2 cells.
Hence, our designed caspase-3 sensor can be used for screening the basal caspase-3 activity or
casapse-3 activation rate of different cell lines. Due the different behaviors exhibited by caspase3 activation or inhibition in different cell lines, our EGFP-based caspase-3 sensors have the
capability to detect enzymatic activation in living cells in real time to facilitate an understanding
of the activation or inhibition mechanisms and pathways of apoptosis.

4. 10 Fluorescence imaging of caspase-3 sensors with optimal cleavage linkers

Based on the analyses of the multiple cleavage sites in our trypsin sensors, the cleavage
site on F-helix exhibits a fast enzymatic reaction possibly due to large exposure to the surface
and good accessibility for proteases. In order to further confirm the recognition sites on F-helix
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with high accessibility for proteases and provide a quick response to caspase-3, EGFP-C3C with
a recognition sequence, VDEVDG, at F-helix, was designed and also transfected into HeLa and
MIA PaCa-2 cells, respectively. The fluorescence signal of EGFP-C3C following 1 μM STS
induction exhibited a significant increase when excited at 398 nm and an obvious decrease while
excited at 488 nm, resulting in a larger relative signal change of 14 in HeLa cells (Figure 4.16),
which revealed a similar pattern of fluorescence signal change as EGFP-C3B in HeLa cells,
although relative signal changes of both EGFP-C3B and EGFP-C3C have nearly 4-fold
difference. This result demonstrated that EGFP-C3C with recognition sites at an optimal grafting
location, and with good accessibility, could provide fast enzymatic response under the lower
basal caspase-3 activity in HeLa cells. In addition, the fluorescence signal of EGFP-C3C
following 1 μM STS stimulation also exhibited a significant increase when excited at 398 nm
and a significant decrease while excited at 488 nm, resulting in a larger relative signal change of
14 in MIA PaCa-2 cells (Figure 4.17). Compared to the relative fluorescence signal change of
EGFP-C3B in MIA PaCa-2 cells, EGFP-C3C showed only 2-fold higher relative signal change
and similar fluorescence signal change pattern in this cell line, which provided further
confirmation of a fast response to caspase-3 due to optimal cleavage linker in EGFP-C3C and a
higher potential caspase-3 activation or a higher basal caspase-3 activity in MIA PaCa-2 cells.
Similarly, a slight shorter half-time for maximum caspase-3 activation using EGFP-C3C
detection was also observed in MIA PaCa-2 cells (16.3 ± 5.9 min), compared to HeLa cells (18.3
± 3.4 min), as shown in Figure 4.18. Moreover, based on fluorescence signal diffusion in
different subcellular compartments, a strong fluorescence signal increase was first observed in
cytoplasm following 1 μM STS stimulation, and then exhibited a dynamic decrease in the
cytoplasm and a concurrent increase in the nucleus of the living cells (Figure 4.19). This
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Figure 4. 14. Inhibition of caspase-3 activation detected with EGFP-C3B in living cells.
Caspase-3 inhibitor, Ac-DEVD-CHO at a final concentration of 20 μM, was incubated with
HeLa cells transfected EGFP-C3B sensors for overnight. The representative images of HeLa
cells transfected with EGFP-C3B, emitted at 510 nm with excitation of 398 nm (A) and 488 nm
(B) before and after induction with 1 μM STS for 32 min. The relative fluorescence signal
change at 510 nm has a similar pattern exhibiting a slight increase with excitation at 398 nm (C)
and 488 nm (D) upon caspase-3 activation by STS induction at different time intervals. The
arrows show the time of STS induction. The fluorescence ratiometric change (F398nm/F488nm) (E)
at 510 nm of HeLa cells transfected with EGFP-C3B with incubation of caspase-3 inhibitor
following 1 μM STS induction under excitation of both wavelengths revealed no change.
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Figure 4. 15. Shorter half-time for maximum caspase-3 activation in MIA PaCa-2 cells.
Fluorescence ratiometric signal changes among EGFP-wt (○), EGFP-C3B with DEVD-CHO
inhibition (◊), EGFP-C3N without cleavage sites (∆), EGFP-C3B in HeLa cells (●) and EGFPC3B in MIA PaCa-2 cells (■) following 1 μM STS induction were compared to reveal a
significant shorter half-time for maximum caspase-3 activation in MIA PaCa-2 cells.
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Figure 4. 16. Fluorescence imaging and signal change of EGFP-C3C in HeLa cells following
STS induction.
The representative images of HeLa cells transfected with EGFP-C3C, emitted at 510 nm with
excitation of 398 nm (A) and 488 nm (B) before and after induction with 1 μM STS for 20 min.
The relative fluorescence signal change at 510 nm exhibited a significant increase with excitation
at 398 nm (C) and a slight increase with excitation at 488 nm (D) upon caspase-3 activation by
STS induction at different time intervals. The arrows show the time of STS induction.
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Figure 4. 17. Fluorescence imaging and signal change of EGFP-C3C in MIA PaCa-2 cells
following STS induction.
Representative images of MIA PaCa-2 cells transfected with EGFP-C3C, emitted at 510 nm with
excitation of 398 nm (A) and 488 nm (B) before and after induction with 1 μM STS for 20 min.
The relative fluorescence signal change at 510 nm exhibited a significant increase with excitation
at 398 nm (C) and a slight increase with excitation at 488 nm (D) upon caspase-3 activation by
STS induction at different time intervals. The arrows show the time of STS induction.
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Figure 4. 18. Comparison of fluorescence ratiometric signal change of EGFP-C3C in different
cell lines.
Fluorescence ratiometric signal change of EGFP-C3C was determined in HeLa cells (■) and
MIA PaCa-2 cells (●) following 1 μM STS induction. A shorter half-time for maximum caspase3 activation in MIA PaCa-2 cells (16.3 ± 5.9 min) was observed, compared to the half-time for
maximum caspase-3 activation in HeLa cells (18.3 ± 3.4 min). The HeLa cells transfected with
EGFP-C3C (♦) without STS induction exhibited no change in fluorescence ratiometric signal,
suggesting good photostability of EGFP-C3C under excitation at both wavelengths.
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Figure 4. 19. Caspase-3 activation in cytosol followed by migration from the cytosol to the
nucleus.
HeLa cells transfected with EGFP-C3C sensor exhibited a strong fluorescence increase in the
cytoplasm following 1 μM STS induction in real time and then a fluorescence increase in the
nucleus was observed when excited at 398 nm. The subsequent migration demonstrated that
caspase-3 activation was initiated in the cytoplasm and transferred to the nucleus of the cells.
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fluorescence signal migration in the different subcellular compartments provided a clear
demonstration that caspase-3 activation was initiated in the cytosol following STS induction and
then the active caspase-3 migrated from cytosol to nucleus to accomplish DNA fragmentation
and apoptosis, which is also in agreement with the previous reports of caspase-3 activation
patterns in living cells (Kim, Chun et al. 2003; Ramuz, Isnardon et al. 2003). However, the
migration mechanisms of activated casapse-3 between different subcellular compartments are
still not clear.
Due to the significant fluorescence signal change when excited at both wavelengths, the
photostability, as characterized by autofluorescence, photoactivation or photobleaching, is
necessary to examine in living cells following 1 μM STS induction. Cell imaging of HeLa cells
transfected with EGFP-C3C without STS treatment was acquired. The fluorescence signal
resulting from excitation of both wavelengths exhibited similar trends without obvious
fluorescence signal change or ratiometric fluorescence signal change, as shown in Figure 4.18.
This result clearly indicated that the ratiometric fluorescence signal change resulted from
cleavage of the EGFP-based caspase-3 sensors through the activated caspase-3 in living cells,
rather than by photoactivation, autofluorescence or photobleaching.

4. 11 Fluorescence imaging of caspase-8 sensors

Because caspase-3 is an effector caspase and can be activated by an initiator caspase such
as caspase-8, we also designed a caspase-8 sensor, EGFP-C8A, using a similar grafting strategy
with PCR amplification. The imaging of HeLa or MIA PaCa-2 cells transfected with EGFP-C8A
was acquired following 1 μM STS induction, which showed a similar fluorescence ratiometric
signal change pattern as EGFP-C3B and EGFP-C3C although a smaller relative signal change of
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EGFP-C8A was observed in both HeLa and MIA PaCa-2 cells (Figure 4.20 and 4.21). During
stimulation with 1 μM STS to activate caspase-3 or caspase-8, the half-time for maximum
caspase-3 activation ranged between 15-30 min in both cell lines using EGFP-C3B or EGFPC3C. However, the half-time for maximum caspase-8 activation using EGFP-C8A determination
exhibited a little shorter and is approximately 15 min in living cells following stimulation with 1
μM STS. The longer half-time for maximum caspase-3 activation compared with maximum
caspase-8 activation is possibly due to the downregulation of procaspase-3 cleavage by activated
caspase-8 or caspase-9 in living cells. Therefore, the timescale or half-time for the maximum
activation of initiator caspases and effector caspases exhibited minor differences. Although the
timescale for caspase-3 or caspase-8 activation in living cells ranged from 1 to 2 hours based on
previous reports, the timescale for caspase-3 or caspase-8 activation in both cell lines determined
with our designed EGFP-based caspase sensors was less than one hour. From the comprehensive
analyses, previously-reported timescales for caspase-3 or caspase-8 activation were determined
with caspase recognition peptide substrate kits that detect population-dependent caspase activity
in cell lystates, or with GFP-based FRET methods in living cells. Detectable signal change of the
population-dependent caspase activity determination in cell lysates can be reduced due to effects
from negative cells, weakly respsonsive cells or the loss of caspase activity during the cell lysis
process.
Although EGFP-based FRET caspase probes avoid the limitations of populationdependent caspase activity determination and have been successfully applied to the real-time
detection of caspase activation or inhibition in living cells, weak FRET efficiency from
imbalanced fluorescence intensity, poor orientation, less optimal distance and wavelength crosstalk between the donor and the acceptor of those FRET-based caspase probes is still an obstacle
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Figure 4. 20. Fluorescence imaging and signal change of EGFP-C8A in HeLa cells following
STS induction.
Representative images of HeLa cells transfected with EGFP-C8A, emitted at 510 nm with
excitation of 398 nm (A) and 488 nm (B) before and after induction with 1 μM STS for 20 min.
The relative fluorescence signal change at 510 nm exhibited an increase with excitation at 398
nm (C) and a decrease with excitation at 488 nm (D) upon caspase-3 activation by STS induction
at different time intervals. The arrows show the time of STS induction. The fluorescence
ratiometric change (F398nm/F488nm) (E) at 510 nm for HeLa cells transfected with EGFP-C8A
following 1 μM STS induction with excitation of both wavelengths revealed a relative signal
change of 2.0.
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Figure 4. 21. Fluorescence imaging and signal change of EGFP-C8A MIA PaCa-2 cells
following STS induction.
The representative images of MIA PaCa-2 cells transfected with EGFP-C8A, emitted at 510 nm
with excitation of 398 nm (A) and 488 nm (B) before and after induction with 1 μM STS for 20
min. The relative fluorescence signal change at 510 nm showed an increase with excitation at
398 nm (C) and a decrease with excitation at 488 nm (D) upon caspase-3 activation by STS
induction at different time intervals. The arrows show the time of STS induction. The
fluorescence ratiometric change (F398nm/F488nm) (E) at 510 nm for HeLa cells transfected with
EGFP-C8A following 1 μM STS induction with excitation of both wavelengths revealed a
relative signal change of 4.2.
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in living systems. Therefore, FRET-based caspase probes can not provide highly-sensitive
detection signals or significant FRET signal change at the lower caspase-3 or caspase-8 activity
level or lower basal caspase-3 or caspase-8 activity in different cell lines even when caspase-3 or
caspase-8 is already activated. Moreover, detection of early stages of caspase-3 activation or
apoptosis or the lower caspase-3 activity in living cells can be overlooked due to low FRET
efficiency or low sensitivity of FRET-based caspase probes. This may increase the half-time
value for maximum caspase activation using those probes. On the other hand, our designed
caspase-3 or caspase-8 sensors are built in a single EGFP scaffold and can be cleaved under
much lower caspase-3 or caspase-8 activity levels to reveal high sensitivity, which can provide a
more accurate activation timescale during determination of caspase-3 or caspase-8 activity in
living cells. Therefore, a shorter half-time for maximum caspase activation is exhibited using our
designed EGFP-based caspase sensors than that determined with other methods or probes, such
as population-dependent caspase determination in cell lysates or FRET-based caspase probes in
living systems. Although caspase-3 was activated during the first 1 hour of induction with 1 μM
STS, the HeLa or MIA PaCa-2 cells still retain no obvious morphology changes prior to
apoptosis, like significant cell shrinkage, which also improved our determination of caspase-3 or
caspase-8 activation in real time. Therefore, EGFP-C3B and EGFP-C3C are sensitive caspase-3
sensors, which can be used for real-time detection of caspase-3 activity in living cells and also
can be used for detecting much lower caspase-3 activity in the early stages of apoptosis.
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4. 12 Another new pathway for caspase-8 activation in living cells

According to current investigations, caspase-8 activation is well characterized through
the death receptor-mediated pathway during apoptosis. Caspase-8 activation through
mitochondria-mediated pathway is not well documented. However, a fluorescence ratiometric
signal change was detected in living cells transfected with caspase-8 sensor, EGFP-C8A,
following stimulation with staurosporine, a well-studied caspase or apoptosis trigger in the
mitochondria-mediated pathway. This important finding that caspase-8 can be activated not only
through the death receptor-mediated pathway, but also through the mitochondria-mediated
pathway was first demonstrated here. Compared to EGFP-C3B or EGFP-C3C in HeLa or MIA
PaCa-2 cells, the relative signal change of EGFP-C8A is much smaller following stimulation
with 1 μM STS. One possible reason for the smaller relative signal change of EGFP-C8A is that
the mitochondria-mediated pathway for caspase-8 activation can not result in a high caspase-8
activity level in living cells so that the population-dependent caspase-8 determination method or
FRET-based caspase-8 probes is not sensitive enough to produce a significant signal change
under such lower caspase-8 activity conditions. As for the interactions between both pathways
for members of the caspase family, the death receptor-mediated pathway functions to regulate
the mitochondria-mediated pathway for the activation of caspases or apoptosis (Figure 4.1). For
example, the active caspase-8 from the death receptor-mediated pathway can result in cleavage
of regulator protein, Bid, followed by subsequent activation of Bad and Bax to regulate the
mitochondria-mediated pathway for accomplishing caspase-9 and caspase-3 activation in the
cascade system of caspase regulation and apoptosis. Since this new caspase-8 activation pathway
is first described here, verification of this caspase-8 activation pathway and its mechanisms still
require to be further investigated.
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4. 13 Confirmation of caspase-3 activation

In order to confirm caspase-3 activation, a fluorogenic caspase-3 substrate kit, Z-DEVDAFC, was used to determine caspase-3 activity following 1 μM STS treatment in cell lysates.
HeLa or MIA PaCa-2 cells treated with 1 μM STS were harvested at various time points (0, 30,
60, 120 min and 24 h) and lysed to obtain cell lysates. The total protein was extracted from the
cell lysates. The mixture of fluorogenic caspase-3 substrate kit, Z-DEVD-AFC and cell lystate
supernatant was incubated in a dark box at 37 ˚C for one hour, and then the fluorescence
emission intensity at 508 nm was determined via fluorescence microplate reader at excitation of
380 nm. Because the fluorescent leaving group of Z-DEVD-AFC can be released from the
substrate to emit strong fluorescence after cleavage by active caspase-3, the fluorescence
intensity at 508 nm of excitation can be used to determine relative units of caspase-3 activity
level in the cell lysates, which can be compared to commercially-available active caspase-3 with
known concentration. Figure 4.22 showed that the relative fluorescence intensity of HeLa cell
lysates following STS induction for 30 min was similar level with that of the standard active
caspase-3 solution at 0.03 μg. The fluorescence intensity reached the highest level following STS
induction for 120 min. This result indicated caspase-3 was already activated at a picromolar or
nanomolar level in intact HeLa or MIA PaCa-2 cells. The caspase-3 in HeLa cells can be fully
activated to reach a maximum level following STS induction for 2 hours, which provides strong
evidence for confirming that the fluorescence signal change is due to the cleavage of our
designed caspase-3 sensors by active caspase-3 in living cells. Moreover, the caspase-3
activation pattern in HeLa cells as determined through the caspase-3 fluorogenic substrate, ZDEVD-AFC, is further verified by the half-time for maximum caspase-3 activation determined
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Figure 4. 22. Verification of caspase-3 activation in living cells following STS induction.
The determination of caspase-3 activity using Ac-DEVD-AFC exhibits an initial activation of
caspase-3 at 30 min following 1 μM STS induction in HeLa (empty) and MIA PaCa-2 cells
(striped). Compared to the positive control, purified caspase-3, a large amount of caspase-3 was
activated in HeLa and MIA PaCa-2 cells at 30 min, and MIA PaCa-2 exhibits a high potential for
caspase-3 activation following STS stimulation. With increasing induction time, caspase-3
activation increases after 2 h or overnight.
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using our caspase-3 sensors in living cells. In addition, the relative fluorescence intensity of MIA
PaCa-2 is 3-fold higher than that of HeLa cell lysates following stimulation with STS in the first
hour, although similar fluorescence or caspase-3 activation pattern is observed in both cell lines.
This result indicated the basal caspase-3 activity in MIA PaCa-2 cells is obviously higher than
that of HeLa cells, which should also provide a better explanation for the observed larger relative
signal change of our caspase-3 sensors in MIA PaCa-2 cells, which is approximately 3-4 fold
higher than the relative signal change of our caspase-3 sensors detected in HeLa cells.
Another confirmation experiment was conducted using a cell permeable caspase-3 probe,
DEVD-NucView488 caspase-3 substrate, in living cells. This caspase-3 substrate is composed of
a caspase-3 substrate moiety and a dye that fluoresces upon DNA binding through the connection
of a caspase-3 cleavable linker. In living cells, the caspase-3 substrate moiety can be cleaved to
release the non-fluorescent dye from the conjugation if the caspase-3 is activated. When the nonfluorescent dye migrates to the cell nucleus to bind DNA, the fluorescence is activated as shown
in Figure 4.23. Prior to cell imaging, DEVD-NucView488 caspase-3 substrate was incubated
with the cultured HeLa cells at 37 ºC for 45 min according to the manufacture’s instructions.
During the HeLa cell imaging acquisition, 1 μM STS was used to activate caspase-3 in living
cells. Fluorescence signal in the stimulated cells with STS induction was observed to reveal a
slight gradual increase and become stronger and stronger from no fluorescence conditions
(Figure 4.24A, 4.24B and 4.24C). A quick jump of fluorescence signal was observed following
STS induction for 30 min (Figure 4.24D). This result also suggests caspase-3 can be activated
through STS induction and caspase-3 is activated to the extent that cleavage of the the substrate
conjugation occurs, which is also consistent with the timescale or half-time for maximum
caspase-3 activation in living cells, determined using both our designed EGFP-based caspase-3
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Figure 4. 23. Diagram of DEVD-NucView488 caspase-3 substrate for living cell imaging.
The DEVD-NucView488 caspase-3 substrate is composed of nonfluorescent DNA dye and
caspase-3 substrate moiety. In living cell systems, when caspase-3 is activated in the cytoplasm
of cells, the nonfluorescent DNA dye is released from the caspase-3 substrate due to cleavage
followed by migration to the nucleus of cells. The fluorescence signal is quickly turned on when
the DNA dye binds to DNA.
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Figure 4. 24. Detection of caspase-3 activation using DEVD-NucView488 caspase-3 substrate in
living cells following STS induction.
Caspase-3 activation was evaluated and confirmed using DEVD-NucView488 caspase-3
substrate in HeLa cells following 1 μM STS induction in real time. HeLa cells (A) incubated
with DEVD-NucView488 caspase-3 substrate exhibited no fluorescence before induction (B)
with 1 μM STS stimulation under excitation of 488 nm in fluorescence microscopy, while the
cells showed strong fluorescence following induction (C) with 1 μM STS for approximately 45
min. The relative fluorescence unit (RFU) change (D) was used as the indicator of caspase-3
activation in live HeLa cells in real time. A fluorescent on-off mode was observed following 1
μM STS induction, which mainly resulted from the binding of DNA, not from direct cleavage of
the caspase-3 substrate.
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sensors and the fluorogenic caspase-3 substrate kit. Similarly, for the co-incubation of DEVDNucView488 caspase-3 substrate and caspase-3 inhibitor (Ac-DEVD-CHO) in the cultured
living HeLa cells, the gradual increase or quick turn-on for fluorescence signal of DEVDNucView488 caspase-3 substrate is not observed following 1 μM STS induction (Figure 4. 25).
Therefore, half-life timescale of less than 1 hour for casapse-3 activation is verified by another
direct method in living cells, which provides a strong evidence that our designed EGFP-based
caspase sensors could be used for real-time detection of caspase-3 activation in living cells at
lower activity levels or dynamically imaging the early stages of apoptosis in living cells.
In addition, the half-time for maximum caspase-3 activation is 18.3 ± 3.4 min as detected
by EGFP-C3C, which is shorter than 48.5 ± 11.2 min observed with the commercially available
DEVD-NucView488 caspase-3 substrate detection under identical inducer concentrations in
HeLa cells (Figure 4. 26). Similarly, the half-time for maximum caspase-3 activation detected
with EGFP-C3C (16.3 ± 5.9 min) in MIA PaCa-2 cells was also shorter, compared to the halftime for maximum caspase-3 activation detected by DEVD-NucView488 caspase-3 substrate
(24.8 ± 6.2 min) in MIA PaCa-2 cells. These results were due to the direct monitoring of
caspase-3 action in the cytosol by our EGFP-based caspase-3 sensor, rather than real detection of
caspase-3 activity after its migration from the ctyosol to the nuclei to accomplish DNA dye
cleavage and DNA binding.
Moreover, Western blot of cell lysates following 1 μM STS stimulation was also
exploited to test caspase-3 activation in HeLa cells and MIA PaCa-2 cells. The results indicated
that caspase-3 in both cell lines following STS stimulation at various time intervals revealed a
gradient increase in the amount of active caspase-3. Meanwhile, the two cell lines exhibited
different capabilities to activate procaspase-3 based on the amount of cleaved caspase-3 band
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Figure 4. 25. Inhibition of caspase-3 was evaluated using DEVD-NucView488 caspase-3
substrate in living cells following STS induction.
HeLa cells were incubated with 20 μM caspase-3 inhibitor, DEVD-CHO, overnight. DEVDNucView488 caspase-3 substrate was added and incubated 45 min prior to cell imaging. The
HeLa cells (A) showed no fluorescence signal before induction (B) or after induction (C) with 1
μM STS stimulation. The fluorescence intensity of randomly-selected cells was acquired using
fluorescence microscope detection with a time course mode under excitation of 488 nm and
exposure of 600 ms following 1 μM STS induction and no fluorescence on-off signal was
observed (D).
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Figure 4. 26. Comparison of half-time for maximum caspase-3 activation in living cells using
EGFP-C3C and DEVD-NucView488 caspase-3 substrate.
The half-time for maximum caspase-3 activation in HeLa cells determined using our designed
EGFP-C3C sensor and DEVD-NucView488 caspase-3 substrate. EGFP-C3C with an optimal
cleavage linker was observed to have a shorter half-time for maximum caspase-3 activation (18.3
± 3.4 min) than DEVD-NucView488 caspase-3 substrate (48.5 ± 11.2 min) in HeLa cells
following 1 μM STS stimulation.
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following STS stimulation (Figure 4.27). The caspase-3 activation pattern is highly consistent
with the detection of caspase-3 activation using our designed EGFP-based caspase-3 sensors as
well as the caspase-3 fluorogenic substrate kit, Z-DEVD-AFC, and DEVD-NucView488
caspase-3 substrate.
Although the caspase-3 fluorogenic substrates, Z-DEVD-AFC, DEVD-NucView488
caspase-3 substrate, and Western blot technique can determine caspase-3 activity for tracking the
caspase-3 activation pattern or processes in cells through cell lysates or intact living cells, several
drawbacks of these methods were revealed. Z-DEVD-AFC only can be used to cell lysates for
determining caspase-3 activity. Caspase-3 activity in cell lysates is not the real activity in living
cells because the lysis conditions do not duplicate the environment of intact living cells.
Additionally, caspase-3 activity can be damaged during cell lysis. Although cell-permeable
caspase-3 substrates are available to determine caspase-3 activity in living cells in real time,
problems exist with their cell-permeable efficiency, retention in intact cells and correct
translocation. Through the comprehensive comparison between DEVD-NucView488 caspase-3
substrate and designed EGFP-caspase-3 sensors, limitations of the DEVD-NucView488 caspase3 substrate were also identified. First, the determination of caspase-3 activity using this DEVDNucView488 caspase-3 substrate does not directly monitor caspase-3 activity in living cells,
because the fluorescence signal change is due to the binding between DNA and its dye, not due
to the cleavage by caspase-3. Secondly, this substrate is used to detect caspase-3 activity in
living cells in a single wavelength mode, which can not eliminate the effects from background or
photobleaching. In addition, since no fluorescence in living cells incubated with that substrate
was observed in the initial stage before caspase-3 activation, it is more difficult to set up the
suitable exposure time for obtaining cell imaging and fluorescence signal change. Moreover, the
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Figure 4. 27. Caspase-3 activation in different cell lines detected using Western blot.
Caspase-3 activation in the lysates of both HeLa and MIA PaCa-2 cells was detected by Western
blot using anti-caspase-3 antibody. A faster caspase-3 activation and increased amount of the
activated caspase-3 in MIA PaCa-2 cells following 1 μM STS induction were observed.
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degradation of this caspase-3 substrate during storage will result in the cleavage of the cell
permeable tag or the dye conjugated with it. If the cell permeable tag is removed due to
degradation, it will reduce the cell permeability to produce a negative result due to lack of
binding between the dye and DNA. On the other hand, if the dye conjugated on the substrate is
removed due to degradation, it may move to the nucleus and bind to the DNA to produce
fluorescence signal or false positive result before caspase-3 activation with STS stimulation. All
of these limitations are successfully avoided by our genetic EGFP-based caspase sensors with the
ratiometric measurement mode.

4. 14 Analysis of pH change following STS induction in living cells

It is well-known that caspase-3 activation in living cells has two pathways: the
mitochondria and ligand-binding pathways. Previous investigations have revealed the
mitochondria alkalization or cytosolic acidification during apoptosis due to inducers such as UV
light, STS and other inducers, through the mitochondria pathway. However, the accurate time
points for mitochondria alkalization and cytosolic acidification during apoptosis, and the
relationship between mitochondria alkalization and cytosolic acidification compared with the
caspase-3 activation time schedule in various cell lines, are still not clear. In order to confirm
whether the fluorescence signal change of EGFP-based caspase-3 sensors in HeLa cells or MIA
PaCa-2 cells is due to the effect of pH change following 1 μM STS stimulation, the BCECF-AM
pH probe was used to test pH change. The BCECF-AM pH probe has the characteristics of a pHsensitive fluorescence signal change during excitation at 490 nm and pH-insensitive fluorescence
signal change during excitation at 440 nm. Therefore, the ratio of fluorescence signal
(F490nm/F440nm) of BCECF-AM pH probe should have a corresponding change following a pH
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change due to the effect of inducers in living cells, rather than because of photobleaching or
background effects. The results indicated that the ratio of fluorescence signal of BCECF-AM pH
probe didn’t show obvious change in HeLa cells or MIA PaCa-2 cells following 1 μM STS
stimulation, as shown in Figure 4.28. On the other hand, as a positive control, the ratio of
fluorescence signal change in the cells with incubation of BCECF-AM pH probes exhibited a
significant increase following the addition of 20 or 50 mM NH4Cl and obvious decrease due to
washing using fresh buffer for removing NH4Cl, as shown in Figure 4.29. These results clearly
demonstrated that the fluorescence signal change of our designed caspase-3 sensors in living
cells is due to the cleavage of EGFP-based caspase sensors under the active caspase-3 action
following STS stimulation, rather than the pH change effects from STS stimulation. In addition,
these results also indicated that the caspase-3 activation in living cells could occur prior to
mitochondria alkalization or cytosolic acidification during apoptosis.

4. 15 Spectral signal change of caspase-3 sensor in living cells

In order to further confirm the caspas-3 activation and the fluorescence signal change due
to cleavage of EGFP-based caspase-3 sensors by activated caspase-3 in living cells, fluorescence
spectral signal change of EGFP-C3C expressed in cultured MIA PaCa-2 living cells was
measured and evalulated via fluorescence spectrophotometer following the caspase-3 activation
using 1 μM STS induction. The fluorescence spectral signal change of the cultured MIA PaCa-2
cells with transfection of EGFP-wt was also evaluated under the identical conditions in parallel
as a control. When we conducted the exciation scanning based on the fluorescence emission
wavelength of 508 nm and compared to the excitation spectra of EGFP-wt and EGFP-C3C in
living cells, the maximum excitation wavelength of EGFP-wt occurs at 470 nm (Figure 4.30A),
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Figure 4. 28. pH change analysis in living cells following STS induction.
pH change analysis was conducted using BCECF-AM pH probe in HeLa or MIA PaCa-2 cells
following 1μM STS induction. No obvious changes in ratiometric fluorescence signal
(F490nm/F440nm) of the living cells incubated with BCECF-AM pH probe were observed following
STS induction, suggesting that the caspase-3 inducer, 1μM STS, didn’t result in significant pH
change at the early stage of caspase-3 activation or apoptosis.
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Figure 4. 29. pH change analysis in living cells following NH4Cl stimulation.
Analysis of pH change was conducted using BCECF-AM pH probe in HeLa or MIA PaCa-2
cells following NH4Cl stimulation. A ratiometric fluorescence signal change (F490nm/F440nm) for
the living cells incubated with BCECF-AM pH probe exhibited a significant increase following
20 mM or 50 mM NH4Cl stimulation, and a significant decrease following the buffer washing,
which indicated that BCECF-AM pH probe is a sensitive probe for detecting pH change in living
cells.
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Figure 4. 30. The excitation spectra of EGFP-based caspase-3 sensors in living cells.
The EGFP-based caspase-3 sensor, EGFP-C3C, was transfected into MIA PaCa-2 cells. The
excitation spectrum of EGFP-C3C cultured on the glass coverslip was scanned using the
fluorescence spectrophotometer. EGFP-wt was used as the control under identical conditions.
The maximum excitation peak of EGFP-wt (A) occurred at 470 nm and the excitation peaks of
EGFP-C3C (B) were observed at 470 nm as a major peak and 398 nm as a minor peak at the
emission of 508 nm.
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while EGFP-C3C has an observed main peak at 470 nm and a minor peak at 398 nm (Figure
4.30B). The maximum excitation wavelengths of both EGFP-wt and EGFP-C3C are blue-shifted,
compared to their maximum excitation peak at 490 nm in Tris buffer (10 mM Tris, 1 mM DTT,
pH 7.4) or caspase-3 reaction buffer (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 10 mM
DTT, 10% Sucrose, pH 7.5). Similarly, the fluorescence emission spectra of EGFP-wt and
EGFP-C3C in living cells were also scanned under both 398 and 470 nm excitation, which shows
the maximum emission peaks of EGFP-based caspase-3 sensor, EGFP-C3C and EGFP-wt at 508
nm under the both excitation wavelengths.
In order to track the fluorescence signal change and understand the fluorescence signal
change pattern of EGFP-based caspase-3 sensors in living cells, fluorescence emission spectra
scanning of EGFP-C3C in transfected MIA PaCa-2 cells were acquired using a fluorescence
spectrophotometer, with excitations of both 398 and 470 nm. The fluorescence spectral signal
changes of EGFP-C3C with both wavelengths of excitation were obtained and analyzed at
various time intervals (0, 5, 10, 20, 30, 45, 60 min) following 1 μM STS induction to activate
caspase-3 in living cells (Figure 4.31A and 4.31B). The results indicated that maximum
fluorescence emission at 508 nm of EGFP-C3C revealed slight increase by 16% with excitation
of 398 nm (Figure 4.31C) and simultaneously a slight decrease by 12% with excitation of 470
nm (Figure 4.31D) corresponding to the increasing time of STS induction. In contrast, EGFP-wt,
used as the control under identical conditions, revealed no signal change in maximum
fluorescence emission under excitation of the two wavelengths following STS stimulation at the
various time intervals, as shown in Figure 4.32A and 4.32B. Therefore, the relative fluorescence
emission intensity of EGFP-wt with excitation at both 398 and 470 nm was also not observed in
intact MIA PaCa-2 cells following STS stimulation, as shown in Figure 4.32C and 4.32D. When
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Figure 4. 31. Fluorescence emission spectrum scanning of EGFP-C3C in MIA PaCa-2 cells
following 1 μM STS induction.
Fluorescence emission spectra of EGFP-C3C at 508 nm in MIA PaCa-2 cells following 1 μM
STS induction exhibited a ratiometric change. The fluorescence intensity of EGFP-C3C at 508
nm exhibited a gradual increase with excitation of 398 nm (A) and a corresponding decrease
with excitation of 490 nm (B) following 1 μM STS induction at various time intervals, 0 (●), 10
(■), 30 (♦), and 60 min (▲). More than 16% increase of the maximum fluorescence signal
change was observed under the excitation of 398nm (C) and approximately 10% decrease of the
maximum fluorescence signal change was observed under the excitation of 490 nm (D).
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Figure 4. 32. Fluorescence emission spectrum scanning of EGFP-wt in MIA PaCa-2 cells
following 1 μM STS induction.
The fluorescence intensity of EGFP-wt at 508 nm exhibited no change with excitation at either
398 nm (A) or 490 nm (B) following 1 μM STS induction at various time points, 0 (●), 10 (■),
30 (♦), and 60 min (▲). The relative fluorescence signal change showed a flat line in various
time at both 398nm (C) and 490 nm (D) of excitation.
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Figure 4. 33. Ratiometric fluorescence signal change in maximum fluorescence emission.
Fluorescence ratiometric change increased by more than 30% in MIA PaCa-2 cells with
transfection of EGFP-C3B (■) following 1 μM STS induction at various times; however, no
fluorescence ratiometric change was observed in MIA PaCa-2 cells with transfection of the
control, EGFP-wt (●).
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we evaluated fluorescence signal change in ratiometric measurement expressed in F398nm/F488nm,
the fluorescence ratiometric signal change reached 30% for EGFP-based casapse-3 sensor,
EGFP-C3C, but no change for the control, EGFP-wt (Figure 4.33). These results obtained
through fluorescence spectrophotometer acquisition were consistent with those of the
fluorescence signal changes of EGFP-based caspase-3 sensors in living cells measured by
fluorescence microscopy following STS induction, which showed similar fluorescence signal
change patterns and half-life times for caspase-3 activation in living cells. However, the
fluorescence signal change, or relative signal change of casapse-3 sensor in living cells acquired
with the fluorescence spectrophotometer is much smaller than the relative signal change acquired
with the fluorescence microscope. This may be due to that spectrophotomer monitors the
behavior of large population of cells including EGFP tranfected and no EGFP transfected while
fluorescence microscope monitors the performance of the individual cell with EGFP transfected.
During the acquisition with fluorescence microscope, the fluorescence signal change following
STS induction mainly resulted from the single green cell with EGFP transfected and positive
reaction. Conversely, the fluorescence signal acquired using the fluorescence spectrophotometer
was produced by the total population of cells with various behavior, which resulted in the smaller
fluorescence signal change and smaller relative signal change due to both positive and negative
response in living cells. Although the opposite trend in fluorescence signal change between the
studies in vitro and in living cells was observed, the fluorescence signal change acquired with
both methods in living cells following STS induction exhibited similar trends and half-life
timescales, which suggested that the developed EGFP-based caspase-3 sensors are able to
monitor caspase-3 activation or inhibition in real time in living cells and can be applied to
understand mechanisms or pathways of apoptosis and diseases related to apoptosis.
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4. 16 Caspase-3 activation using different inducers

Due to the two pathways for caspase-3 activation in living cells, the mitochondrionmediated pathway and the death-receptor-mediated pathway, different caspase-3 activation
triggers can be used through different pathways and detected using our designed EGFP-based
caspase-3 sensors. It is well characterized that staurosporine is a commonly-used and fast
caspase-3 activation trigger in the mitochondria pathway. The caspase-3 activation and inhibition
in living cells by STS is also successfully detected via our developed caspase-3 sensors. On the
other hand, we also used the trigger, TNFα, for the death-receptor mediated pathway to stimulate
the caspase-3 activation and detected the optical signal change following caspase-3 activation in
living cells using our developed caspase-3 sensors. TNFα with a final concentration of 10 ng/ml
was used to activate caspase-3 in MIA PaCa-2 and HeLa cells. The MIA PaCa-2 cells transfected
with EGFP-C3C sensor were observed to exhibit a slight ratiometric fluorescence signal increase
following 10 ng/ml TNFα stimulation for 2 hrs (Figure 4.34A) and a larger ratiometric
fluorescence signal increase after TNFα stimulation for 4 hrs (Figure 4.34B) with a relative
signal change of 2.5. In contrast, in the HeLa cells transfected with EGFP-C3C sensor, no
observed fluorescence signal changes occurred during 2 hrs induction with the same TNFα
concentration (Figure 4.34C) and only a slight fluorescence signal increase was observed
following TNFα stimulation for 10 hrs (Figure 4.34D) with a relative signal change of 1.2, or a
20% ratiometric fluorescence increase. These results provide further confirmation that the higher
potential of caspase-3 activation was exhibited in MIA PaCa-2 cells. However, compared with
caspase-3 activation using STS, TNFα has an obvious slow rate and requires longer time for
caspase-3 activation in living cells. When comparing caspase-3 activation in both cell lines, the
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Figure 4. 34. Fluorescence signal change of cells transfected with EGFP-C3C following TNFα
stimulation.
Fluorescence ratiometric signal in MIA PaCa-2 cells transfected with EGFP-C3C following
induction with 10 ng/ml TNFα exhibited no obvious change during the first 2 h stimulation (A)
and a gradient increase after 4 h stimulation (B) to achieve a relative signal change of 2.5
following TNFα stimulation for 10 h. Similarly, fluorescence ratiometric signal in HeLa cells
transfected with EGFP-C3C following induction with 10 ng/ml TNFα exhibited no obvious
change during the first 2 h stimulation (C) and a gradient increase after 4 h stimulation (D) to
achieve a relative signal change of 1.3 following TNFα stimulation for 10 h.
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caspase-3 activity in cell lysates of both cell lines was also determined using the fluorogenic
caspase-3 substrate, Ac-DEVD-AFC. No active caspase-3 was detected in the cell lysates of
HeLa cells following TNFα induction, and the initiation of caspase-3 activation in MIA PaCa-2
cells was detected with TNF-α stimulation after 2 hrs (Figure 4.35), which is in good agreement
with the results obtained using our developed caspase-3 sensor in living cells in real time. On the
other hand, the results showing no activated caspase-3 in HeLa cells and a lower level of
caspase-3 activation in MIA PaCa-2 cells following TNF-α stimulation may be due to this trigger
with a slow response for caspase-3 activation in living cells so that it needs the longer time for
caspase-3 activation in many cells lines. According to newly-reported investigation, TNF-α alone
exhibited less potential for apoptosis in living cells (Wang, Du et al. 2008). However, TNFα
combined with either a protein synthesis inhibitor, cycloheximine, or Smac mimetic, a small
molecule mimic of Smac/Diablo protein, can significantly shorten the timescale of apoptosis or
increase caspase-3 and caspase-8 activity in a short time period (Wang, Du et al. 2008).
Therefore, the cotreatment with both TNFα and protein synthesis inhibitors should accelerate the
activation of caspase-3 or caspase-8, and improve the relative signal change of our designed
EGFP-based caspase sensors in living cells. All these possibilities will be investigated using
fluorescence imaging in parallel with Western blot.
Previous investigations reported that tributyltin (TBT) is a faster caspase-3 activation
trigger and can result in caspase-3 activation at approximately 30 min (Stridh, Kimland et al.
1998; Nopp, Lundahl et al. 2002; Jurkiewicz, Averill-Bates et al. 2004; Nakatsu, Kotake et al.
2007) without pH change prior to caspase-3 activation following induction. The HeLa cells
transfected with EGFP-C3C sensor were induced with TBT, and the ratiometric fluorescence
signal change exhibited a concentration-dependent mode following TBT stimulation. The
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Figure 4. 35. Caspase-3 activity determination in HeLa and MIA PaCa-2 cells following 10
ng/ml TNFα induction.
The caspase-3 activity determination in cell lysates using Ac-DEVD-AFC exhibits an initial
activation of caspase-3 at 120 min following 10 ng/ml TNFα induction in MIA PaCa-2 (purple).
Compared to the positive control, active caspase-3, 15 nM caspase-3 was activated in MIA
PaCa-2 cells at 240 min. However, no caspase-3 activation was determined in lysates of HeLa
cells (cyan) following 10 ng/ml TNFα induction at various time intervals. Therefore, further
confirmation was obtained that MIA PaCa-2 exhibits a high potential for caspase-3 activation.
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ratiometric fluorescence signal exhibited a gradient increase and reached the highest-level as a
relative signal change of approximately 1.3 following induction of 2 μM TBT for 60 min in
HeLa cells (Figure 4.36A). However, the ratiometric fluorescence signal exhibited a rapid
increase to reach the peak within 30 min following 2 mM TBT stimulation in an identical cell
line with a relative signal change of 1.8 (Figure 4.36B). These results demonstrate that TBT can
be used to activate caspase-3 in living cells during a short time period in a concentrationdependent mode, which is consistent with previous reports.
Although artemisinin was first used as a drug for malaria, currently it is also reported to
have the potential to induce apoptosis in different cell lines and is used as an anticancer drug.
Since designed EGFP-based caspase-3 sensors have the capability to detect caspase-3 activation
or inhibition in living cells, caspase-3 activation status was evaluated using the disgned caspase3 sensor, EGFP-C3C, in DU-145 cells following induction of dihydroartemisinin (DHA). The
ratiometric fluorescence signal change of DU-145 cells transfected with EGFP-C3C exhibited a
slight increase with a relative signal change of less than 1.1 during real-time fluorescence
acquisition following stimulation with 100 μM DHA (Figure 4.37A). However, compared to the
control, a 5% ratiometric fluorescence signal change in DU-145 cells transfected with EGFP-wt
following identical stimulation was observed (Figure 4.37B). The ratiometric fluorescence signal
change due to stimulation of 100 μM DHA was still in the range of less 15%. The small signal
change is possibly due to less optimal concentrations of this inducer or trace amount of caspase-3
activation in the early stage of apoptosis at this concentration condition, which still needs to be
further evaluated by Western blot or other methods. In addition, since this inducer functions to
down regulate transferrin receptor (TfR) expression through the mitochondria pathway, another
possible reason is that ferrous is necessary for accomplishing down regulation and apoptosis.
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Figure 4. 36. Fluorescence signal change of HeLa cells transfected with EGFP-C3C following
TBT stimulation.
Fluorescence ratiometric signal HeLa cells transfected with EGFP-C3C following 2 μM TBT
induction exhibited a slight increase with a relative signal change of 1.3 during 2 h stimulation
(A) and a fast and enhanced increase following 2 mM TBT induction during the first 1 h (B) to
achieve a relative signal change of 1.7, which indicates that caspase-3 activation in living cells is
a concentration-dependent inducer. The higher concentration of TBT resulted in shorter half-time
for maximum caspase-3 activation (15 min).
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Figure 4. 37. Fluorescence signal change of DU-145 cells transfected with EGFP-C3C following
DHA stimulation.
Fluorescence ratiometric signal in DU-145 cells transfected EGFP-C3C following 100 μM DHA
induction exhibited a slight increase with a relative signal change of 1.1 during 90 min
stimulation (A). However, fluorescence ratiometric signal in DU-145 cells transfected EGFP-wt
following identical stimulation exhibited no obvious change (B).
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4. 17 Inconsistent spectral signal change between living cells and in vitro following caspase3 action

It is so exciting that the developed EGFP-based caspase-3 sensors such as EGFP-C3B
and EGFP-C3C exhibited high sensitivity and excellent specificity to monitor caspase-3
activation or inhibition under the induction with STS, TBT, TNFα and DHA in living cell
systems. The ratiometric fluorescence signal changes of EGFP-based caspase-3 sensors at
excitation of 398 nm and 488 nm provide the enhancement of relative signal response to track
the low concentration level of caspase-3 at the early stage of apoptosis in different cell lines, and
avoided the problems associated with poor fluorescence intensity, photobleaching and backgroup
interference using current commercially-available caspase-3 subtrates conjugated with
chromogenic or fluorogenic dyes with single wavelength detection mode. Moreover, the
developed EGFP-based caspase-3 sensors revealed comparable or better kinetic parameters
(smaller Km and larger kcat/Km values) than those of other caspase-3 substrates.
Unfortunately, although all of above characterizations of the developed EGFP-based
caspase-3 sensors will offer tremendous potential to the sensitive detection of caspase-3 activity
in living systems in real time, contradict results obtaining in various buffer conditions in vitro,
which exhibited fluorescene signal increase at 398 nm excitation and concurrent decrease at 488
nm excitation upon the caspase-3 digestion of the developed EGFP-based caspase-3 sensors in
buffer conditions in vitro.
As shown in Figure 4.8, 15 μM EGFP-C3B buffered in caspase-3 reaction buffer (20 mM
HEPES, 100 mM NaCl, 1 mM EDTA, 10 mM DTT, 0.1% CHAPS, 10% Sucrose, pH 7.4)
exhibited a decrease in absorbance at 398 nm and an increase in absorbance at 490 nm following
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caspase-3 digestion at the final concentration of 31.25 nM. Similarly, the fluorescence emission
at 508 nm exhibited a decrease when excited at 398 nm and an increase when excited at 490 nm.
Based on the previous reports, neither 10% sucrose nor 10% glycerol appear to produce any
difference in caspase-3 activity in their buffer systems. In order to understand the effect on
cleavage of EGFP-C3B from 10% glycerol in the buffer system, another caspase-3 reaction
buffer (20 mM HEPES, 100 mM NaCl, 1 mM EDTA, 10 mM DTT, 0.1% CHAPS, 10%
Glycerol, pH 7.4) was applied to the caspase-3 digestion of EGFP-C3B. These results exhibited a
signal change pattern identical to caspase-3 digestion in the buffer system containing 10%
sucrose (Figure 4. 38). On the other hand, various compositions in 7 different buffer conditions
were investigated to confirm the effects on the absorbance or fluorescence signal change pattern
of EGFP-based caspase-3 sensors upon the caspase-3 digestion and still exhibited the similar
signal change pattern.
As already discussed in the Section 4.4 of this chapter, the compositions of CHAPS,
glycerol or sucrose, EDTA and NaCl play the critical role for caspase-3 activation in buffer
system in vitro. A hypothesis is that these inconsistent results may be due to the different
environments for caspases activation or conformation changes of the developed EGFP-based
caspase-3 sensors between buffer conditions in vitro compared to the cellular environment in
living cells. In order to evaluate the conformation change of caspase-3 sensors, EGFP-C3B and
EGFP-C3C in the optimal caspase-3 reaction buffer (20 mM HEPES, 100 mM NaCl, 1 mM
EDTA, 10 mM DTT, 0.1% CHAPS, 10% Sucrose, pH 7.5), CD spectroscopy scanning was
performed to observe any conformation changes compared to caspase-3 sensors in 10 mM Tris
buffer condition (Figure 4.39). Based on the analysis of CD spectroscopy, the necessary
components for caspase-3 activation in the reaction buffer system, CHAPS, glycerol and sucrose
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Figure 4. 38. Spectral signal change of EGFP-C3B under the caspase-3 reaction buffer
containing 10% glycerol following caspase-3 digestion.
The maximum absorption (A) of EGFP-C3B exhibited a decrease at 398 nm and an increase at
490 nm following caspase-3 digestion in the caspase-3 reaction buffer (20 mM HEPES, 100 mM
NaCl, 1 mM EDTA, 10 mM DTT, 0.1% CHAPS, 10% Glycerol, pH 7.4). The maximum
fluorescence emission at 508 nm exhibited a decrease when excited at 398 nm (B) and an
increase when excited at 490 nm (C) after caspase-3 cleavage. The spectra of EGFP-C3B before
and after caspase-3 digestion are in solid and dashed lines, respectively.
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Figure 4. 39. Conformational change analysis in various caspase-3 reaction buffers using CD
spectroscopy.
The secondary structures of caspase-3 sensor, EGFP-C3B, buffered in B0 (10 mM Tris, 1 mM
DTT, pH 7.4) (○), B1 (□), B2 (◊), B3 (●), B4 (■), B5 (♦), B6 (▲), and B7 (▼) were monitored
using CD spectroscopy. The conformation exhibited significant changes in buffers B1, B2, B3,
B4, B5, B6, with 0.1% CHAPS or 10% glycerol.
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possibly result in the change of the secondary structure of our EGFP-based caspase-3 sensors,
which is the most probable reason for the observed opposite spectral behavior in living cell or in

vitro studies. In addition, it is also possible that caspases have oligomeric states in vitro or in
vivo, which requires a detailed investigation if large amount of enzymes are available.
Scince the inconsistent spectral signal response directions of EGFP-based caspase-3
sensors were exhibited between the buffer system in vitro and in living cells following caspase-3
digestion and caspase-3 activation via inducters, and the reasons resulting in the inconsistent
spectral change in both systems are still not clear, other factors for caspas-3 activation or
avoiding the conformational change of the developed EGFP-based caspase-3 sensors will need to
be further systematically investigated. This is still a big hamper to use the developed EGFPbased caspase-3 sensor for the simultaneous detection or monitoring of caspase-3 activity or
activation both in vitro and in living cells. According to current status of progress, the developed
EGFP-based caspase-3 sensors could be separately used to detect caspase-3 activity in vitro and
caspase-3 activation or inhibition in living cells under the corresponding optimal conditions.

4. 18 Conclusions and significance

Based on the comprehensive analyses of caspase-3 and caspase-8 sensor variants, the
novel strategy for protease sensor development by grafting an enzymatic cleavage linker on an
EGFP scaffold at the sensitive location 172 for chromophore spectral signal change is further
confirmed and extended to the widely applications. Compared to current mimic peptide-based
chromogenic or fluorescent caspase probes, DEVD-NucView488 caspase-3 substrate, and GFPbased FRET caspase sensors, our developed caspase-3 and caspase-8 sensors with ratiometric
measurement manner exhibited strong advantages in sensitivity, relative signal change range and
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specificity. The significant advance for dynamically rapid response to caspase activation or
inhibition in living cells is also good at quantitatively determining the lower casapse activity in
living cells due to the high sensitivity of our designed caspase-3 sensors. Moreover, because of
the high sensitivity of our designed caspase sensors, the half-life times for caspase-3 or caspase-8
activation in individual living cells determined with our noninvasive caspase-3 or caspase-8
sensors are significantly shorter than those determined with current population-dependent cell
lysate-based detections, FRET-based caspase probes and DEVD-NucView488 caspase-3
substrate, which will greatly enhance dynamic imaging for early stages of caspase activation or
apoptosis, and improve our understanding of the mechanisms of caspase activation and the
apoptosis regulation pathways. Furthermore, our sensitive caspase sensors will provide a good
opportunity for high-throughput screening caspase activators and caspase inhibitors, and for
validating the target or new drugs related to caspase activity or apoptosis in various cell lines and
transgenic animals.
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Chapter 5

5. 1

EGFP-based thrombin sensors

Introduction

5.1.1 Biological function of thrombin

Thrombin, one of the most important members in serine protease family, plays a crucial
role in a wide range of physiological and pathological biological processes, which is involved in
homeostasis, thrombosis, tumor invasion, cell differentiation, angiogenesis, tissue injury, platelet
aggregation and blood coagulation. Its proteolysis activity is highly related to these physiological
and pathological processes, and responsible for the conversion of fibrinogen to fibrin and the
activation of blood coagulation and plasma factors such as factor V, factor VIII, factor XIII, and
protein C. Thrombin has been widely investigated due to its multiple functions since it was
discovered, named and sequenced (Goldsack, Chambers et al. 1998). Thrombin is generated
from its precursor prothrombin after tissue injury and involved in converting fibrinogen to fibrin
during clotting cascade and mediating cellular functions through proteolytically activating
protease activated receptors (PAR1, PAR3 and PAR4) on the cell surface (Coughlin 1999;
Anderluh and Dolenc 2002). Following the activation of these receptors, numerous cellular
effects such as chemotaxis, proliferation, extracellular matrix turnover and release of cytokines
are initiated. Therefore, a series of tissue repair processes, the inflammatory pathogenesis and
fibroproliferative disorder including pulmonary fibrosis and atherosclerosis are related to these
receptor activations. On the other hand, many research reports have revealed that some
neurodegenerative diseases such as Alzheimer’s disease, and a number of tumors due to fibrin
formation and deposition, could result from the disorder of thrombin activation. Due to these
multiple functions of thrombin, physiological and pathological mechanisms of some diseases
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related to thrombin, factors or pathways of thrombin activation and its receptors on the cell
surface, determination of thrombin activity in living cells or in vivo, investigation of thrombin
triggers or inhibitors, development of agonists and antagonists for thrombin receptors are
involved in extensive investigation and become a current heated medical field. In order to probe
these physiological or pathological processes, thrombin activity determination is highly
necessary.

5.1.2 Thrombin structure and active sites

Thrombin, a trypsin-like member of the chymotrypsin family of serine proteases, reveals
a similar structure and catalytic mechanism with trypsin. Two polypeptide chains, 36-residue Achain and 259-residue B-chain, form the basic frame of thrombin through a covalent linkage of a
disulfide bridge, as shown in Figure 5.1. This basic structure of thrombin was first demonstrated
by the solution of crystallographic structure of thrombin (Bode, Mayr et al. 1989; Bode, Turk et
al. 1992). Both chains are organized in two adjacent β-barrels and the functional moiety,
catalytic domains of thrombin are located in B-chain of thrombin (Lesk and Fordham 1996). The
active site cleft is provided by Ser195, His57 and Asp102 between the junction of both chains. In
addition, the large insertion loops shape a deep and narrow, canyon-like active site cleft, which
offers the narrow specificity of thrombin (Huntington 2005; Bode 2006). Another particular
characteristic of thrombin molecule is its uneven charge distribution on the thrombin surface,
which results in high positive and negative electrostatic field strength. Hence, two positivelycharged sites, Exosite I and Exosite II, located to the right and left of the thrombin active site
cleft, respectively, are responsible for functions of a direct and specific substrate or inhibitor
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Figure 5. 1. The model structure of thrombin (PDB, 2UUF).
The residues of catalytic triad, His57, Asp102 and Ser195, are shown in red, blue and purple
color at the cleft region between the two β-barrel domains. The Exosite I and Exosite II are
located to both sides of active site of thrombin. The Na+ is shown in cyan color and bound to the
Na+-binding site.
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interaction. Meanwhile, a negative pocket, Na+-binding site has been found to be an important
allosteric modulator of thrombin (Di Cera, Dang et al. 1997).

5.1.3 Thrombin substrate specificity

A wealth of structural information now is available for thrombin, which is greatly
benefited for the rational design of its substrates and inhibitors. Although an unusually deep and
narrow active site cleft provides one of the primary causes for the narrow specificity of thrombin,
the observed modularity of thrombin allows diversity in this specificity; its "mix-and-match"
nature is exemplified by its interactions with macromolecules. Therefore, extensive
investigations have been devoted to probe the specificity of thrombin for a sensitive and specific
thrombin detection, or a novel and effective thrombin inhibitor development.
First, thrombin specificity was often investigated using chromogenic or fluorogenic
peptide substrates. Based on previous literature reports, the substrate P1 residue should be in
agreement with the known primary specificity of thrombin for basic residues, and the P1 position
always prefer to positively-charged residue Arg. Analysis of a synthetic substrate library has
indicated that thrombin has a strong preference for aliphatic amino acids at the P4 position, little
preference at P3, and strict preference for proline at the P2 position. The kinetic parameters,

kcat/Km, of these substrates conjugated to preferable amino acid residues and dyes, are ranged
from 103 to 107 M-1S-1 (Sadasivan and Yee 2000). Second, analysis of natural protein substrates
such as PAR1, PAR4, Factor XIII, Factor VIII, and prothrombin, demonstrate highly-conserved
ligand preference for proline, arginine and glycine or serine at the P2, P1 and P1’ position (Ayala,
Cantwell et al. 2001; Bode 2006). Therefore, the substrates with arginine in the P1 position,
proline or a proline homolog in the P2 position, and an apolar amino acid in the P3 position were
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identified to have better specificity for thrombin (Harris, Backes et al. 2000). However, limited
reports are available for protein-based substrate specificity, especially for their kinetic properties.

5.1.4 Current methods for detection of thrombin

The most common thrombin determination is still focused on blood or cell lysate assays
using chromogenic or fluorogenic small molecule dyes conjugated to a short peptide to monitor
fixed cell imaging (Tung, Gerszten et al. 2002). The most common chromophores linked to short
peptide fragments of 3-6 amino acids mimic the sequence encompassing the P1 to Pn cleavage
sites (usually up to P3) are p-nitroaniline, 7-amino-4-methylcoumarin and fluorescein
isothiocyanate-labeled casein. These probes are not ideal for the continuous dynamic imaging of
enzyme actions due to limited lifetime, specificity and stability resulting from a lack of defined
structure in solution due to their short sequences. Moreover, P1’ to P3’ sequence is still difficult
to be optimized in these peptide probes and fast degradation of these short peptides also hinder
the delivery to specific sub-cellular locations. Fluorescent proteins with self-encoded
chromophores are capable of monitoring numerous cellular events in living cells or organisms
via live cell imaging. A GFP-pair probe has been developed to monitor thrombin activity through
the change of fluorescence resonance energy transfer to facilitate screening of inhibitors (Zhang
2004). However, no detailed reports about substrate specificity beyond P4 site. DNA aptamer or
nano-particle probes for thrombin activity determination are also reported with high sensitivity
(Xiao, Lubin et al. 2005). However, their determination mechanism is indirect, which depends on
the binding ability from negative charged DNA and positive charged probes with complication
of non-specific electrostatic interaction. Therefore, there is a strong need to have thrombin
sensors that allow us to better probe substrate specficity.
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5.1.5 Significance of this study

In this chapter, we have successfully designed a series of thrombin sensors for the
determination of thrombin activity in vitro using our grafting approach. Their optical change
upon the action of thrombin was systematically investigated and steady state kinetic studies were
conducted to obtain their kinetic parameters, Michaelis constants (Km), turnover numbers (kcat)
and specificity constants (kcat/Km) for optimizing the cleavage linker in our designed thrombin
sensors. The thrombin sensor development can further confirm our hypothesis of novel strategy
of protease sensor and extend its application to various proteases. Moreover, the substrate
specificity of thrombin can be investigated using our developed thrombin sensors.

5. 2 Construction of thrombin sensors

In order to develop sensitive thrombin sensors with optimal cleavage linkers for thrombin
digestion for in vitro studies and in living cell imaging, a series of specific cleavage linkers for
thrombin were designed and inserted at the position 172 in EGFP to obtain different variants of
thrombin sensors. A ratiometric signal change in absorbance or fluorescence was exhibited upon
the cleavage of the thrombin linker. Based on previous design of sensitive EGFP-based trypsin
sensors, caspase-3 and caspase-8 sensors, novel thrombin sensors are constructed through the
insertion of a thrombin cleavage site based on calmodulin EF-hand motif at the position Glu172
of EGFP due to the high flexibility of the EF-hand, which can improve the accessibility of
cleavage site for thrombin. On the other hand, amino acid residues from P1 to P4 and P1’ to P2’
were designed to examine their specificity to thrombin and compare the exposure degree of
cleavage site for testing thrombin accessibility. In order to design the amino acid residues from
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P1 to P4 and P1’ to P2 for improving substrate specificity, five cleavage linkers with residues,
Gly-Arg-Gly, Phe-Asn-Pro-Arg-Gly-Phe, Phe-Thr-Pro-Arg-Gly-Phe, Phe-Asn-Pro-Arg-Ser-Phe
and Phe-Thr-Pro-Arg-Gly-Phe, are based on the sequences of thrombin activation receptors
(PAR1, PAR3 and PAR4) and some natural thrombin cleavable protein substrates. Different
variants of thrombin sensor and their cleavage linkers for thrombin were shown in Table 5.1. The
EGFP plasmid encoding the sequence of thrombin cleavage linkers was amplified through PCR
for obtaining corresponding EGFP-based thrombin sensors.

Table 5. 1. Designed thrombin sensors and their cleavage linkers
Thrombin sensor name

The cleavage linker sequences

EGFP-Th1

EEEIREAFRVFDKDGRGYISAAELRHVMTNL

EGFP-Th2

EEEIREAFRVFDKDGNGYISAFNPRGFMTNL

EGFP-Th3

EEEIREAFRVFDKDGNGYISAFNPRSFMTNL

EGFP-Th4

EEEIREAFRVFDKDGNGYISAFTPRGFMTNL

EGFP-Th5

EEEIREAFRVFDKDGNGYISAFTPRSFMTNL

5. 3

Optical properties of thrombin sensors

All variants of our designed EGFP-based thrombin sensors are successfully expressed in

E. coli and exhibit strong fluorescence. Through nickel affinity column purification, purified
EGFP-based thrombin sensors exhibit two strong absorption peaks, which are at 397 and 490
nm. Two absorption peaks are resulted from both states of chromophore, ionic form and neutral
form. However, different variants of these EGFP-based thrombin sensors have various
proportions of ionic form and neutral form chromophore due to insertion of various cleavage
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linkers for thrombin. Due the cleavage sites in different locations between EGFP-Th1, EGFPTh2 and EGFP-Th3, EGFP-Th1 has the slight more proportion of ionic chromophore form.
EGFP-Th2 and EGFP-Th3 has no obvious difference due to cleavage site in the same location
although the residue in the P2’ position.

5. 4

Optical change of thrombin sensors

To detect optical signal change upon the action of thrombin cleavage, the UV-visible
absorption spectra of EGFP-Th2 in thrombin reaction buffer (50 mM Tris, 150 mM NaCl, 2.5
mM CaCl2, pH 8.0) before and after thrombin cleavage. Following thrombin cleavage, the
maximum absorption of EGFP-Th2 at 490 nm increased by 30.9% and concurrently decreased
by 21.3% at 398 nm (Figure 5.2). Similarly, EGFP-Th2 exhibited a ratiometric fluorescence
change by a 25.74% decrease in maximum fluorescence emission intensity at 508 nm at an
excitation wavelength of 398 nm (Figure 5.3A) and a corresponding 23.63% increase at an
excitation wavelength of 490 nm (Figure 5.3B).

5. 5

Verification of thrombin sensors cleavage

To verify the cleavage site of EGFP-based thrombin sensors, digestion reaction of 10 μM
EGFP-Th1 and EGFP-Th2 was performed by adding stock solution of thrombin (GE Healthcare)
up to a final concentration of 30 nM in thrombin reaction buffer (50 mM Tris, 150 mM NaCl, 2.5
mM CaCl2, pH 8.0). The resulting cleavage products were examined using SDS-PAGE and
MALDI mass spectrometry. EGFP-based thrombin sensors are specifically cleaved into two
major fragments by thrombin, approximately 20 and 8 kDa from EGFP-Th2 (Figure 5.4). The
cleaved mixtures subjected to further analysis by MALDI mass spectrometry. MALDI mass
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Figure 5. 2. Absorption spectra of EGFP-Th2 following thrombin digestion.
The 15 μM intact EGFP-Th2 (solid line) was cleaved by 20 nM thrombin to result in a decrease
in absorbance at 398 nm and an increase at 490 nm (dash line) in thrombin reaction buffer (50
mM Tris, 150 mM NaCl, 2.5 mM CaCl2, pH 8.0) at room temperature for overnight digestion.
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Figure 5. 3. Fluorescence spectra of EGFP-Th2 following thrombin digestion.
The 15 μM intact EGFP-Th2 (solid line) was cleaved by 20 nM thrombin in thrombin reaction
buffer (50 mM Tris, 150 mM NaCl, 2.5 mM CaCl2, pH 8.0) at room temperature for overnight
digestion to result in a decrease (dash line) in fluorescence emission at 508 nm while excited at
398 nm (A) and an increase (dash line) in fluorescence emission at 508 nm while excited at 490
nm (B).
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Figure 5. 4. The cleavage confirmation of EGFP-Th2 thrombin digestion.
The verification of cleavage of EGFP-Th2 by thrombin in thrombin reaction buffer (50 mM Tris,
150 mM NaCl, 2.5 mM CaCl2, pH 8.0) at room temperature for overnight digestion was
confirmed using SDS-PAGE (A) and MALDI mass spectrometry (B). M is the protein marker.
Lanes 1 and 2 are EGFP-Th2 without and with thrombin digestion. Following thrombin
digestion, EGFP-Th2 was specifically cleaved into two major fragments with molecular mass of
20 and 8 kDa. The MALDI mass spectrometry analysis shows two major fragments with
molecular masses of 21309.4 and 7931.1 Da.
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spectrometry analysis reveals that the fragments produced from EGFP-Th2 have molecular
masses of 21309.4 and 7931.1 Da, which corresponds to the calculated mass values of 22646.6
and 7914.8Da for the large and small fragments of EGFP-Th2 and indicates that the cleavage
occurs in the cleavage linkers, respectively.

5. 6 Kinetic study of thrombin sensors

In order to investigate the optimal cleavage linkers for thrombin and to determine the
steady-state kinetic parameters, kcat, Km, and kcat/Km for hydrolysis of EGFP-based thrombin
sensors upon the action of thrombin, initial rates were measured at various EGFP-based thrombin
sensor concentrations in thrombin digestion buffer (50 mM Tris, 150 mM NaCl, 2.5 mM CaCl2,
pH 8.0) at room temperature following digestion with a final concentration of 125 nM thrombin.
The kinetic parameters of EGFP-Th2 were fitted using Michalis-menten equation, as shown in
Figure 5.5. The kinetic parameters, kcat, Km, and kcat/Km, are 0.29 ± 0.02 /s, 2.81 ± 0.69 μM, and
105000 ± 14600 M-1S-1.
In order to design a optimal cleavage linker for thrombin and improve thrombin
specificity of EGFP-based thrombin sensors, the P1, P2, P3 and P4 position in P region and P1’
and P2’ position in P’ region in thrombin sensor were systematically studied. Another four
specific cleavage linkers (Phe-Asn-Pro-Arg-Gly-Phe, Phe-Asn-Pro-Arg-Ser-Phe, Phe-Thr-ProArg-Gly-Phe and Phe-Thr-Pro-Arg-Ser-Phe) for thrombin were designed to obtain different
thrombin sensor variants. The studies on kinetic parameters of these thrombin sensors were
performed in thrombin digestion buffer (50 mM Tris, 150 mM NaCl, 2.5 mM CaCl2, pH 8.0).
Compared to the thrombin sensor with cleavage linker (Gly-Arg-Gly), the turnover number, kcat,
has significant increase of 5 fold and Km has a significant decrease of 10 fold. Therefore,
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Figure 5. 5. Kinetic studies of EGFP-Th2 conducted in thrombin digestion buffer.
EGFP-Th2 at concentration from 2-32 μM in thrombin reaction buffer (50 mM Tris, 150 mM
NaCl, 2.5 mM CaCl2, pH 8.0) at room temperature was conducted thrombin digestion. The
absorbance signal change was monitored at 490 nm in time course mode. The catalytic kinetic
-1 -1
parameters, kcat, Km, and kcat/Km, are 0.29 ± 0.02 /s, 2.81 ± 0.69 μM, and 105000 ± 14600 M S
through Michaelis-Menten equation fitting, respectively. The data presented in mean ± SD, are
fitting kinetic parameters and fitting errors.
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substrate specificity (kcat/Km) of these four thrombin sensor variants is resulted in 50-fold
increase. The kinetic parameters for all of these thrombin sensor variants are shown in Table 5.2.

Table 5. 2. Catalytic parameters for thrombin in thrombin reaction buffer
-1

4

-1 -1

Thrombin sensors

kcat (s )

Km (μM)

kcat/Km (×10 M s )

EGFP-Th1

0.06 ± 0.001

20.92 ± 0.96

0.28 ± 0.07

EGFP-Th2

0.29 ± 0.02

2.81 ± 0.69

10.49 ± 1.46

EGFP-Th3

0.23 ± 0.01

2.86 ± 0.28

8.02 ± 0.62

EGFP-Th4

0.67 ± 0.06

11.37 ± 1.83

5.94 ± 0.05

EGFP-Th5

0.93 ± 0.14

12.78 ± 3.48

7.32 ± 0.92

Conditions: 50 mM Tris, 150 mM NaCl, 2.5 mM CaCl2, pH 8.0, 25 ˚C.
The data presented in mean ± SD, are fitting kinetic parameters and fitting errors.

5. 7

Extinction coefficient constants of products after thrombin sensor cleavage

After thrombin sensor samples were cleaved completely through thrombin digestion
overnight, the absorbance of products at 490 nm was measured and then extinction coefficients
were calculated through Beer-Lambert law. The extinction coefficients of the variants of these
thrombin sensors have no obvious difference due to similar helix-loop-helix cleavage linkers
although the recognition residues are different. Their extinction coefficient constants of these
cleavage products were shown in Table 5.3.
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Table 5. 3. Extinction coefficients of cleaved products from thrombin sensors
Thrombin sensor

Extinction coefficients (ε) (μM-1cm-1)

EGFP-Th1

0.037 ± 0.005

EGFP-Th2

0.031 ± 0.004

EGFP-Th3

0.030 ± 0.003

EGFP-Th4

0.035 ± 0.007

EGFP-Th5

0.033 ± 0.004

Conditions: 50 mM Tris, 150 mM NaCl, 2.5 mM CaCl2, pH 8.0, 25 ˚C.
The data presented in mean ± SD, are extinction coefficients and stardard deviations from different samples at various
concentrations (2-20 μM) following trypsin complete digestion, n = 6.

5. 8

Relative signal change calculation of thrombin sensors

In order to evaluate the response of thrombin sensors to thrombin, the relative absorbance
change between before thrombin cleavage and after thrombin cleavage was measured and
calculated by the Equation 2 in the section of materials and methods. The relative signal change
of thrombin sensor variants is shown in Table 5.4. EGFP-Th1, a cleavage site in loop-III region,
revealed a large relative signal change. However, EGFP-Th2 and EGFP-Th3, cleavage sites in Fhelix, showed no significant difference in relative signal change. The difference in relative signal
change of these thrombin sensors are possibly due to slight difference in conformation of cleaved
products, which is still not clear. Compared to our trypsin sensors, EGFP-based trypsin sensors
have similar relative signal change for these EGFP-based thrombin sensors where cleavage sites
are located on the F-helix.
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Table 5. 4. The relative signal change of thrombin sensor variants
Thrombin sensor

Relative signal change (DR)

EGFP-Th1

2.64 ± 0.10

EGFP-Th2

1.94 ± 0.23

EGFP-Th3

1.76 ± 0.18

EGFP-Th4

1.88 ± 0.25

EGFP-Th5

1.79 ± 0.14

Conditions: 50 mM Tris, 150 mM NaCl, 2.5 mM CaCl2, pH 8.0, 25 ˚C
The data presented in mean ± SD, are relative signal changes and stardard deviations from different samples at various
concentrations (2-20 μM) following trypsin complete digestion, n = 6.

In our lab, EGFP-based calcium sensors were successfully designed and developed
through the insertion of calcium binding motif, EF-hand, from calmodulin, which can be
expressed in mammalian cells and can be used for tracking calcium signaling in vitro and in
living cells (Zou, Ye et al. 2005). According to this grafting strategy, the specific cleavable
linker for thrombin can be inserted in EGFP to develop sensitive thrombin sensors. On the on
hand, EGFP can be easily expressed in bacteria and mammalian cells, which offers EGFP-based
thrombin sensors for exploiting thrombin activity in vitro and investigating real-time thrombin
activation or inhibition in living cells. On the other hand, EGFP-based thrombin sensors have
characteristics of double wavelengths change in opposite directions for absorbance and
fluorescence, which also provides the ratiometric measurement to determine thrombin activity.
As well known, loop-III has strong binding affinity for calcium and helices connected to
loop-III can improve the flexibility of EF-hand (Ye, Shealy et al. 2003; Ye, Lee et al. 2005). The
cleavage sites for thrombin were located in the modified EF-hand motif, which was grafted into
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EGFP to develop the sensitive thrombin sensors. According to our kinetic studies of thrombin
sensors, the cleavage site in loop-III revealed the slow enzymatic reaction and lower substrate
specificity to thrombin possibly due to the less accessibility to thrombin at this cleavage site,
which is consistent with our previous result that the trypsin sensor with a cleavage site in loop-III
can not be cleaved by trypsin. With the addition of flexible helices on both sides of the loop-III,
the accessibility to thrombin and the cleavage rate on F-helix are significantly increased. A larger
relative signal change of these thrombin sensors with specific cleavage site at F-helix is
provided.
Due to the designed thrombin sensor variants based on EGFP, these sensors have great
potential to determine thrombin activity, thrombin activation or pathway in living system such as
targeted to extracellular space in real time. Meanwhile, compared to catalytic kinetic parameters
of commercially available thrombin kits, the binding affinity and specificity of our EGFP-based
thrombin sensor variants to thrombin are significantly increased due to the lack of P’ region
residue design in thrombin detection kits containing small molecular dye (Rijkers, Wielders et al.
1995). The kinetic parameters of our designed thrombin sensors obviously reach or overpass
these substrates. Similarly, our trypsin sensor variants, caspase sensor variants and thrombin
sensor variants have obvious larger substrate specificity (kcat/Km) for proteases. The major reason
for enhanced specificity is still attributed to the compact β-barrel structure of EGFP. Following
the grafting of enzymatic cleavage linker on the chromophore-sensitive location, the cleavage
linkers can provide the high accessibility to enzymes. Therefore, the class of protease sensors
exhibited a strong binding capability or smaller Km value to result in larger kcat/Km value.
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5. 9

Conclusions and significance

We have successfully developed EGFP-based thrombin sensors with optimal cleavage
linkers on F-helix, which exhibit fast response, high sensitivity and specificity, large relative
signal change with thrombin cleavage. The catalytic kinetic parameters of kcat, Km, and kcat/Km, of
EGFP-Th2 are 0.29 ± 0.02/s, 2.81 ± 0.69 μM and 104900 ± 14600 M-1S-1, respectively. Since
EGFP have the capability to express in both bacteria and mammalian cells without requirements
of cofactors and the successful monitoring trysinogen, caspase-3 or caspase-8 activation and
inhibition in living cells using our developed EGFP-based trypsin sensors, caspase-3 sensors and
caspase-8 sensors, the significant advantages of our engineered thrombin sensors will have the
potential to real-time track thrombin activity or activation processes in living system such as
extracellular environment with a ratiometric measurement mode, which can avoid the influence
from environment, such as expression level, background. Signal peptides for extracellular
environment can assist our thrombin sensors to track thrombin activity or investigate thrombin
activation pathway in the specific cellular locations for understanding the mechanisms of
thrombin regulation pathways. These thrombin sensors will be greatly benefited for probing
physiological process and pathological mechanisms of diseases corresponding to the imbalance
of thrombin activation and inhibition. Moreover, this method for protease sensor development
will be promising to investigate other diseases related to protease activity.
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Chapter 6

6. 1

Fluorescence properties of EGFP fragments

Introduction

A novel strategy for protease sensor development has been successfully established
through a grafting approach to obtain various protease sensors including trypsin sensors,
chymotrypsin sensors, caspase sensors and thrombin sensors. Although all of these protease
sensors can be cleaved by their specific proteases, they still retained their strong fluorescence in
native conditions. Which fragment of EGFP variants can emit the strong fluorescence after
digestion? What is the minimum or essential sequence for chromophore formation or
fluorescence of EGFP?
Extensive research has been conducted to understand mechanisms of chromopohore
formation in GFP (Heim, Prasher et al. 1994; Dopf and Horiagon 1996; Reid and Flynn 1997;
Wachter, King et al. 1997; Enoki, Saeki et al. 2004), which can be applied to develop various
new sensors for monitoring cellular processes. One of the earliest studies demonstrated the
cleavage of GFP through proteases, and obtained protease-derived chromopeptides from GFP
under denatured conditions and pH-dependent spectral characteristics (Shimomura 1979). The
chromophore was determined to be a cyclization of the residues Ser65-dehydroTyr66-Gly67
within the polypeptide through papain digestion of GFP and HPLC isolation (Cody, Prasher et al.
1993). The protease-sensitive positions of GFP were also identified to be the loop areas at
positions 157, 172, or 189 through the digestion of modified GFP with inserted protease cleavage
linker (Chiang, Okou et al. 2001). A series of deletion studies of GFP determined the minimum
domain for fluorescence to be the amino acid residues from 2 to 232 in GFP, which was the
earliest investigation of the minimal region of GFP required for its fluorescence and provided the
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key amino acids at the termini for its structure and function of GFP (Dopf and Horiagon 1996).
A more defined map of the minimal functional domain of GFP based on single amino acid
truncation studies from both ends of an enhanced version of GFP indicated that the minimal
fluorescent domain spans the region from amino acids 7 to 229 in GFP (Li, Zhang et al. 1997).
Truncation of GFP mutants up to nine amino acids at the C terminus had no deleterious effect on
the fluorescence intensity of GFP, but a longer deletion up to 11 amino acids caused a decrease
in maximal fluorescence as analyzed by spectrofluorimetry and fluorescence-activated cell
sorting (FACS) (Kim and Kaang 1998).
In this chapter, we would like to further understand the chromophore formation and minidomain for chromophore formation or essential sequences for fluorescence of EGFP. We
successfully separated the two major fragments following protease digestion and identified
accurate cleavage sites of EGFP-T1 containing trypsin cleavage linker. The optical properties of
both fragments were examined through spectroscopic methods to reveal the weak fluorescence
from large fragment due to the maintaince of the chromophore in this large fragment. It is also
the first time report that the large fragment containing 172 amino acid residues of EGFP is the
critical sequence for chromophore formation and fluorescence.

6. 2

Protease sensitivity of EGFP

Commonly used proteases such as trypsin, chymotrypsin and thrombin have different
specificities. The protease sensitivity of EGFP-T1 to trypsin, chymotrypsin and thrombin was
monitored and evaluated through SDS-PAGE. Figure 6.1A shows that the intact protein (EGFPT1, 34 kDa) was first cleaved by trypsin into three fragments with molecular masses of 23, 20
and 8 kDa following digestion for 1 to 6 h. The fragment of 23 kDa was further digested and
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converted to 20 kDa, and the fragment of 8 kDa remained unchanged following digestion up to
24 h. Similarly, chymotrypsin first cleaved EGFP-T1 into three fragments of 21, 20 and 10 kDa,
and then the 21 kDa band was reduced to 20 kDa when subjected to digestion for 6 h or longer.
Finally, EGFP-T1 was cleaved by chymotrypsin and trypsin into two stable fragments. The
larger fragments had similar molecular mass (approximately 20 kDa, P20) while the smaller
fragments have molecular mass of 8 kDa (P8) or 10 kDa (P10). The P8 and P10 fragments
remained unchanged following digestion up to 24 h.
Figure 6.1B shows semi-quantitative measurement of cleavage rates of this protein by
trypsin obtained by monitoring the P20 fragment formation based on its optical density in SDSPAGE. Compared to the final P20 optical density, P20 fragment formation reached 20% and
40% at 1 h, and reached 50% and 80% at 6 h following trypsin or chymotrypsin digestion,
respectively; EGFP-T1 was fully converted to P20 fragment after digestion for 24 h.
In order to examine the effects of trypsin concentration on hydrolysis of this protein, as
well as the cleavage order, trypsin digestion of EGFP-T1 was performed using different ratios of
protein and trypsin (w/w) (2000:1, 1000:1, 200:1, 100:1). Increasing trypsin concentrations had
no effect on cleavage locations or patterns of EGFP-T1 although the cleavage rate, or P20
formation rate, was greatly accelerated (Figure 6.2A). An intermediate product (31 kDa) was
visualized at low trypsin concentration and with digestion time less than 12 h. The appearance of
the 8 and 23 kDa bands occurred simultaneously with the disappearance of the 31 kDa band. An
increase of the relative trypsin concentration was found to accelerate the cleavage of EGFP-T1 to
produce two final major fragments based on the semi-quantitative optical density of P20 band on
SDS-PAGE (Figure 6.2B). Therefore, the cleavage of EGFP-T1 to produce the fragments
follows the order from 34 to 31 kDa, then from 31 to 23 and 8 kDa, and finally to 20 and 8 kDa.
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Figure 6. 1. The cleavage patterns and kinetics of EGFP-T1 by various proteases.
The cleavage pattern of EGFP-T1 by various proteases was identified via SDS-PAGE (A).
Trypsin, chymotrypsin and thrombin cleavage of EGFP-T1 following digestion for 0, 1, 6, 24 h
were shown in SDS-PAGE. M is protein marker. NP is the sample of EGFP-T1 not subjected to
protease cleavage as the control. Lane 1, 2, 3 and 4 are the samples of EGFP-T1 subjected to no
protease, subjected to trypsin, chymotrypsin, and thrombin digestion at room temperature,
respectively. The ratio of protein to enzyme is 100:1 (w/w). The rate of cleavage of EGFP-T1 is
semi-quantitatively measured based on the formation of P20 (B) fragment using the optical
density of its band in SDS-PAGE following EGFP-T1 trypsin ( ▨ ) and chymotrypsin ( ▧ )
digestion.
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Figure 6. 2. Effects of trypsin concentrations on digestion pattern and kinetics of EGFP-T1.
The trypsin digestion pattern of EGFP-T1 was analyzed through SDS-PAGE under the various
trypsin concentrations (A). EGFP-T1 samples digested with various trypsin concentrations for 0,
1, 6, 12, 24, and 48 h at room temperature were shown in SDS-PAGE. M is protein marker. NP
is the sample of EGFP-T1 not subjected to trypsin digestion as the control. Lane 1, 2, 3 and 4 are
the samples with trypsin digestion at EGFP-T1/trypsin ratios of 2000:1, 1000:1, 200:1 and 100:1
at room temperature. The rate of cleavage (B) of EGFP-T1 is semi-quantitatively measured
based on the formation of the P20 fragment using the optical density of its band in SDS-PAGE
with EGFP-T1/trypsin ratios of 2000:1 (▨), 1000:1 (▧), 200:1 (▤) and 100:1 (▩), respectively.
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6. 3

Separation of EGFP fragments

In order to identify the cleavage sites through protein sequence analysis and mass
spectrometry, and to investigate the optical properties of two major fragments, different
chromatographic methods were used to separate the fragments of EGFP-T1 following trypsin
digestion. P20 and P8 could not be separated under the non-denaturing conditions. Therefore, the
separation was performed under denaturing conditions with 6 M urea and heating in 90˚C water
bath for 5 min. Denatured products were successfully separated in a Hitrap Sephadex 75 size
exclusion column. To improve the purity of both fragments, P20 and P8 collected from FPLC
were further purified by reversed phase HPLC.
Although our mini-GFP was successfully separated in denaturing conditions, many
difficulties in separation were encountered in non-denaturing conditions. The digested protein
fragments of EGFP-T1 cannot bind to the Hitrap Nickel chelating column due to the removal of
the N-terminal His-tag. In non-denaturing condition, the two digested major fragments are coeluted while using Sephadex 75 size exclusion column or Hitrap Q column with salt gradient
elution so that two bands in SDS-PAGE exhibited molecular masses of 20 and 8 kDa,
respectively. Due to the difficulties in separation under the non-denaturing conditions, the pure
P20 fragment was obtained using SDS-PAGE first through excising the corresponding band and
eluting the protein in a Tubeluta tube with dialysis membrane. Because the amount of P20 is
limited from SDS-PAGE electroelution and P8 is still difficult to purify, the purification of P20
and P8 using a combinative FPLC and HPLC under the condition of 6 M urea for denaturation is
conducted. Similar results from N-terminal sequence analysis and molecular weight analysis of
P20 and P8 fragments were exhibited through the separation using SDS-PAGE electroelution
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and combinative FPLC or HPLC methods. As has been discussed above, two bands after trypsin
digestion of EGFP-T1 were always observed in SDS-PAGE although mixture of both fragments
was conducted separation under non-denaturing conditions. This result suggested that the
cleaved mixtures were not separated in non-denaturing conditions, but separated in denaturing
conditions.

6. 4

Cleaved EGFP fragments remain association at the physiological conditions

Proteolytically cleaved EGFP fragments exhibited a strong tendency to interaction with each
other under the physiological conditions, based on several observations. First, the digested
sample mixtures without heating to maintain the native status and with heating in water bath to
convert them into denatured status were loaded on the same SDS-PAGE for verifying the
association capability of two fragments. The samples in the native status have only a single band
with green fluorescence while denatured samples have two bands with molecular masses of 20
kDa and 8 kDa on SDS-PAGE, as shown in Figure 6.3. The strong potential association of P20
and P8 fragments in non-denaturing conditions was confirmed. In addition, when purified under
native conditions, using either Sephadex 75 size exclusion column or Hitrap Q column with salt
gradient elution, the two major digested fragments with molecular masses of 20 and 8 kDa are
co-eluted and appear in SDS-PAGE. Therefore, it is more difficult to separate both fragments in
non-denaturing conditions although EGFP-T1 is cleaved at the insertion linker. Although they
have the strong potential to associate to the full EGFP, this is not a bad thing because we can
exploit this association capability to reconstitute EGFP for tracking protein-protein interactions
in living cells or determining protease activity through a specific signal peptide or linkers to
target the host proteins in specific compartments.
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Figure 6. 3. The verification for the assemble of two major fragments (P20 and P8) through
SDS-PAGE under denaturing and non-denaturing conditions.
M is the protein marker; Lane 1, 2, 3 and 4 are the samples of: uncleaved EGFP-T1 denatured by
adding SDS and heat boiling; mixture of cleaved products with denatured treatment from EGFPT1; mixture of cleaved products without denatured treatment from EGFP-T1, P20 fragment
separated through FPLC with denatured treatment. The mixture of cleaved products of EGFP-T1
without denatured treatment is shown in the associated band with green color in SDS-PAGE and
has similar molecular mass with uncleaved EGFP-T1. Bands with rectangular boxes are yellow
before Coomassie blue staining, and the band with the circular box is green before Coomassie
blue staining.
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6. 5 Cleavage site identification of EGFP-T1 trypsin digestion

In order to identify the cleavage sites through protein sequence analysis and mass
spectrometry, and to investigate the optical properties of two major fragments from EGFP-T1
digestion, high purity P20 and P8 solutions were obtained following separation by FPLC and
HPLC. These samples were used for amino acid sequence analysis. The molecular masses of the
two major fragments were 20842.06 Da for P20 and 7968.58 Da for P8, determined using
MALDI-MS. This result indicates that cleavage sites of EGFP-T1 by trypsin are specific, and the
two fragments generated by trypsin are stable under non-denaturing conditions although there are
33 potential trypsin cleavage sites in this protein. The N-terminal sequence of P20 is
MVSKGEELF based on the Edman degradation analysis. This result indicates that the His-tag
was removed by trypsin digestion, which is consistent with the result that P20 can not bind to the
Hitrap Nickel chelating column. Moreover, the intermediate product (31 kDa) during trypsin
digestion coincides with the removal of His-tag. This result is also consistent with previous
literature report that His-tag can be removed by proteases during storage (Battistutta, Negro et al.
2000). Amino acid sequence analysis of P8 reveals that the N-terminal is HVMTNL, which is
located at the inserted F-helix of EF-hand motif. The calculated molecular mass for the fragment
from HVMTNL in F-helix to the C-terminal is 7946.90 Da, which differs from the observed
molecular mass of 7968.58 Da by 21.68 Da. A possible reason for this difference is that P8 binds
an ion of Na+. The molecular mass from MVSK to the Arg at position –3 in the E-helix is
20844.68, which matches the observed molecular mass (20842.06 Da). However, the calculated
molecular mass from MVSK to Arg at position 2 of the F-helix is 22581.58 Da, which is also
consistent with the 23 kDa band on SDS-PAGE. All of these results are also consistent with
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three cleavage steps shown in SDS-PAGE (Figure 6.1A and 6.2A): a fragment of 31 kDa in the
first step, a fragment of 23 kDa in the second step and a fragment of 20 kDa in the third step are
listed by cleavage order in Figure 6.4. Taken together, EGFP-T1 was specifically cleaved by
trypsin and chymotrypsin at preferable sites and the cleavage process stopped after the preferable
sites were completely cleaved. Moreover, the cleaved protein solution still retained its original
green color, although EGFP-T1 was completely cleaved into two major fragments by trypsin and
chymotrypsin. The chromophore, TYG, is located in the P20 fragment. The identified cleavage
sites based on analysis of MALDI-MS, SDS-PAGE, and the N-terminal sequence of P20 and P8
are clearly shown in Figure 6.4 and Table 6.1.

Table 6. 1. The molecular mass of fragments during EGFP trypsin digestion
Sequence start point

Sequence end point

Observed Mass (Da)

Intact Protein

Calculated Mass (Da)

34451.80

MVSKGE

C-terminal

31 k (SDS-PAGE)

30520.46

MVSKGE

SAAELR

23 k (SDS-PAGE)

22581.58

HVMTNL

C-terminal

7968.58 (MALDI)

7946.90

MVSKGE

EEEIREAFR

20842.06 (MALDI)

20844.68
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Figure 6. 4. The structural model of EGFP-T1 with a protease cleavable linker.
The structural model of EGFP-T1 containing a protease-cleavable helix-loop-helix motif from
calmodulin, generated via Modeller and PyMol software, depicts the cleavable linker, in red,
grafted at position 172 in the loop region of EGFP. His-tag is shown in cyan. The ordinal
designations (1st, 2nd, 3rd) are based on trypsin cleavage kinetics experiments, described in the
text. Following exhaustive trypsin digestion, two major fragments (P20 and P8) result, shown in
green and yellow, respectively.
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6. 6 Cleavage site identification of EGFP-T1 chymotrypsin digestion

As shown in Figure 6.1, EGFP-T1 exhibited two major cleaved bands (called P20c and
P10c fragments) in SDS-PAGE following chymotrypsin digestion. In order to identify the
cleavage sites of EGFP-T1 by chymotrypsin, high purity solutions of P20c and P10c fragments
were successfully separated through combinative FPLC and HPLC. The samples of P20c and
P10c fragments were conducted the amino acid sequence analysis using Edman degradation and
molecular mass analysis using MALDI-MS. The molecular mass of large fragment was 20728.52
Da; the small fragment exhibited multiple peaks with molecular masses of 7604.96, 7480.63 and
6771.25 Da. In addition, the N-terminal sequence of P20c is MVSKGEELF based on the Edman
degradation analysis. Amino acid sequence analysis of P10c reveals that the N-terminal is
TNLDGS, which is also located at the inserted F-helix of EF-hand motif.
Based on the comprehensive analysis between mass spectroscopy and amino acid
sequence, the C-terminal of large fragment (P20c) should be EEEIREAF, which indicates the
chymotrypsin cleavage site is on the inserted E-helix of EGFP-T1 to obtain the large fragment
containing the chromophore of EGFP. The fragment of P10c shown in SDS-PAGE is consistent
with molecular mass of the fragment from RVFDKD to the C-terminal of EGFP-T1, which
exhibited a calculated molecular mass of 9839.99 Da. The N-terminal sequence analysis of the
small fragment purified by FPLC and HPLC is TNLDGS and the multiple peaks with molecular
masses of 7604.96, 7480.63, and 6771.25 Da were shown in the mass spectroscopy. Due to the
multiple cleavage sites in the inserted linker, the calculated molecular masses of the fragments
from TNLDGS to the C-terminal of EGFP-T1, GMDELY, and AAGITL are 7579.94, 7451.26,
and 6742.47 Da, which match to 7604.96, 7480.63 and 6771.25 Da in the results of MALDI-MS,
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respectively. The identified cleavage sites based on analysis of MALDI-MS, SDS-PAGE, and
the N-terminal sequence of P20c and P10c are clearly shown in Figure 6.5 and Table 6.2.

Table 6. 2. The molecular masses of fragments during EGFP-T1 chymotrypsin digestion
Sequence start point

Sequence end point

Observed Mass (Da)

Intact Protein

6. 7

Calculated Mass (Da)

34451.80

MVSKGE

EIREAF

20 k (SDS-PAGE)

20708.49

RVFDKD

C-terminal

10 k (SDS-PAGE)

9839.99

MVSKGE

EIREAF

20728.52 (MALDI)

20708.49

TNLDGS

C-terminal

7604.96 (MALDI)

7579.43

TNLDGS

GMDELY

7480.63 (MALDI)

7451.26

TNLDGS

AAGITL

6771.25 (MALDI)

6742.47

Optical properties of EGFP fragments

Figure 6.6A shows the absorption spectra of purified P20 fragment compared with
uncleaved EGFP-T1 and EGFP-wt. A predominant maximum absorbance for EGFP-wt at 488
nm was observed in Tris buffer (10 mM Tris, 1 mM DTT, pH 7.4), while the intact EGFP-T1
exhibited two absorbance maxima at 398 and 488 nm. Interestingly, purified P20 has a strong
blue shifted absorbance peak at 383 nm under identical Tris buffer conditions at pH 7.4, which is
similar to the maximum absorption of EGFP-wt at pH 3.36 (Figure 6.6A). The maximum
absorbance peak gradually shifts to 354 nm at a final pH of 10.8 with the addition of NaOH
(Figure 6.6B), suggesting that at physiological condition, the chromophore of P20 exists largely
in the neutral state (Brejc, Sixma et al. 1997; Tsien 1998).
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Figure 6. 5. The cleavage pattern of EGFP-T1 by chymotrypsin.
Based on the analysis of N-terminal amino acid sequence of P20c fragment and SDS-PAGE of
EGFP-T1 chymotrypsin digestion, the cleavage site was followed by the sequence of EIREAF to
obtain two major fragments with molecular masses of 20 and 10 kDa. According to the analysis
of N-terminal amino acid sequence of P10c fragment and MALDI-MS of EGFP-T1
chymotrypsin digestion, the possible cleavage sites are followed by sequence LHVM, or GITL
or DELY to obtain the observation of multiple peaks in MALDI-MS with molecular masses of
7604.96, 7480.63 and 6771.25 Da, respectively.
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Figure 6. 6. The characteristics of UV-visible spectra of the P20 fragment.
(A) The characteristics of UV-visible spectra of the P20 fragment (◆) was compared with those
of EGFP-wt ( ● ), EGFP-T1 ( ■ ) and acid-denatured EGFP-wt ( ◇ ) at pH 3.36. The P20
fragment has a maximum absorption peak similar to acid-denatured EGFP-wt at 383 nm, which
is different from the maximum absorption peaks of native EGFP-wt and EGFP-T1. (B) The
characteristics of UV-visible spectra of the P20 fragment at various pH conditions was also
measured. The maximum absorption of the P20 fragment at pH 7.32 (●) gradually shifted from
383 to 454 nm while the P20 fragment in the final pH 10.82 (△) due to the addition of NaOH.
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The purified and lyophilized P20 exhibits yellowish green color while P8 is colorless.
Under UV light, lyophilized P20 or P20 dissolved in water or 10 mM Tris buffer emitted a weak
green fluorescence (Figure 6.7A). The P20 fragment has maximum fluorescence excitation at
490 nm and a shoulder peak at 470 nm, and a fluorescence emission at 505 nm (Figure 6.7B and
6.7C). Both excitation and emission maxima are blue shifted compared with the uncleaved
EGFP-wt and EGFP-T1 with an emission maximum at 510 nm from a single excitation at 398
nm. On the other hand, uncleaved EGFP-T1 has an emission at 510 nm that originates from the
excitation at 398 and 488 nm. Hence, these results further reveal that P20 fragment contains a
mature chromophore in water or 10 mM Tris buffer in the absence of P8.
Several groups have attempted to identify short fragments that are required for
chromopohore formation in fluorescent proteins (Heim, Prasher et al. 1994; Dopf and Horiagon
1996; Reid and Flynn 1997; Wachter, King et al. 1997; Enoki, Saeki et al. 2004). Amino acid
residues 7-229 of GFP were shown to be essential for the fluorescence of the protein (Li, Zhang
et al. 1997; Kim and Kaang 1998). Recently, random deletion and substitution in the longest loop
of GFP demonstrated that only residues I129 and D130 in the loop can be deleted without
altering fluorescence efficiency, and that all other deletions or substitutions irreversibly reduce or
lose the fluorescence of GFP, which damaged the characteristics of the chromophore and
eliminated the fluorescence of GFP (Flores-Ramirez, Rivera et al. 2007).
Departing from previous reported studies on the determination of the minimum domain
for fluorescence by gradually deleting the residues at both termini and loop regions of GFP, we
have engineered protease cleavage sites at different loop locations (157 and 172) of the protein
frame to investigate the kinetic protease cleavage process and proteolytic effects on the optical
properties of chromophore formation. Although GFP was previously reported to be cleaved into

232

Figure 6. 7. The fluorescence characteristics of the P20 fragment.
(A) Fluorescence of P20 and P8 fragments was first examined under the UV lamp. Tube 1, 2, 3
and 4 are the samples of ddH2O, lyophilized P20, lyophilized P20 dissolved in Tris buffer (10
mM Tris, 1 mM DTT, pH 7.4), and lyophilized P8, respectively. The P20 fragment emitted weak
green fluorescence after lyophilization or when dissolved in Tris buffer. The excitation and
emission spectra of P20 fragment were compared with those of EGFP-wt and EGFP-T1 in Tris
buffer (10 mM Tris, 1 mM DTT, pH 7.4). Excitation spectra (B) and emission spectra (C) of
EGFP-wt (○), EGFP-T1 (□ ) and P20 (◇) were obtained, revealing that the P20 fragment has a
similar maximum excitation peak at 490 nm and a shoulder peak 470 nm. However, EGFP-T1
has maximum excitation peaks at 490 and 398 nm. The fluorescence maximum wavelength of
EGFP-wt and EGFP-T1 occurred at 508 nm, however, the maximum emission of the P20
fragment was slightly blue shifted to 505 nm. The fluorescence of P20 fragment was 100-fold
weaker than EGFP-T1.
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fragments upon adding several cleavage sequences (IEGRS) for pronase, factor Xa and trypsin
(Chiang, Okou et al. 2001), the effect on optical properties of GFP by proteolytic degradation
was not reported. Our strategy has shown that both trypsin and chymotrypsin are able to
specifically cleave EGFP variants into two major fragments (Figure 6.1A and 6.2A). The
MALDI-MS and amino acid sequencing results revealed that the grafting region selected is
sensitive to protease action, and the chromophore was found to be located in P20 fragment.
Another fragment, P18, was also obtained through the digestion of EGFP-T2 with cleavage
linker at position 157 of EGFP. Purified P18 and P20 fragments encompass amino acid
sequences 1-157 or 1-172, respectively. Despite the availability of more than 21 trypsin or 27
chymotrypsin cleavage sites in our EGFP variants, the two fragments produced in our cleavage
process remained stable for more than 90 days without the continuing degradation that was
observed in proteolytic cleavage of other globular proteins (Lee, Chen et al. 2002). The
proteolytically-cleaved EGFP fragments maintained strong fluorescence, which is likely a result
of their strong tendency to remain intact under physiological conditions. Such strong protease
stability and specific cleavage likely originated from the unique β-can structure. GFP was
reported to remain folded in 8 M Urea, in pH from 5 to 12, and to have strong tolerance for
several proteases (Ward and Bokman 1982). Therefore, the specific cleavage at the engineered
protease site in the loop of EGFP results in two strongly-interacting fragments, which maintain
protein tertiary structure and protect the chromophore environment.
Consistent with previous reports of short protease-derived peptide fragments containing a
chromophore (chromopeptides) (Shimomura 1979; Cody, Prasher et al. 1993), the optical
properties of P20 fragment were blue shifted from 397 to 383 nm and exhibited only weak
absorbance at 490 nm compared with EGFP-wt and EGFP-T1. The absorption wavelength of the
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P20 fragment is identical to that of EGFP-wt in acid denatured conditions (pH 3.36). In addition,
the absorbance intensity at 383 nm decreases with a simultaneous increase at 454 nm following a
gradual increase of pH (Figure 6.6B). Such pH-dependent optical properties indicate that the
chromophore in the P20 fragment exists mainly in the neutral state. Moreover, the absorption
spectrum of P20 fragment under neutral conditions is very similar to Niwa’s report that the
absorption peak of the fragment containing the chromophore is approximately 386 nm (Niwa,
Inouye et al. 1996).
The P20 fragment also has excitation peaks at 490 nm and a shoulder peak at 470 nm and
an emission peak at 505 nm. This excitation wavelength is slightly blue shifted when comparing
with EGFP-wt. Meanwhile, the fluorescence intensity is approximately 100-fold lower than that
of the intact EGFP-T1. These results indicate that the P20 fragment is able to emit green
fluorescence with weak intensity or low quantum yield, near 0.04. In contrast, Niwa also
reported that short peptides or fragments of GFP were not able to emit fluorescence under
physiological conditions in solution. The lysyl endopeptidase fragments have no fluorescence in
organic solvent or aqueous mixtures, and this fragment only produces fluorescence with low
intensity in ethanol glass at lower temperature, 77 K (Niwa, Inouye et al. 1996). Interestingly, the
absorbance and fluorescence properties of the isolated P20 and P18 fragments are very similar to
that of bacterially-expressed and refolded EGFP fragment (residue 1-158) with peak excitation at
488 nm and peak emission at 507 nm (Demidov, Dokholyan et al. 2006).

6. 8

Conclusions

The engineered EGFP-T1 can be specifically cleaved by trypsin and chymotrypsin at the
engineered region into two major fragments and can not be cleaved by thrombin. According to

235

N-terminal sequence and MALDI-MS analysis of P20 and P8, three cleavage locations are at the
end of the His-tag, the Arg at position –3 in the E-helix and the Arg at position 3 in the F-helix.
The P20 fragment, also named mini-GFP, contains 181 amino acids with a chromophore inside
and has a strong absorption spectrum of protonated form mimicking to that of EGFP-wt at pH
3.36. Although the P20 and P8 peptide segments remain the noncovalent association and still
maintain strong fluorescence after digestion, P20 can emit weak green fluorescence at 503 nm in
neutral Tris buffer in the absence of P8. Compared to previous research achievement that the
minimal domain of GFP for fluorescence is amino acid 7-229, our mini-GFP containing 181
amino acid residues was much shorter to exhibit fluorescence. This research provides a new
direction for tracking the protein-protein interactions by targeting to host protein with this small
domain and for the development of biosensors. However, whether the refolded structure in this
EGFP fragment is same as that of EGFP variants is still unknown and need to be further probed.
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Chapter 7

Investigation of protein-protein interactions using fluorescence
complementation of split EGFP fragments

7. 1

Introduction

During the separation of P20 and P8 fragments after EGFP-T1 digestion, both fragments
have the strong tendency to associate full EGFP in native conditions, which is confirmed in the
Chapter 6. Based on above results, we have the strong desire to confirm that this high potential
association capability is due to two alone fragments or highly requires inductions from other
functional proteins. We hypothesize this high potential association capability can be exploited to
reconstitute EGFP for tracking protein-protein interactions for tracking cellular events or
determining protease activity through a specific signal peptide or linkers to target the host
proteins in specific compartments.
Calcium ion is an important messenger in a variety of signaling pathways in biological
systems with association of specific calcium binding proteins. The common calcium binding
proteins have a calcium-binding motif termed EF-hand, possessing a characteristic helix-loophelix fold (Linse, Brodin et al. 1987; Heizmann and Hunziker 1991; Yang, Jones et al. 2003;
Yang and Yang 2005; Yang, Wilkins et al. 2005). Calbindin D9k is a common cytosolic
calcium-binding protein, which is important to regulate the availability of calcium ions within
cells (Luu, Nie et al. 2004). This protein exhibits the calcium buffering properties and is involved
in modulating calcium absorption and regulating the transient cytosolic calcium ion
concentration in a number of cells. Calbindin D9k consists of four helices and two EF-hands
joined together by a flexible linker region with high calcium binding affinity (Julenius, Thulin et
al. 1998; Julenius, Robblee et al. 2002). Figure 7.1 exhibits the model of calbindin D9k structure
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Figure 7. 1. The molecular model of calbindin D9k and interaction with calcium ions.
The molecular model of calbindin D9k exhibited its consistents of four helices to form two EFhand structures connected by flexible loops. Two calcium-binding pockets located inside offered
the high binding affinity to calcium ions (in blue color).
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and its binding to calcium ions. The binding of calcium ions by EF-hand proteins depends
strongly on the electrostatic interactions between calcium ions and negatively charged residues
of these proteins. The cooperative binding of calcium ions is an essential functional property of
the EF-hand family of calcium-binding proteins. Previous investigations indicated that isolated
calcium binding EF-hand peptides have a potential dimerization and the separated fragments
containing N-terminal EF-hand of calbindin D9k show the strong tendency to dimerize in the
presence of calcium (Linse and Chazin 1995; Kragelund, Jonsson et al. 1998; Julenius, Robblee
et al. 2002).
In this chapter, to further identify minimal fragment for fluorescence of fluorescent
proteins, we constructed a protease cleavage site in EGFP and identified two major EGFP
fragments upon trypsin cleavage first time. The fragment containing the chromophore, called
mini-EGFP or P20, still retains weak fluorescence, which is much shorter than previous report
that minimal domain for fluorescence of GFP is required amino acid residue from 7 to 229. Our
goal is to develop calcium-dependent protein sensor by fusing mini-EGFP fragment with EFhand motifs from calbindin D9k for real-time monitoring calcium dependent protein-protein
interactions in living cells. Our strategy is to fuse EF1 and EF2 of calbindin D9k to N- and Cterminal split EGFP fragments. The chromophore maturation and fluorescence complementation
of split EGFP fragments can be accomplished through the dimerization between EF1 and EF2 of
calbindin D9k with the aid of the trigger, calcium. The HeLa cells co-transfected with EGFP
fragments containing EF-hand motifs exhibited strong fluorescence emission during expression.
In addition, the fluorescence intensity is significantly increased after stimulation of ATP,
ionomycin and calcium. Therefore, this technology have the potential to use as a sensitive
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calcium sensor for tracking calcium signal pathways in living cells in real time and for tracking
the calcium signal pathways in subcellular compartments with the aid of signal peptides.

7. 2

Protein-protein interactions

It is well known that protein-protein interactions play crucial roles in the structural and
functional organization of living cells due to proteins associated with many important
physiological and pathological processes. Investigating these complex physiological and
pathological processes from protein-protein communication is very useful for understanding
some physiological processes, identifying the biochemical abnormalities in unhealthy states,
probing the pathological mechanisms and tracking the drug effect in diseased situations or in
treatment processes (Ozawa, Nogami et al. 2000). A large amount of modern biological research
is focused on how, when and where these protein-interaction associations preform regulations of
physiological and pathological mechanisms and processes. Currently, most of these research
tools are two-hybrid system (Fields and Song 1989; Chien, Bartel et al. 1991), split-ubiquitin
system (Johnsson and Varshavsky 1994; Stagljar, Korostensky et al. 1998; Dunnwald,
Varshavsky et al. 1999), staining with exogenous fluorophores or dyes (Sloan and Hellinga
1998; Doi, Takashima et al. 2002; Lata, Gavutis et al. 2006), fluorescence resonance energy
transfer (FRET) (Li, Ng et al. 2001; He, Olson et al. 2003), and so on. The two-hybrid method
facilitates the identification of potential protein-protein interactions and has been proposed as a
method for the generation of protein interaction maps. However, the two-hybrid technique is
limited to detect protein-protein interactions in the nucleus. The FRET assay, another common
method for investigating protein-protein interactions in living cells, is based on two fluorophores
(donor and acceptor), either chemically linked or genetically fused to two proteins whose
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interaction is to be examined. A high protein expression level for reliable determination of
energy transfer is required in the FRET analysis. In addition, the partial overlap between the
excitation wavelength of the donor and the emission wavelength of the acceptor is also required.
Moreover, the donor and acceptor should be placed within 100 Å in distance with right
orientation. Due to these limitations for detecting protein-protein interaction in living cells, a
novel, convenient and powerful method, fluorescence complementation of split green fluorescent
proteins is developed for detecting specific protein-protein interactions in lving cells. This
stragety is based on the reassembly of two fragments with weak fluorescence or without
fluorescence to result in fluorescence restoration driven by biomolecualr interactions.

7. 3

Current investigations of split GFP

The fluorescecence complementation between fragments of a fluorescent protein was first
discovered and detected in Escherichia coli through the fusion to the interacting peptides,
antiparallel leucine zippers (Ghosh I., Hamilton A.D. et al. 2000; Magliery, Wilson et al. 2005).
The fragments of yellow fluorescent protein (YFP) fused to calmodulin and the M13 calmodulinbinding peptide can produce fluorescent complexes in mammalian cells (Nagai, Sawano et al.
2001). A biomolecular fluorescence complementation assay was exploited and applied to
monitor the interactions between bZIP and Rel family transcription factors based on the
assembly of split YFP fragments. Later, a multicolor fluorescence complementation assay
between fragments of different fluorescent proteins was also created through the dimerization of
the bZIP domains of Fos and Jun to track the gene transcription location in living cells (Hu,
Chinenov et al. 2002; Hu and Kerppola 2003). The split GFP fragments genetically fused to the
N- and C-terminal of maltose binding protein (MBP) were employed to monitor the
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conformation change of MBP through the generation of fluorescence upon the maltose binding
(Jeong, Kim et al. 2006). The chromophore maturation of the split EGFP fragments and
fluorescence emitting can result from the N- and C-terminal halves of interin (VDE) without the
endonuclease domain for monitoring the protein-protein interactions and splicing activity
(Ozawa, Nogami et al. 2000; Ozawa, Takeuchi et al. 2001). The method for visualizing beta and
gamma dimers of G protein was also developed using the fluorescence complementation of split
GFP fragment to investigate the role of subcellular localization in regulating the specificity of G
protein beta-gamma signaling in vivo (Hynes, Tang et al. 2004). Although the history of studies
on fluorescence reconstitution from the split green fluorescent protein fragments was just several
years, to date, the fluorescence complementation of split green fluorescence protein fragments
can investigate protein-protein interactions in living cells for studying the protein folding and
conformation change, understanding the cellular processes and pathways, detecting protease
activity on cellular signaling, determining the gene expression levels and tracking the subcellular
transcription location. Therefore, this promising fluorescence technique will provide great
contributions to physiological and pathological research in the biomedical field.

7. 4

Strategy for calcium-dependent protein-protein interaction

EGFP-T1 can be cleaved by trypsin to obtain two major fragments at the insertion linker.
Both fragments are difficult to separate at the non-denaturing condition and have the potential to
assemble together although EGFP is cleaved by trypsin at the insertion linker. On the other hand,
the large fragment also revealed the optical properties, such as strong absorbance at 383 nm and
weak fluorescence with maximum emission at 505 nm after being separated. Therefore, we
hypothesize that the large fragment and the small fragment can be reconstituted under the
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dimerization of EF-hand motifs from calbindin D9k because the EF1 and EF2 of calbindin D9k
have strong capacity to dimerization due to swaping of EF-hands from the induction of an
extended hydrophobic core (Hakansson, Svensson et al. 2001). Therefore, the experiment was
conducted to fuse EF1 to the carboxyl end of the N-terminal fragment of EGFP and EF2 to the
amino end of the C-terminal fragment of EGFP to N-EGFP-EF1 and C-EGFP-EF2, respectively.
In order to improve the flexibility of EF-hands in both fragment, a linker (GGSGSGSS) was used
to connect the N-EGFP fragment and EF1, or C-EGFP fragment and EF2 (Figure 7.2).

7. 5

Fluorescence imaging of protein-protein interaction

It is interesting to note that the isolated EGFP fragment P20 has fluorescence in 100 fold
weaker than the both fragments obtained from EGFP-T1 following trypsin digestion under
associated status. This observation leads us to hypothesize that the newly generated EGFP
fragments could be applied to fragment complementation to develop sensors capable of
significantly enhanced fluorescence upon association. Since EF-hand motif 1 (EF1) and motif 2
(EF2) from calbindin D9k were reported to exhibit a strong tendency to dimerize (Linse, Brodin
et al. 1987; Linse and Chazin 1995), the capacity for reassembly of the EGFP fragments during
the dimerization of EF-hand motifs from calbindin D9k could be examined. To test this
reassembly capacity, we fused EF1 and EF2 from calbindin D9k to the carboxyl end of the Nterminal fragment of EGFP and the amino end of the C-terminal fragment of EGFP, denoted as
N-EGFP-EF1 and C-EGFP-EF2, respectively. In order to improve the flexibility of EF-hands in
both fragments, a linker (GGSGSGSS) was used to connect the N-EGFP fragment and EF1, or
C-EGFP fragment and EF2, respectively. Meanwhile, in order to further verify the origin of GFP
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Figure 7. 2. The design for calcium-dependent protein-protein interactions.
The design for calcium-dependent protein-protein interaction is diagrammed, based on EGFP
fragments fused to EF-hand motifs of calbindin D9k. C-terminus of N-EGFP fragment is
connected to EF-hand motif 1 (EF1) following Glu172 and EF-hand motif 2 (EF2) is connected
to N-terminus of C-EGFP fragment before Asp173 with an extended GGSGSGGS linker. NEGFP-EF1p and N-EGFP-EF2p, with truncated flanking helices, were also constructed similarly
to explore the minimal requisites for the expected association. Helix-loop-helix structures (EF1
and EF2 from calbindin D9k) are highlighted in blue, red and blue, respectively. The partial EFhand motifs are highlighted in purple. GGSGSGGS linker is shown in black. The connection
sites of Glu172 in the C-terminus of N-EGFP fragment and Asp173 in the N-terminus of CEGFP fragments are highlighted in green and cyan color, respectively. Fluorescence
complementation is postulated to result from the reconstitution of both EGFP fragments guided
by the calcium-dependent dimerization of EF1 and EF2.
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assembly due to dimerization in living cells, N-EGFP-EF1p and N-EGFP-EF2p with incomplete
flanking helices were also designed and created.
In order to track fluorescence complementation of EGFP fragments, N-EGFP-EF1 and CEGFP-EF2 were co-transfected into HeLa cells according to above methods (Materials and

Methods) to allow protein expression for 24-48 h. Fluorescence imaging was acquired using an
epifluorescence microscope with excitation at 398 and 488 nm for 50 ms exposure time. HeLa
cells with co-transfection of both EGFP fragments revealed strong fluorescence (Figure 7.3A). In
contrast, no significant fluorescence was acquired through 488 nm excitation even under 1000
ms exposure time with co-transfection of N-EGFP-EF1p and C-EGFP-EF2p (Figure 7.3B) or
individual transfection of N-EGFP-EF1p in HeLa cells (Figure 7.3C). These results clearly
indicated that although N-EGFP-EF1 encompasses the entire chromophore sequence, it can not
fully fold to form the mature chromophore necessary for emitting strong fluorescence. Moreover,
co-transfection of two fragments, N-EGFP-EF1p and C-EGFP-EF2p with an incomplete EFhand motif, also fails to produce fluorescence complementation due to inability of dimerization
from incomplete EF-hand motifs. Taken together, fluorescence complementation or
chromophore maturation was achieved by fusion of two identified EGFP fragments to intact EFhand motifs (EF1 and EF2) from calbindin D9k with strong dimerization capacity.

7. 6

Calcium effect on protein-protein interaction

In order to test the effects of calcium on fluorescence complementation of EGFP
fragments in living cells, fluorescence of HeLa cells with co-transfection of EGFP fragments was
acquired using epifluorescence microscope in a course model. The fluorescence signal change
was analyzed following the addition of calcium triggers and calcium in living cells. As shown in
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Figure 7.4, the fluorescence signal shows a 20% increase in response to stimulation with 1 μM
ionomycin, a calcium channel trigger whose function stimulates opening of the calcium channel
on the cell membrane, which increases the intracellular calcium concentration due to flux of
extracellular calcium. Following the stimulation with ionomycin, fluorescence signal exhibits
another 10% increase with the addition of 5 mM calcium. Therefore, the fluorescence
complementation of EGFP fragments fused to EF-hand motifs from calbindin D9k can be
moderated by the change in Ca2+ concentration, which is possibly due to an indirect adjustment
of reassembly of split EGFP fragments through the calcium-mediated dimerization of EF-hand
motifs from calbindin D9k (Linse, Brodin et al. 1987).
In order to further confirm calcium effect on fluorescence complementation of EGFP
fragments originated from the dimerization of EF-hand motifs, the HeLa cells with cotransfection of N-EGFP-EF1 and C-EGFP-EF2 was harvested after expression for 72 hours. The
proteins were extracted from cell lysates through sonication. The supernatant containing proteins
was collected after centrifuging at 14000 rpm for 10 minutes. 200 μl of supernatant was diluted
to 1 ml in 1.7 ml fluorescence cuvette with a pathway of 1 cm. Fluorescence spectra were
scanned from 600 to 500 nm with excitation at 490 nm. The maximum emission at 508 nm has
slight decrease with the various concentrations of EGTA. The decrease in fluorescence intensity
at 508 nm is maximal at the 0.5 mM of final concentration of EGTA, which is approximately 5%
decrease total, as shown in Figure 7.5. This result suggests that fluorescence reconstitution of
EGFP fragments is induced by the dimerization of EF-hands of calbindin D9k upon calcium
condition. However, the fluorescence complementation is irreversible due to the chromophore
formation although the fluorescence intensity has the minor decrease.
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Figure 7. 3. The fluorescence complementation of split EGFP fragments fused to EF-hand
motifs was confirmed in living cells via co-transfection.
The strong fluorescence complementation in HeLa cells through (A) the co-transfection of NEGFP-EF1 and C-EGFP-EF2 under excitation of 488 nm proceeded via the dimerization of EFhand motifs and was monitored by fluorescence microscopy with 50 ms exposure time. The
weak fluorescence in HeLa cells with (B) individual transfection of N-EGFP-EF1, and (C) cotransfection of N-EGFP-EF1p and C-EGFP-EF2p at excitation of 488 nm with 1000 ms
exposure time.
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Figure 7. 4. The effects of calcium on fluorescence complementation of EGFP fragments in
living cells.
The change in fluorescence signal from HeLa cells upon co-transfection with the genes for NEGFP-EF1 and C-EGFP-EF2 followed by promotion of calcium influx by ionomycin, and with
extracellular addition of calcium. The fluorescence signal is increased by about 20% with
addition of 1 μM ionomycin and another 10% with the addition of 5 mM calcium.
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Figure 7. 5. Fluorescence signal change in extract of HeLa cells with co-transfection of NEGFP-EF1 and C-EGFP-EF2 through EGTA titration.
The fluorescence emission signal at 508 nm of the extract of HeLa cells with co-transfection of
both fragments exhibited a decrease by 5% with the addition of EGTA up to 0.5 mM while
excited at 490 nm. The smaller fluorescence signal change is possibly due to the irreversible
dimerization of EF-hand motifs from calbindin D9k.
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7. 7

Optical properties of N-EGFP-EF1 and C-EGFP-EF2 expressed in bacteria

In order to examine the optical properties of two EGFP fragments fused to EF-hand
motifs and calcium-dependent protein-protein interactions in buffer conditions, both EGFP
fragments were expressed in E. coli and purified to evaluate the optical properties in vitro. Due
to both EGFP fragments expressed in inclusion body, the purification of both fragments was
conducted under the urea-denatured conditions to unfold the proteins and then refold back. The
refolded protein fragments was separated using Nickel chelating affinity column according to
above-stated methods. The purified proteins are evaluated and confirmed through MALDI-MS
examination. The fragment of N-EGFP-EF1 exhibited fluorescent spectra with maximum
excitation peak at 403 nm (Figure 7.6A) and maximum excitation peak at 468 nm (Figure 7.6B),
which further verified EGFP fragment containing chromophore could emit fluorescence,
although it only retained 172 amino acid residues (1-172) of original EGFP. This maximum
excitation and emission wavelengths is close to previous reports that large split intein-EGFP
fragment expressed in E. coli (DE3) pLys and purified with intein column exhibited maximum
excitation spectrum at 360 nm and emission spectrum at 460 nm (Demidov, Dokholyan et al.
2006). However, the maximum excitation and emission peaks of N-EGFP-EF1 from bacterial
expression are blue shifted when compared to the spectra of P20 fragments from separation of
EGFP-T1 digestion. These results clearly demonstrated that the chromophore could fold and
mature in smaller EGFP fragment with amino acid residues (1-172). Additionally, the
chromophore folding, formation and maturation is highly affected by its environment because
the matured chromophore of P20 fragment is directly come from fully folded EGFP-T1, while
the chromophore folding in N-EGFP-EF1 fragment is weak possibly due to shorter sequence.
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Figure 7. 6. Fluorescence spectra of purified N-EGFP-EF1 fragment from E. coli expression.
The maximum excitation wavelength (A) and emission wavelength (B) of 10 μM N-EGFP-EF1
was observed at 403 and 468 nm in Tris-HCl buffer (10 mM Tris, 1 mM DTT, pH 7.4),
respectively.
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In order to test the calcium effect on the fluorescence signal enhancement due to
calcium-dependent heterodimerization of EF-hand motifs from calbindin D9k, we have
conducted the calcium titration in the mixture of purified N-EGFP-EF1 and C-EGFP-EF2
fragments. The purified N-EGFP-EF1 and C-EGFP-EF2 fragments buffered in Tris-HCl buffer
(10 mM Tris, 100 mM NaCl, 1 mM DTT, pH 7.4) were mixed according to the ratio of 1:1.
When the fluorescence signal at 468 nm of mixture of purified N-EGFP-EF1 and C-EGFP-EF2
fragments was compared to the individual N-EGFP-EF1 fragment, the fluorescence signal
doesn’t have any difference under the both conditions, which confirms the fluorescence signal of
N-EGFP-EF1 fragment containing chromophore doesn’t affected by the small fragment, CEGFP-EF2 under the calcium-free buffer condition. However, a stepwise increase of the
fluorescence signal at 468 nm was observed when calcium titration in the mixture of both
fragments was conducted up to calcium concentration of 4 mM (Figure 7.7) and exhibited 20%
enhancement through the calcium titration (Figure 7.8). This result gave a clear explanation that
fluorescence signal change is calcium-dependent and the enhancement of fluorescence
complementation from EGFP fragments can be resulted from heterodimerization of EF1 and EF2
motifs under the calcium induction.

7. 8

EF-hand dimerization and EGFP fragment complementation

Fluorescence complementation of split green fluorescent proteins was developed for
detecting specific protein-protein interactions in living cells. This strategy is based on the
reassembly of two fragments with weak fluorescence or without fluorescence, to result in
fluorescence restoration driven by biomolecular interactions. This method is promising since
protein-protein interaction in living cells can be directly visualized. This method is promising

252

Figure 7. 7. Fluorescence signal change of purified N-EGFP-EF1 and C-EGFP-EF2 upon
calcium action.
Both EGFP fragments with concentration of 15 μM were incubated in protein refold buffer (20
mM Tris, 100 mM NaCl, 1 mM DTT, pH 7.4) and then calcium titration was conducted in the
mixture of both EGFP fragments. Fluorescence emission signal of the incubation mixture with
both EGFP fragments at 468 nm gradually increases with the addition of calcium ions when
excited at 403 nm. Precipitation was observed when calcium concentration reached to 4 mM.
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Figure 7. 8. Relative fluorescence emission change of purified N-EGFP-EF1 and C-EGFP-EF2
during calcium titration.
During calcium titration, fluorescence emission signal of the incubation mixture with both EGFP
fragments at 468 nm gradually increases when excited at 403 nm. The fluorescence
complementation enhancement of N-EGFP-EF1 and EGFP-EF2 fragments was observed and
exhibited nearly 20% increase up to 4 mM calcium.
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since protein-protein interactions in living cells can be directly visualized. Currently, fluorescent
complementation of split GFP fragments was achieved via various types of molecular
recognitions. Antiparallel leucine zippers were added to NGFP and CGFP fragments containing
1-157 and 158-238 amino acid residues without green fluorescence to rebuild a new fluorescent
protein with a matured chromophore to understand mechanism of protein assembly (Ghosh,
Hamilton et al. 2000; Wilson, Magliery et al. 2004; Magliery, Wilson et al. 2005). NGFP and
CGFP fragments connected to maltose binding protein (MBP) were used to monitor the
conformation change through fluorescence complementation assay upon maltose binding (Jeong,
Kim et al. 2006). Moreover, protein splicing-based reconstitution of split GFP fragments has
been applied to monitor protein-protein interactions in bacteria and in vivo (Ozawa, Nogami et
al. 2000; Ozawa, Takeuchi et al. 2001; Cabantous, Terwilliger et al. 2005), screen proteins
expressed at different cellular environment, improve protein folding and solubility (Wilson,
Magliery et al. 2004; Cabantous, Terwilliger et al. 2005; Cabantous and Waldo 2006), and
simultaneously visualize interactive biochemical processes (Prasher, Eckenrode et al. 1992;
Chalfie, Tu et al. 1994; Heim, Prasher et al. 1994; Marshall, Molloy et al. 1995; Tsien 1998;
Pollok and Heim 1999; Hu, Chinenov et al. 2002; Hu and Kerppola 2003). Furthermore, DNA
hybrization was also used to facilitate fluorescent complementation (Demidov, Dokholyan et al.
2006) and coiled-coiled interaction was recently used to monitor metal-dependent GFP emission
(Mizuno, Murao et al. 2007).
Our strategy has shown that the fluorescence complementation of split EGFP fragment
can be accomplished by fragment complementation based on the calcium-dependent
heterodimerization of EF-hand motifs from calbindin D9k and the identified split EGFP
fragments. EF-hand calcium binding proteins with a helix-loop-helix calcium-binding motif
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represent one of the major types of calcium binding proteins that have been found in all
organisms, ranking as the 5th most common binding motif found in eukaryotic genomes. Based
on sequence prediction, there are more than 3000 calcium-binding proteins in eukaryote and 500
in prokaryocyte (Zhou, Yang et al. 2006). Upon stimulation by first massager, agonist, such as
ATP, intercellular calcium concentration increases significantly. Trigger proteins with paired EFhand motifs, such as calmodulin and troponin C, regulate more than 100 biological processes in
response to calcium binding. Other binding proteins with EF-hand motifs, such as calbindin D9k
and pavalbumin, function as buffers to maintain calcium ion concentration. EF-hand motifs in
proteins are normally paired and coupled to form a compact domain. For example, the smaller
unit with paired two EF-hand motifs exists in calbindin D9k. Such coupled EF-hand motif
interactions contribute greatly to the cooperativity of calcium binding which is essential for
calcium-controlled activities to switch on/off over a narrow range of free calcium concentration.
Isolated EF-hand motifs have a strong tendency of dimerization. EF-hand motif III from skeletal
troponin C has been shown to dimerized in the presence of calcium (Delbaere, Vandonselaar et
al. 1989; Shaw, Hodges et al. 1990; Shaw, Hodges et al. 1991). The other EF-motifs such as
rabbit skeletal troponin C, the C-terminal EF-hand from E6-binding protein (E6bp4), third EFhand motifs from silver hake parvalbumin and N-terminal EF-hand from human S100B protein
were shown to form dimers (Kay, Forman-Kay et al. 1991; Revett, King et al. 1997; Chen, Hong
et al. 1998). Using fragment complementation, Linse’s group also showed that the EF-hand motif
1 (residues 1-43) from calbindin D9k has strong dimerization affinity with EF-hand motif 2
(residues 44-75) (3.6 × 1011 M-1) (Berggard, Julenius et al. 2001) in the presence of calcium.
Such heterodimerization constant in the presence of calcium is more than six orders of
magnitude greater than the association constant for formation of homodimers (Julenius, Robblee
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et al. 2002). About 11 hydrophobic core residues are responsible for their dimerization and the
stability of the intact domain, which is the calcium-dependent protein-protein interaction. Figure
7.3 clearly shows that HeLa cells with the co-transfection of the split EGFP fragments fused with
EF-hand motifs of calbindin D9k (N-EGFP-EF1 and C-EGFP-EF2) exhibit strong fluorescence
signal, suggesting the chromophore maturation or florescence complementation is achieved. In
contrast, no fluorescence was observed in HeLa cells transfected with a single fragment of NEGFP-EF1, or co-transfection with N-EGFP-EF1p and C-EGFP-EF2p with incomplete EF-hand
motifs. We further demonstrated that an increase of intraceullar calcium concentration after
stimulation with ionomycin results in a significant increase of fluorescence. Giving the diverse
role of EF-hand proteins in signal transduction, calcium homeostasis and the strong dimerization
of isolated EF-hand motifs, this reported technology can be further developed to simultaneously
sense calcium concentration change and calcium-dependent protein-protein interactions in living
cells in real time.

7. 9

Conclusions

Through connecting the EF hand motifs of calbindin D9k on split enhanced green
fluorescent protein fragments, a novel fluorescence complementation method was developed to
monitor the calcium ion contractions in living cells in real time due to the dimerization of EF
hand motifs of calbindin D9k upon effect from calcium ions. Due to the significant increase in
fluorescence intensity after the stimulation with ionomycin and calcium, this technology can be
used for a sensitive calcium sensor to track calcium signal pathways in living cells in real time.
On the other hand, this technology can be used for tracking the calcium signal pathways in
subcellular compartments with the aid of signal peptides.
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Chapter 8

Conclusion and significance

Based on our previous work on the development of calcium sensor (Zou et al, 2007) and
the change in optical properties of protease sensor variants with a grafting cleavage linker at
different loop regions in EGFP following protease digestion, the sensitive position immediately
following Glu172 of EGFP is identified to be a suitable grafting site for the design of protease
sensor and the optical signal of designed protease sensors exhibits the ratiometric change upon
protease action. A variety of specific cleavage linkers for trypsin, caspase-3, caspase-8 and
thrombin were inserted into the identified chromophore-sensitive location to obtain various
trypsin, caspase-3, caspase-8 and thrombin sensors. The cleavage linkers flanking sequences that
have highly helical property result in a large optical signal change in chromophore environment,
which in turn exhibits the significant ratiometric optical signal change upon protease cleavage.
From the screening and analyses of optimal cleavage linker for specific proteases, the cleavage
linker flanked both E-helix and F-helix significantly improve the flexibility of cleavage linker
and accessibility for proteases, which provides the largest ratiometric optical signal change for
developed protease sensors. This ratiometric measurement strategy has been successfully
exploited to real-time track trypsin, caspase-3 and caspase-8 activation and inhibition in living
cells, which eliminates drawbacks or limitations of the currently-available methods to determine
protease activity. The substrate kinetic properties, especially Km, of these developed proteinbased protease sensors, are comparable or better than the current commercially-available
protease substrates conjugated to chromogenic or fluorigenic dyes. Then, enzymatic specificity
of these developed protein-based sensors is usually better than those commercially-avaiable
substrates. We have successfully applied the developed EGFP-based protease sensors to monitor

258

activation of trypsin, caspase-3 and caspase-8 by different inducers at least two cell lines (HeLa
and MIA PaCa-2). These developed protease sensors also have potential to target different
subcellular compartments such as ER and mitochondria for tracking protease activation or
inhibiton in the different subcellular environments with the aid of signal peptides. Moreover,
trypsinogen activation in pancreatic cancer cells, MIA PaCa-2 cells is the first time observed
using our trypsin sensor although this cell line lack of granule structure. The activation of
caspase-3 thorugh STS induction can be observed a clear translocation from cytosol to nuclei
using our caspase-3 sensors and our developed casapse-3 sensors can provide a sensitive
detection of caspase-3 activation at low concentration level during the early stage of apoptosis,
which is difficult to realize using commercially-available caspase-3 probes such as NucView488
caspase-3 substrate, due to its low sensitivity or indirect detection of caspase-3 activity. In
addition, our protease sensors can real-time monitor trypsin or caspase-3 inhibition in living
cells. Therefore, A grafting approach to engineer a specific cleavage linker for proteases into a
stable scaffold host protein, EGFP, to determine the protease activity, and to investigate protease
activation or inhibition pathways in living cells has been successfully established, which opens
an avenue for tracking protease-dependent physiological and pathological mechanisms or
processes, and provides a novel and effective method for the investigation on mechanisms, new
drug development or screening for diseases related to protease activity.
The digested mixture of protease sensors still retains strong fluorescence although they
are fully cleaved the designed cleavage site to two major fragments. The separation of both
major fragments and identification of cleavage sites or pattern indicate the chromophore is
maintained in the large fragment (amino acid residue, 1-172) for its weak fluorescence, which
exhibits that the mini-domain for fluorescence of EGFP is much less shorter than that of
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currently reported investigations. Meanwhile, both cleaved EGFP fragments have high tendency
to associate for emitting strong fluorescence under the physiological conditions. Due to the
strong heterodimerization capability of EF-hand motif (EF1 and EF2) from calbindin D9k under
the induction of calcium, EF1 and EF2 are fused to the C-terminal of N-EGFP fragment (residue
1-172) and the N-terminal C-EGFP fragment (residue 173-238), respectively. The constructed NEGFP-EF1 and C-EGFP-EF1 could be used for monitoring calcium-dependent protein-protein
interaction in living cells. The fluorescence enhancement through the co-transfection of both NEGFP-EF1 and C-EGFP-EF1 can be applied to track the change in calcium concentration or
calcium signaling pathways, and to simultaneously monitor protein-protein interactions in living
cells in real time.
The significance of these works is multi-fold. First, the creative thoughts of designing
protease sensors in a single EGFP will provide extensive investigation and knowledge on the key
factors of protease activation and inhibition in living organisms for understanding the
mechanisms and pathways of many diseases related to protease activity. Additionally, this
strategy may be further extended to the application of other important proteases. Second,
application of our design approach to the development of protease sensors, without the use of
FRET pairs, results in correlative ratiometric measurements, which eliminates many drawbacks
and limitations of the currently-available FRET-based protease sensors or protease substrates
conjugated with small peptide dyes. In addition, the design of sensitive protease sensors in a
single EGFP offers a quick enzymatic response at lower protease concentration with pico
molarity level in living cells, especially for caspases, to determine the early stage of caspase
activation or apoptosis, which is more difficult to accomplish using FRET-based GFP pairs
protease sensors. Also, the designed protease sensors can be targeted to different subcellular
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compartments in living cells such as mitochondria or ER, which are the essential subcellular
locations for probing enzymogen activation pathways with the aid of signal peptides.
Although our developed protease sensors exhibit multiple advantages in the detection of
protease activation or inhibition in living system, there are also several limitations that need to be
further addressed for the application in living cells or in vivo. First, trypsin sensors need to be
conducted studies in more cell lines, such as Panc-1, Capan-1, Capan-2, CFPAC-1 and BxPC-3
cell lines. Second, as for caspase-3 and caspase-8 sensors, the reverse optical signal change
between in living cells and in vitro needs to be further investigated. More control or confirmation
experiments such as Western blot need to be further conducted. Third, protease concentration
needs to be further quantitatively normalized in single individual cell to understand protease
activation or inhibition mechanisms, rather than the normalization of population-dependent
protease concentration in a large amount of cells. Fourth, further structural analysis for
chromophore change of our developed protease sensor upon cleavage needs to be identified
using NMR or X-ray.
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